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Abstract 
Cdc37 is a molecular chaperone that consists of three domains. The N-terminal 
domain is involved in client protein binding and contains conserved serine residues 
that are important for function and are phosphorylated by casein kinase II. The middle 
domain contains the Hsp90-binding and homodimerisation regions. The C-terminal 
domain is at present of unknown function. The Schizosaccharomyces pombe cdc37 
gene has been identified and was found to be essential for cell viability. To further 
study S. pombe Cdc37, a range of mutants were generated using both random and 
directed mutagenesis. Temperature-sensitive, truncation, 5 amino acid insertion and 
point mutation mutants of cdc37 were created and characterised to gain a better 
understanding of this chaperone in S. pombe. 
Expression of only the N-terminal domain of S. pombe Cdc37, lacking the postulated• 
Hsp90-binding and homodimerisation regions, can sustain cell viability in a cdc37z\ 
strain, indicating that the middle and C-terminal domains are dispensable for the 
essential function of Cdc37. The N-terminal domain is the most conserved region of 
Cdc37 across species and contains highly conserved serine residues known to be 
phosphorylated in other organisms. Mutational analysis of these conserved serine 
residues in S. pombe Cdc37 identified serine 14 as important for function. 
To study the effect of rapid loss of Cdc37 function three temperature-sensitive 
mutants were generated by random and directed mutagenesis and a fourth was a kind 
gift from the Shiozaki lab and was analysed in parallel. Cdc37 temperature-sensitive 
mutant cells at the restrictive temperature stop dividing within a single cell cycle. 
Cdc37 protein levels were not changed at the non-permissive temperature in mutants, 
indicating that cell inviability arises from defective function of the mutant Cdc37 
protein. Morphologically, temperature-sensitive mutant cells arrest with a uniform 
phenotype, being elongated, characteristic of the cdc phenotype. About 80% of these 
elongated cells contained a single nucleus with a 2C DNA content, indicating that 
cdc37 temperature-sensitive mutants arrest in G2. The only exception was cdc374, 
where half the cells leaked through to mitosis after 8 hours at the restrictive 
temperature and displayed divided nuclei and septa, arresting with defects in 
cytokinesis. Characterisation of cdc37 temperature-sensitive mutants led to the 
identification of Cdc2 as a client protein and a principal candidate for the cause of the 
G2 cell cycle arrest. Cdc2 activity was dramatically reduced within one hour at the 
non-permissive temperature in cdc37 temperature-sensitive mutants, but Cdc2 protein 
levels remained constant. Biochemical and genetic interactions between Cdc37 and 
Cdc2 were observed, supporting the idea of Cdc2 as a client of Cdc37. 
Cdc37 is believed to deliver client protein kinases to the co-chaperone Hsp90, 
forming a heterocmp1ex. A small fraction of total cellular Cdc37 in S. pombe forms a 
high molecular weight complex which also contains Hsp90. Cdc37 was found to 
biochemically and genetically interact with Hsp90, indicating that these co-






1.0 	Molecular chaperones 
1.1 	Introduction 
Cells are the basic units of life, containing a wide variety of different types of 
proteins, each carrying out specific functions. Proteins are elegantly regulated by a 
variety of pathways essential for cell viability and division. The creation of a protein 
begins with gene expression, transcribing the encoding gene from chromosomal 
DNA. This ultimately produces an RNA template of the chromosomal DNA 
sequence, called an mRNA. The mRNA template is then translated by ribosomal 
complexes, generating a linear nascent polypeptide chain composed of a specific 
sequence of amino acids, called the primary structure. The amino acid sequence of the 
linear polypeptide determines its final three-dimensional structure, the native state, 
which is imperative for achieving proper function of the protein (Dobson, 2004). 
Upon translation, the nascent polypeptide chains in their primary structure enter a new 
regulatory pathway run by molecular chaperone proteins in both prokaryotic and 
eukaryotic systems. These molecular chaperone proteins are defined as 'proteins that 
help in the folding of other proteins, typically through cycles of binding and release, 
but do not form part of the final native structure' (Young et al., 2004). The proteins on 
which molecular chaperones act are referred to as 'client proteins'. Molecular 
chaperones represent a highly specialised network of proteins, each with specific roles 
and interactions with client proteins and co-chaperones to ensure efficient protein 
quality control within the cell. A list of the different types of molecular chaperone 
proteins described in this Chapter is given in Table 1.1. The "quality control" 
mechanisms carried out by molecular chaperone proteins (summarised schematically 
in Figure 1. 1), include client folding, maintaining client proteins in an activation 
competent state, targeting clients for degradation, client translocation, client complex 
assembly with partner proteins and refolding misfolded client polypeptides. These 
chaperone activities towards client proteins are crucial to the cell under normal 
growth conditions for regulation of biological activity both spatially and temporally. 
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Table 1.1: A table of molecular chaperone proteins and the names given to 
homologues from different organisms. 





Hsp 100 - - - C1pA 
SKD3 Hsp104 Hsp104 (AN: 








Grp94 (ER) - - - 
Trap75 
(mitochondrial)  
- - - 
Hsp70 Hsp70 protein 
8 isoform 1 
variant (Hsp70 
(P8I1V))  
Ssal AN: NP593704 - 
Hsp70 (P8I1V) Ssa2 AN: NP593704 - 
Hsp70 (P8I1V) Ssa3 AN: NP593704 - 
Hsp70 (P8I1V) Ssa4 AN: NP593704 - 
Hsp70 (P8I1V) Ssbl AN: 
BAA12279  
- 
Hsp70 (P81 IV) Ssb2 AN: 
BAA12279  
- 
Hsp709B Sscl AN:NP593459 - 
Hsp709B Ssc3 AN:NP593459 - 
AN: CAI 12428 Ssel AN: 





 NP001018245  
- 
Hsp70 9B Ssgl  





Kar2 AN: NB593245 - 
Grp75 
(mitochondrial)  





Hsp 60 Chaperonin 
(mitochondrial)  
- - GroEL 
- - 
- SecB 
Hsp40 DnajBl Sisi - DnaJ 
Hdjl Ydji AN:NP596309 - 
Dna] A2 Apjl AN: NP595426 - 
HsplO HsplO HsplO 
(mitochondrial)  
- GroES 
Other Cdc37  P50 Cdc37 Cdc37 - 
chaperones Immunophillin Cyp40 
Cyclophilin_D  
Cpr6 - - 
Cyclophilin D Cpr7 - - 
FKBP52 - - - 
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Table 1.1 continued: 
Function Group  Mammalian S. cerevisiae S. pombe E. ccli 
Regulate co- p23 p23 Sbai AN: NP594586 - 
chaperones  
Chaperones Trigger Factor Mpl 1 Ssb-Ssz-Zuo ribosome Trigger 
that bind assembly factor 
translating chaperone 
polypeptides (RAC) 
Scaffold Hop  Hop Stil AN: NP588 123 - 
chaperones Hip  Hip - - - 
Chaperones Bag-1  Bag-i - - - 
involved in CHIP CHIP - - - 
degradation  
ER 	endoplasmic reticulum 
no orthologue 
AN 	accession number 
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Figure 1.1: An overview of some of the roles of molecular chaperone proteins within 
the cell. A Chaperones can themselves be active in folding/activating the client, B or 
deliver the client to a co-chaperone that carries out these processes. C Chaperones can 
promote the association of the client and a partner protein or D translocate the client 
to a different cellular region or organelle so it can be folded/activated by other 
proteins. E Chaperones can also hold the client in an activation competent state so 
that it can be activated and/or folded by a co-chaperone, preventing the client nascent 
polypeptides from forming insoluble aggregates. 
The chaperone folds 
and/or activates the 
client protein 
B 	The chaperone L * delivers the client to a co-chaperone for 
folding/activating 
C 	The chaperone 
promotes the 
association of the 
client with another 
protein 
t*t 
D 	The chaperone 
translocates the client to 	 Translocation 
a sub-cellular 
compartment where it 
can be folded/activated 
E 
Chaperone holds the 
client in an activation IL4 I' competent state  preventing it from  
forming insoluble Aggregate into Degradation aggregates insoluble 
complexes 
~~4 T 0 0 0 
Nascent Client in Chaperone Co-chaperone Client 
polypeptide native. 3D partner 
conformation protein 
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Molecular chaperones also play an important role in cell stress responses stimulated 
by a number of factors including heat and osmotic stress. In response to heat stress in 
Drosophila, the production of a group of molecular chaperone proteins called the heat 
shock proteins (Hsps) dramatically increased (Ish-Horowicz et al., 1979). The 
elevated expression of molecular chaperones such as Hsps protects the cell under 
stress conditions by maintaining cellular protein levels and preventing client protein 
inactivation and aggregation into insoluble complexes. GroEL is an Hsp protein in E. 
coli that protects the client RNA polymerase holoenzyme from heat inactivation 
(Ziemienowicz et al., 1993). In addition, if this client is already inactivated by heat 
stress, then in the presence of ATP, GroEL can reactivate the client returning it to its 
native, biologically functional state (Ziemienowicz et al., 1993). Molecular 
chaperones also protect clients from being unfolded, but those proteins that are 
denatured are bound by other chaperones such as small heat shock proteins (e.g. 
Hsp30), inhibiting their accumulation into insoluble aggregates and maintaining them 
in a folding-competent state for other chaperones to fold and/or activate (Heikkila, 
2004). 
1.1.1 	Chaperone-chaperone interactions 
Molecular chaperone proteins interact with each other in a highly organised network 
to maintain effective protein quality control within cells. Associations between 
molecular chaperones are highly specific; for example in S. cerevisiae Hsp40 
chaperones Sisi and Ydj 1 interact with the Hsp70 co-chaperone Ssal but not Ssb1/2, 
also an Hsp70 chaperone (Lu and Cyr, 1998). Chaperones such as Hop have been 
found to act as scaffolds, linking specific combinations of co-chaperones such as 
Hsp90 to Hsp70 (Chen et al., 1996). The interactions between co-chaperones to form 
these various complexes can be highly competitive. Hop and the Immunophillin 
Cyp40 compete for binding of Hsc70 (Heat shock cognate 70) of the Hsp70 molecular 
chaperone family (Carrello et al., 2004). The various interactions between molecular 
co-chaperone proteins and clients form a range of heterocomplexes in vivo. The 
chaperone function towards clients of individual molecular chaperones can be 
modulated by associating with different co-chaperones in these heterocomplexes. The 
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molecular chaperone Hsp70 has a role in protein folding in association with Hsp40 
co-chaperones (Lu and Cyr, 1998), but interactions with the co-chaperones CHIP (C-
terminus of Hsp70 interacting protein) (Meacham et al., 2001) and Bag-1 (Demand et 
al., 2001) mediate client protein degradation. Specific combinations of molecular 
chaperones are required in these heterocomplexes to carry out different types of 
chaperone function. The Hsp40 chaperone, Ydjl, in association with the Hsp70 
chaperone Ssal, can prevent certain client proteins from forming insoluble aggregates 
in S. cerevisiae, but the combination of Ydj i and another Hsp70 chaperone, Ssb 1, 
cannot (Cyr, 1995). 
1.1.2 	Recognition of client proteins by molecular chaperones 
Each molecular chaperone recognises and binds a specific set of client proteins in 
particular conformational states, creating a network of precise chaperone-client 
interactions that sustain effective cellular quality control. Chaperones display a high 
degree of substrate specificity, recognising certain types of clients based on their 
unique polypeptide chain sequence. For example, Ydji and Sisi are both Hsp40 
chaperones in S. cerevisiae that have very different sequence recognition 
requirements of client polypeptides (Fan et al., 2004). Sisl preferentially associates 
with polypeptides enriched in hydrophobic residues which are mainly aromatic or 
lysine and generally only occur in pairs, but Ydj 1 favours polypeptides with a 
hydrophobic core of at least 3 or 4 amino acids adjacent to one another (Fan et al., 
2004). Molecular chaperone proteins recognise specific clients to ensure they enter 
the appropriate path in the quality control network. 
Molecular chaperones also exhibit substrate specificity based on the structural state of 
the client protein. Different chaperones preferentially associate with specific 
conformations and folding states of clients. The prokaryotic GroEL favours clients in 
a 'molten globule' conformation (see Figure 1.2) (Martin et al., 1991), whereas the S. 
cerevisiae Hsp40 chaperone, Ydj i, binds non-native, unfolded polypeptides (Cyr, 
1995). Interestingly, DnaK in E. coli binds both short hydrophobic peptides in an 
extended conformation and proteins such as RepA and Lambda P in a native 
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Figure 1.2: An overview of protein folding showing how domains of a newly 
synthesized polypeptide achieve a "molten globule" state. The subsequent folding 
steps occur at a slower rate and by multiple pathways, which often involve molecular 
chaperone proteins. Misfolded proteins are recognised by another set of molecular 
















conformation (Wawrzynow and Zylicz, 1995). The ability of molecular chaperones to 
recognise specific client conformations is most likely to ensure that they carry out 
their specific type of chaperone activity on clients in the appropriate structural state. 
The mechanism by which chaperones recognise these different client conformations is 
still unknown and an intriguing question in the field. 
	
1.1.3 	Molecular chaperone function towards client proteins 
Molecular chaperones are essential in maintaining quality control of cellular proteins 
which is fundamental to cell viability. A highly organised network of interacting 
molecular co-chaperone proteins associates with specific client proteins to promote 
efficient production, activation, localisation and degradation of the cellular protein 
pool as required by the cell. In the following section the various roles of molecular 
chaperone proteins are reviewed, to provide a better understanding of the function of 
these essential proteins within the cell. 
1.1.4 	Folding of client proteins by molecular chaperones 
The precise folding of a client protein is essential for achieving a biologically 
functional, native state that corresponds to the structure most stable under 
physiological conditions (Dobson, 2004). The amino acid sequence of the nascent 
polypeptide itself contains all the necessary information to reach its functional, native, 
three-dimensional structure (Dobson, 2004), but a polypeptide cannot spontaneously 
fold itself accurately to achieve its native state. This is partly due to the peptide bond 
properties of the polypeptide which confer a high degree of conformational flexibility 
to the backbone of the protein and the amino acid side chains that enable a number of 
largely non-covalent interactions (Banal et al., 2004). Consequently, the numbers of 
possible structures for each polypeptide are numerous. The final native structure is 
believed to be achieved by a stochastic search through the various conformations that 
are accessible to the polypeptide (Dobson, 2004). Protein folding as a spontaneous 
process is slow and often generates misfolded structures. To achieve accurate, 
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efficient folding, molecular chaperone proteins assist in the folding process (Wegele 
et al., 2004) as shown for Hsp70 in Figure 1.3. 
Client folding is typically carried out by ATP-dependent molecular chaperones. 
Folding of clients by the E. coli chaperone GroEL in association with the co-
chaperone GroES requires around 100 ATP molecules per protein client monomer 
(Martin et al., 1991). The ATP-dependent folding of client proteins is a two step 
process. Firstly, folding of the denatured client by the molecular chaperone occurs as 
an ATP-independent formation of a binary complex between the client and chaperone, 
then secondly, ATP-dependent release of the client in its native state (Gao et al., 
1992). Folding of client proteins is often a co-operative process between co-
chaperones. In vitro, the E. coli molecular chaperone DnaK recognises nascent 
polypeptides and in association with the co-chaperone DnaJ stabilises the client, 
preventing aggregation (Langer et al., 1992). The client is then transferred by GrpE to 
the ATPase chaperone GroEL, which in the presence of ATP catalyses the folding and 
maturation of the client (Langer et al., 1992). 
1.1.5 	Translocation of client polypeptides by molecular chaperones 
Many proteins are synthesised as precursor polypeptides that require post-
translational modifications and translocation to cellular organelles or a different 
region of the cell in order to achieve a native, biologically functional state. Molecular 
chaperone proteins have a crucial role in promoting the translocation of certain clients 
during their maturation process. It is imperative that nascent precursor polypeptides 
are maintained in a translocation-competent state by chaperones such as SecB in E. 
coli to enable efficient translocation to organelles such as the endoplasmic reticulum 
(ER) (Lecker et al., 1989). The translocation of precursor polypeptides such as 
invertase in S. cerevisiae is carried out by the Hsp70 family chaperone Bip (also 
known as GRP78), transporting the client into the lumen of the ER (Nguyen et al., 
1991; Vogel et al., 1990). The ER is a "protein factory" containing an abundance of 
molecular chaperones that form various quality control pathways for clients to attain a 
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Figure 1.3: Folding of nascent polypeptides by the molecular chaperone Hsp70. The 
chaperone binds specifically to the hydrophobic amino acids of the polypeptide in 
association with an Hsp40 chaperone protein. The Hsp70 chaperone hydrolyses a 
molecule of ATP which induces conformational changes that stabilise the complex. 
Hsp40 disassociates and then Hsp70 releases the client which is induced by the rapid 
re-binding of ATP after ADP release. Obtained from (Alberts et al., 2002). 
r.. 














native, biologically functional state. Around one third of all cellular proteins in 
eukaryotes are translocated to the ER, a highly specialised organelle for protein 
folding that has a unique oxidising potential that supports disulphide bond formation 
during protein folding (Kleizen and Braakman, 2004). 
	
1.1.6 	Maintenance of clients in a folding or activation competent state by 
chaperones 
Nascent polypeptides must be maintained by molecular chaperones in a folding or 
activation competent state, ready for folding, translocation or activation by other 
chaperones. Sustaining client polypeptides in a folding competent state prevents them 
from binding one another and forming insoluble aggregates, which can be targeted for 
degradation. Proteins such as proOmpA in E. coli are maintained in an export-
competent state by the chaperone SecB (a Chaperonin) to enable translocation 
promoting maturation of the client and to inhibit aggregation into insoluble complexes 
(Lecker et al., 1990). The ability of molecular chaperones to maintain clients in a 
folding competent state is also essential during some stress responses to maintain 
cellular protein levels. In response to heat stress in Xenopus oocytes, small heat shock 
proteins (shsp) bind denatured clients, inhibiting their aggregation and maintaining 
them in a folding-competent state until other cellular chaperones are able to fold them 
into their native state (Heikkila, 2004). 
1.1.7 	Misfolding and refolding of client proteins by molecular 
chaperones 
Client polypeptides can misfold themselves if left unaided. Occasionally client 
polypeptides are inaccurately folded by molecular chaperones or unfolded from their 
native state under stress conditions such as heat. An important aspect of the chaperone 
network is to refold misfolded and unfolded client proteins accurately. A cycle of 
protein folding in E. coli has been identified that ensures that misfolded proteins are 
refolded and not released by the chaperone GroEL until they have reached their 
correct native conformation (Martin et al., 1993). GroEL in its ADP-bound state is 
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stabilised by GroES. Once the nascent polypeptide has bound GroEL, ADP and 
GroES are released from the complex. Exchanging ADP for ATP promotes the re-
association of GroES to the complex; GroEL then carries out ATP hydrolysis and 
discharges the client. If the client is partially or incorrectly folded, it rebinds GroEL 
and the cycle continues until the client has achieved its correct native state and is then 
released. 
1.1.8 	Molecular chaperones prevent nascent polypeptides forming 
insoluble aggregates 
Chaperones bind nascent polypeptides as early as possible, associating with them at 
the point of translation from ribosomes, to prevent them from forming insoluble 
aggregates and to promote their accurate and efficient folding to the native state. 
Nascent polypeptide chains can form insoluble aggregate complexes, due to their 
hydrophobic nature and interchain hydrogen bonding (Banal et al., 2004). The rate of 
translation from ribosomes producing nascent polypeptide chains is much slower than 
the rate of folding of protein domains, and these domains cannot be folded until the 
entire sequence required for folding is free from the ribosomal complex (Banal et al., 
2004). The problem of nascent polypeptides forming aggregates is accentuated by the 
fact that numerous ribosomes carrying out translation are usually located within close 
proximity (Young et al., 2004). Therefore, hydrophobic nascent polypeptide chains 
must be stabilised to prevent aggregation. The molecular chaperone Trigger Factor in 
E. coli associates with nascent polypeptides as they are being, translated by the 
ribosome to overcome the problem of nascent polypeptides collating into insoluble 
aggregates (Figure 1.4) (Hesterkamp et al., 1996). Trigger factor is thought to scan the 
nascent polypeptide as it is being translated by the ribosome, to identify and shield 
hydrophobic patches of sequence from aggregating (Young et al., 2004). The 
interaction between Trigger Factor and the client polypeptide is rapid and does not 
involve any folding by this chaperone (Maier et al., 2001). The Trigger Factor 
chaperone disassociates from the polypeptide once the ribosome has left the complex 
(Hesterkamp et al., 1996). 
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Figure 1.4: Chaperones associate with polypeptides as they are being translated from 
the ribosome. Molecular chaperones bind the amino terminus of the extending 
polypeptide chain as it leaves the ribosome, stabilising the client and preventing it 
from forming insoluble aggregates. Once the polypeptide has been fully translated, 








Once non-native polypeptides have been fully translated, another set of chaperones 
protect them from forming insoluble aggregates, maintaining them in a folding 
competent state. The Hsp40 chaperone Ydj 1 from S. cerevisiae forms complexes with 
non-native polypeptides, preventing formation of insoluble aggregates (Cyr, 1995). 
Specific sets of co-chaperones interact to stabilise nascent polypeptides, preventing 
aggregation. Ydj 1 associates with the Hsp70 co-chaperone Ssal in preventing 
aggregation of specific client polypeptides, although it is unable to carry out this 
function with the Hsp70 chaperone Ssbl/2 (Cyr, 1995). If nascent polypeptides do 
form aggregates, for example after exposure to stresses such as heat, then molecular 
chaperones are in place in the network to resolve this. Chaperones such as C1pA, a 
Hsp 100 family chaperone, is unable to protect client proteins from thermal 
denaturation, but can actively resolubilise heat inactivated and denatured clients from 
insoluble aggregates (Parsell et al., 1994). 
Molecular chaperone proteins also interact with aggregates of prion proteins. These 
insoluble aggregates can have a detrimental affect on individual cells and tissue, 
causing human diseases such as variant CJD and Huntington's. Recent data has 
shown that chaperone proteins display a range of activities towards prion proteins and 
their propagation. Prion aggregates are believed to be formed by nucleated 
conforinational conversion, whereby a prion seed associates with non-prion protein 
forms which then undergo conversion to prions building the aggregate (Scheibel et al., 
2004). Sisi, an Hsp40 molecular chaperone, promotes the propagation of RNQ+ prion 
proteins in S. cerevisiae, whereas Ydj 1 does not (Lopez et aL, 2003). PSI+ is also a 
prion protein whose propagation is dependent on an intermediate protein level of the 
chaperone Hsp 104 in S. cerevisiae, as excess or limiting levels of this molecular 
chaperone were found to reduce PSI+ prion protein levels (Chernoff et al., 1995). The 
reasons for the complexity of the relationships between molecular chaperone proteins 
and prion protein propagation are currently not fully understood, although it is clear 
that molecular chaperones have a direct influence. 
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1.1.9 	Targeted degradation of client proteins by molecular chaperones 
Quality control of client proteins by molecular chaperones also involves their 
degradation. This process is necessary to remove misfolded or mutant client proteins, 
and or reduce protein levels according to cell requirements. CHIP is a chaperone 
dependent E3 ubiquitin—protein ligase that represents the link between protein folding 
and protein degradation in quality control. Overexpression of CHIP increases the level 
of ubiquitination and rate of degradation of client proteins (Jana et al., 2005). CHIP 
preferentially associates with the misfolded client protein ER-a, which it ubiquitinates 
and targets for degradation (Tateishi et al., 2004). CHIP mediated degradation of 
client proteins occurs in association with co-chaperones better known for their folding 
ability. In vitro, the addition of Hsp70 and Hsp40 was found to greatly enhance the 
level of ubiquitination on client proteins by CHIP (Peng et al., 2004). Client proteins 
are degraded by the proteasome, as human cells treated with the proteasome inhibitor 
ALLN were unable to degrade the misfolded cystic fibrosis transmembrane receptor 
(CFTR) mutant CFTRAF508, a client known to be targeted for degradation by CHIP 
(Meacham et al., 2001). There is a further regulatory step to this pathway, as CHIP is 
negatively regulated by H5pBP1 when it is associated with Hsc70 (Alberti et al., 
2004). HspBP1 has been shown to interfere with CHIP-induced degradation of clients 
such as CFTR, preventing their proteolysis and promoting client maturation (Alberti 
et al., 2004). 
1.1.10 	Summary 
There are many molecular chaperone proteins, interacting with each other to form a 
highly organized network for the quality control of cellular proteins. Co-chaperones 
associate in a number of different combinations to carry out a variety of different roles 
to regulate cellular protein levels and aid the cellular stress response. One of these 




Cdc37 is a molecular chaperone that was identified in two distinct ways. The cdc37 
gene was identified during a screen for S. cerevisiae mutants that arrest in START 
(Reed, 1980; Reed, 1980). The Cdc37 protein was concurrently identified as a 50 kDa 
protein called p50 that interacts with the v-src kinase in chicken cells (Hunter and 
Sefton, 1980). Clients of the molecular chaperone Cdc37 are predominantly protein 
kinases such as Cdk4 (Dai et al., 1996; Lamphere et al., 1997; Stepanova et al., 1996) 
and Raf-1 (Grammatikakis et al., 1999) which bind the N-terminal domain of Cdc37 
(Shao et al., 2003). Cdc37 interacts with a wide variety of client proteins and co-
chaperones, forming a range of high molecular weight complexes (Boudeau et al., 
2003; Mahony et al., 1998; Stepanova et al., 1996; Wang et al., 2002). Cdc37 has 
been found to interact with the co-chaperone Hsp90 (Abbas-Terki et al., 2002; 
Milison et al., 2004; Miyata and Nishida, 2004; Roe et al., 2004; Shao et al., 2003; 
Shao et al., 2003; Siligardi et al., 2002; Zhang et al., 2004), and is thought to deliver 
client protein kinases to this ATP-dependent chaperone (MacLean and Picard, 2003). 
In this section Cdc37 and its interactions with both the co-chaperone Hsp90 and client 
proteins including Cdc28 in S. cerevisiae will be reviewed. 
1.2.2 	The cdc37 gene 
The cdc37 gene has been identified as essential in numerous organisms and appears to 
be restricted to animal and fungi. An alignment of Cdc37 homologues from different 
species shows low overall sequence identity (Figure 1.5). There is greater sequence 
identity among Cdc37 homologues of the lower and higher eukaryotic groups than 
between them. For example, overall sequence identity between the mammalian Cdc37 
homologues from chick and human is 84% (Huang et al., 1998) but only 25% 
between the human and S. cerevisiae proteins. Despite low overall sequence identity, 
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terminal domain of Cdc37 is the most highly conserved region and is involved in 
client protein interactions (Shao et al., 2003). The N-terminal domain protein 
sequence displays 80% identity between the yeasts S. pombe and S. cerevisiae and 
50% identity between S. pombe and human. Cdc37 homology across species may be 
more highly conserved at the structural or functional level of the protein, than in the 
sequence of amino acids, as Cdc37 proteins from different organisms are functional 
homologues. Cdc37 from C. albicans can rescue the S. cerevisiae temperature-
sensitive mutant cdc37-34 at the restrictive temperature (Ni et al., 2004). 
Interestingly, a protein called Harc (Hsp90-associating relative of Cdc37) with 
similarity to human Cdc37 has been identified in human cells and is thought to be a 
duplication of Cdc37 that occurred during vertebrate evolution (Scholz et al., 2001). 
The protein sequence of Harc shares only 31% homology with human Cdc37 across 
the whole protein (Scholz et al., 2001). Harc is a 35 kDa protein comprised of three 
domains that interacts with a range of co-chaperones including Hsp70, Hop, the 
Immunophillin Cyp40, and like its Cdc37 homologue binds the co-chaperone Hsp90 
by its middle domain (Scholz et al., 2001). In contrast to Cdc37, Harc does not bind 
protein kinases such as Raf-1 and v-src (Scholz et al., 2001). 
1.2.3 	The Cdc37 protein 
Cdc37 comprises around 0.1% of total cellular soluble protein in Drosophila cells 
(Kimura et al., 1997). The mRNA in S. pombe (Rustici et al., 2004) and protein levels 
in S. cerevisiae (Gerber et al., 1995) of Cdc37 do not fluctuate during the cell cycle. 
Furthermore, cellular Cdc37 protein levels in S. cerevisiae remain at a constant level 
in both stationary and exponentially growing cells (Gerber et al., 1995). It has been 
suggested that Cdc37 protein levels may be affected by post-translational 
mechanisms, as human cells expressing a Cdc37AC-terminus mutant contained 
elevated Cdc37 protein levels (Schwarze et al., 2003). The localisation of the Cdc37 
protein in S. pombe (Tatebe and Shiozaki, 2003) and human (Lange et al., 2002; 
Perdew et al., 1997) cells is largely cytoplasmic, being diffuse throughout this region. 
However, in S. pombe cells, distinct localisation of Cdc37 in the chromatin region of 
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the nucleus was also observed (Tatebe and Shiozaki, 2003). In contrast, the Cdc37 
protein in human cells displayed specific perinuclear localization (Lange et al., 2002; 
Perdew et al., 1997) and was also seen to localize specifically to the spindle 
microtubules and midbody co-localising with the client protein kinase Aurora B 
(Lange et al., 2002). 
1.2.4 	Cdc37 protein structure 
Structurally, three domains of human Cdc37 have been defined by limited proteolysis 
and peptide analysis and are referred to as the N-terminal, middle and C-terminal 
domains (Shao et al., 2003) The N-terminal domain of Cdc37 was found to consist of 
amino acids 1-126, the middle region is composed of residues 128-282 and the C-
terminal domain of amino acids 283-378 (Shao et al., 2003). Intriguingly, the C-
terminal domain of Cdc37 in S. cerevisiae is completely dispensable, as expression of 
the mutant Cdc37AC-terminus does not compromise chaperone function, maintaining 
the activity of clients such as Hck (Scholz et al., 2000) and v-src (Lee et al., 2002). 
Removal of both the middle and C-terminal domains of S. cerevisiae Cdc37 reduces 
chaperone activity by 70% (Lee et al., 2002). Crystallisation studies of portions of the 
middle and C-terminal domains of human Cdc37 (amino acids 148 to 347) identified 
a 6-helix bundle (amino acids 148-245), connected by a long single helix (residues 
246 to 286) and 'a disordered polypeptide chain (amino acids 309-3 15) to a small 3-
helix bundle (residues 316-347) (Figure 1.6) (Roe et al., 2004). 
The Cdc37 protein has a molecular weight of 68 kDa in S. cerevisiae, but migrated at 
130 kDa by gel filtration chromatography, indicating that Cdc37 occurs as a dimer 
(Kimura et al., 1997). Crystallisation studies of a truncated human Cdc37 protein 
comprising codons 148 to 347 showed that it forms a dimer with amino acids 218 to 
255 forming the main hydrophobic interface between the two monomers (Figure 1.7) 
(Roe et al., 2004). The core of the dimerisation interaction involves the close packing 
of the main and side chains of Gln247 an Tyr248 in the first turn of the long 
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Figure 1.6: The crystal structure determined for human Cdc37 amino acids 148 to 
347 (Roe et al., 2004). A 6-helix bundle (amino acids 148-245) was identified, 
connected by a long single helix (residues 246 to 286) and a disordered polypeptide 
chain (amino acids 309-315) to a small 3-helix bundle (residues 316-347) 
Figure 1.7: Crystal structure of amino acids 148 to 347 of human Cdc37 forming a 
dimer, and a 90° rotation of the diagram (Roe et al., 2004). 
t1Y 
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connecting helix with their equivalent partners in the other monomer (Roe et al., 
2004). The interaction between the hydrophobic patches of either Cdc37 monomer is 
reinforced by carboxyl-carboxylate interactions between the side chains of Asp294 
from each of the monomers, a network of hydrogen bonds involving side chains of 
Arg246 and G1u250 on one monomer and G1u221 and G1u225 on the other and ion-
pairs between Lys240 and Asp245 from separate monomers (Roe et al., 2004). 
However, by analytical centrifugation the C-terminal half (amino acids 128-379) and 
the N-terminal half (30-127aa) of human Cdc37 were both seen to homodimerise as 
N- and N-terminal and C- and C-terminal domain interactions, although the C- and C-
terminal homodimerisation appears stronger (Siligardi et al., 2002). 
1.2.5 	Phosphorylation of Cdc37 
The extreme N-terminal region (first 40 amino acids) of Cdc37 displays the highest 
level of homology among species and contains a number of conserved serine residues. 
Serines 14 and 17 in S. cerevisiae (Bandhakavi et al., 2003) and serine 13 (equivalent 
to S. cerevisiae serine 14) in rat (Miyata and Nishida, 2004) and human (Shao et al., 
2003), have been identified as important sites of phosphorylation. Treatment of cells 
with TBB, a specific inhibitor of the kinase Casein kinase II (CKII), significantly 
reduced phosphorylation of Cdc37 in vivo (Miyata and Nishida, 2004). CKII 
phosphorylates recombinant Cdc37 in vitro (Shao et al., 2003) and mutation of the 
conserved serine 13 residue to alanine in the rat Cdc37 protein inhibited 
phosphorylation by CKII (Miyata and Nishida, 2004). Phosphorylation by CKII of the 
conserved N-terminal serine residues, serine 13 in rat and serines 14 and 17 in S. 
cerevisiae, are required for Cdc37 activity (Bandhakavi et al., 2003; Miyata and 
Nishida, 2004). There is evidence that Cdc37 and CMI maintain each other's activity 
in a feedback loop of activation (Bandhakavi et al., 2003). Zdsl and Zds2, multi-copy 
suppressors of the S. cerevisiae CMI temperature-sensitive mutant cka2-13, may play 
a crucial role in Cdc37-CKII interactions because their overexpression enhances 
Cdc37 protein levels (Bandhakavi et al., 2003). 
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Phosphorylation of conserved Cdc37 serine residues by CMI is important for client 
protein binding and molecular chaperone activity. Inhibition of Cdc37 
phosphorylation by mutating conserved N-terminal serine 13 to alanine results in 
significantly reduced binding affinity in vivo towards several client kinases such as 
Akt, Aurora-B and Cdk4 and reduction in protein levels of client proteins MOK and 
Raf-1 (Miyata and Nishida, 2004). Phosphorylation of serine 13 in human and rat 
Cdc37 is crucial for the ability of Cdc37 to form heterocomplexes with the co-
chaperone Hsp90 and client proteins (Miyata and Nishida, 2004; Shao et al., 2003). 
Mutation of rat Cdc37 serine 13 to alanine inhibited interactions between Hsp90 and 
protein clients, but binding between Hsp90 and the mutant Cdc37 was not 
compromised (Miyata and Nishida, 2004). Mutation of human Cdc37 serine 13 to 
alanine or glutamic acid only reduced Cdc37 binding affinity towards Hsp90 by 40 
and 10% respectively (Shao et al., 2003). However, phosphorylation site mutants of S. 
cerevisiae Cdc37 reduced binding affinity towards Hsp90 in the yeast-two-hybrid 
assay (Millson et al., 2004). Mutations of serine 13 to alanine, inhibiting CKII 
phosphorylation, appear to affect human Cdc37 function towards Hsp90, as these 
Cdc37 mutants were unable to stimulate nucleotide modulated conformational 
switching in Hsp90 (Shao et al., 2003). 
1.2.6 	Cdc37 chaperone function towards client proteins 
Cdc37 has been found to interact with a variety of clients which are predominantly 
protein kinases but also include steroid hormone receptors in mammalian systems 
(MacLean and Picard, 2003). Cdc37 is essential for maintaining protein levels and 
activity of specific protein clients. Cdc37 is also involved in the translocation of 
clients, promoting the assembly of complexes between clients and their partner 
proteins and delivering clients to other co-chaperones. In this section the role of 
Cdc37 as a molecular chaperone towards client proteins will be reviewed. 
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1.2.6.1 	Client proteins of the Cdc37 molecular chaperone 
Cdc37 was first isolated as a 50 kDa protein by co-immunoprecipitating with the 
client protein kinase v-src from transfected chicken cells (Hunter and Sefton, 1980). 
An ever expanding list of Cdc37 client proteins now exists, the majority of which are 
protein kinases such as Cdk4 (Dai et al., 1996; Lamphere et al., 1997; Stepanova et 
al., 1996) and Raf-1 (Grammatikakis et al., 1999). However, Cdc37 also associates 
with non-kinase clients such as the steroid hormone receptor, the androgen receptor 
(AR) (Rao et al., 2001), the polysaccharide Hyalurinan and related 
glycosaminoglycans (Grammatikakis et al., 1995). Cdc37 exhibits a high degree of 
specificity towards the type of client proteins it associates with, for example, Cdc37 
interacts with the androgen hormone receptor (Rao et al., 2001), but not the 
glucocorticoid receptor (Kimura et al., 1997). 
Cdc37 binds client proteins in a dynamic manner, and the addition of molybdate can 
stabilise the interaction to enable detection of associating proteins (Hartson et al., 
2000; Hutchison et al., 1992). The N-terminal domain of human Cdc37 binds client 
proteins (Shao et al., 2003). Cdc37 binds the kinase catalytic domain of client proteins 
such as MOK (Miyata and Nishida, 2004), Lck (Prince and Matts, 2004), Raf 
(Silverstein et al., 1998) and LKB1 (Boudeau et al., 2003). More specifically, Cdc37 
interacts with the N-terminal lobe of the kinase catalytic domain of the client protein 
kinases Lck and eIF2a (Scroggins et al., 2003). The residues G1y15 and Lys18 of the 
client kinases' ATP binding motif, that are important for kinase activity of the client 
protein Cdk4, are crucial for Cdc37 binding (Zhao et al., 2004). Cdc37 binds non-
kinase hormone receptor clients, such as AR, by their C-terminal domain (Rao et al., 
2001). 
The molecular chaperone Cdc37 is associated with protein clients at a very early stage 
in their maturation. Cdc37 was identified in purified ribosomal complexes, indicating 
that Cdc37 associates with clients prior to their full translation (Shao et al., 2001). 
Cdc37 preferentially associates with newly synthesised immature and inactive 
polypeptides instead of mature forms of the protein kinase client Lck (Hartson et al., 
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2000) and eIF2a (Shao et al., 2001). Cdc37 associates with client proteins like eIF2u 
until they have attained a mature and activated state (Shao et al., 2001). 
	
1.2.6.2 	Cdc37 chaperone activity - maintaining client protein levels 
Removal of Cdc37 from Drosophila cells by RNAi treatment resulted in considerably 
reduced Aurora B protein levels (Lange et al., 2002). The chaperone function of 
Cdc37 is required for the stability of a number of client proteins including Stel 1 in S. 
cerevisiae (Abbas-Terki et al., 2000) and LKB 1 in HeLa cells (Boudeau et al., 2003). 
Human Cdc37 can sustain the protein levels of clients such as the kinase Zap70 in a 
concentration dependent manner, but was unable to prolong the half life of a Zap70 
kinase domain mutant protein, indicating that Cdc37 is not involved in targeting 
clients for degradation (Matsuda et al., 1999). The ability of Cdc37 to stabilise protein 
levels of clients such as Raf- 1, can occur independently of maintaining the activity of 
the client (Grammatikakis et al., 1999). However, the ability of Cdc37 to maintain 
protein levels and client activity often goes hand-in-hand, as Cdc37 can hold client 
proteins in an activation competent state ready for folding and activation by other 
chaperones such as Hdj-1 and Hsp70 (Kimura et al., 1997). 
1.2.6.3 	Cdc37 chaperone activity - sustaining client activity 
Cdc37 is essential for preserving the activity of a number of client proteins including 
Aurora B (Lange et al., 2002), IKK (Chen et al., 2002), reverse transcriptase (Wang et 
al., 2002) and Raf-1 (Grammatikakis et al., 1999). Cdc37 promotes the activation and 
maturation of client protein kinases like eIF2a kinase and only disassociates when 
they have achieved a mature and active state (Shao et al., 2001). However, Cdc37 
does not appear to activate client proteins itself, but promotes client activation by 
associating with ATPase chaperones. Cdc37 can stimulate activation of client proteins 
such as the eIF2a kinase in the presence of the ATPase chaperone Hsp90 (Shao et al., 
2001). The ability to maintain the activity of a protein client often occurs in parallel 
with maintaining its protein levels. However, in the S. cerevisiae temperature- 
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sensitive mutant cdc37-34, AR activation was dramatically reduced at the restrictive 
temperature, but its protein levels remained constant (Fliss et al., 1997). 
	
1.2.6.4 	Cdc37 chaperone activity - Translocation of client proteins to 
promote their activation 
Cdc37 is also involved in the activation of client proteins by playing a role in their 
translocation from one cellular region to another in association with ATPase 
chaperones. Certain clients require translocation in order to be properly folded and 
activated by other protein partners. One such client is Raf that requires translocation 
from the cytosol to the plasma membrane, where it is activated by Ras. Cdc37 and 
Hsp90 bind the client protein kinase Raf in the cytosol and at the plasma membrane, 
indicating that these chaperones may be involved in its translocation promoting the 
clients activation (Wartmann and Davis, 1994). 
1.2.6.5 	Cdc37 chaperone activity - promoting complex assembly of client 
proteins with their partner proteins 
In the presence of Cdc37 a 3-fold increase in the kinase activity of the Cdk4-cyclin D 
complex was observed (Lamphere et al., 1997). Interestingly, Cdc37 itself does not 
increase the activity of the complex (Lamphere et al., 1997) as the addition of Cdc37 
to bound Cdk4-cyclin complexes does not enhance their activity (Stepanova et al., 
1996). Cdc37 only binds Cdk4 (Lamphere et al., 1997; Stepanova et al., 1996) and not 
its cyclin partners (Stepanova et al., 1996). Cdc37 binds Cdk4 and facilitates 
assembly with the cyclin partners in a concentration dependent manner (Lamphere et 
al., 1997; Stepanova et al., 1996). This has also been observed for Cdk9 and its 
partner cyclin T in human cell lines (Lamphere et al., 1997; OKeeffe et al., 2000). 
1.2.6.6 	Cdc37 chaperone activity - in association with other chaperones 
A number of interactions between Cdc37 and co-chaperones have been identified both 
biochemically and genetically. Cdc37 genetically interacts with Hsp40 chaperones in 
S. cerevisiae, as a double mutant of CDC37 and YDJJ temperature-sensitive mutants 
was lethal at temperatures permissive for each individual mutant (Mort-Bontemps-
Soret et al., 2002). Biochemically interactions have been detected between Cdc37 and 
the co-chaperones p23, Hop, FKBP52, Cyp40 (immunophillin) (Hartson et al., 2000) 
and Cpr7 (immunophillin) (Abbas-Terki et al., 2002). Cdc37 and Stil, the S. 
cerevisiae homologue of mammalian Hop, physically interact (Abbas-Terki et al., 
2002) and have similar chaperone roles towards clients, as overexpression of Cdc37 
can restore v-src activity to near wildtype levels in a S. cerevisiae StilA strain (Lee et 
al., 2002). 
Cdc37 interacts with a variety of clients and co-chaperones, forming a range of 
heterocomplexes in vivo (Boudeau et al., 2003; Mahony et al., 1998; Stepanova et al., 
1996; Wang et al., 2002). For example, human Cdc37 and FKBP52 can 
simultaneously occur in association with Hsp90 in complexes with immature clients 
HRI or Lck (Hartson et al., 2000). Research to date has concentrated on the 
interaction between the chaperone proteins Hsp90 and Cdc37 which suggests that 
Cdc37 directs client protein kinases to Hsp90 forming a heterocomplex (MacLean and 
Picard, 2003). Client protein kinases such as Cdk4 bind both. Cdc37 and the 
chaperone Hsp90 as determined by co-immunoprecipitation (Dai et al., 1996; 
Stepanova et al., 1996) and interactions between Cdc37 and Hsp90 have also been 
identified in both mammalian and yeast systems (Abbas-Terki et al., 2002; Lamphere 
et al., 1997; Millson et al., 2004; Miyata and Nishida, 2004; Perdew et al., 1997; Roe 
et al., 2004; Shao et al., 2003; Shao et al., 2003; Siligardi et al., 2002; Zhang et al., 
2004). Cdc37 appears to compete for Hsp90 binding with the TPR binding domain 
co-chaperones Cpr6/Cyp4O (Siligardi et al., 2002) and Hop (Silverstein et al., 1998) 
which form an alternative range of heterocomplexes with Hsp90. 
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Loss of function of one chaperone heterocomplex can result in the client being taken 
up in another with a different set of co-chaperones. Geldanamycin (GA) inhibits 
Hsp90 ATPase activity and the ability of the Hsp90-Cdc37 complex to bind client 
proteins such as guanylate cyclase (Kumar et al., 2001) and Cdk9 (OKeeffe et al., 
2000), which are instead found complexed with the ATPase chaperone Hsp70. Cdc37 
can also interact with Hsp70 in certain instances, maintaining client proteins in an 
activation competent state in vitro, ready for reactivation by Hsp70 (Kimura et al., 
1997). The molecular chaperone Hsp90 and its association with Cdc37 will be 
reviewed in the following section. 
1.2.7 	Hsp90 
1.2.7.1 	The Hsp90 gene and protein 
The Hsp90 gene(s) is essential as HSP90 temperature-sensitive mutants in S. 
cerevisiae arrest cell division at the restrictive temperature (Kimura et al., 1994). The 
HSP90 gene was originally identified due to its radically increased RNA levels in 
response to heat shock in yeast (Finkelstein et al., 1982) that produced a 90 kDa 
protein (Finkelstein and Strausberg, 1983). Under normal growth conditions, the 
Hsp90 molecular chaperone represents —0.5-1% of total cellular soluble protein in S. 
cerevisiae (Kimura et al., 1997). Homology of the Hsp90 protein sequence among 
species is much greater than observed for Cdc37, with 60% sequence conservation 
between human and S. cerevisiae homologues. In mammalian and yeast systems two 
isoforms of Hsp90 have been identified. In S. cerevisiae the Hsp90 isoforms, referred 
to as Hsc82 and Hsp82, exhibit 97% homology in protein sequence and are functional 
equivalents, but have very different expression patterns, with Hsc82 being much more 
abundant (Borkovich et al., 1989). In multicellular organisms additional versions of 
Hsp90 have been identified in organelles such as Grp94 in the endoplasmic reticulum 
of human cells (Sorger and Pelham, 1987). 
	
1.2.7.2 	The Hsp90 molecular chaperone 
Hsp90 associates with a wide range of client proteins that are predominantly involved 
in signal transduction and cell cycle control, such as protein kinases (Picard, 2002) 
which it binds at both the N- and C- terminal lobes of the catalytic domains of the 
client kinases Lck and eIF2c& (Scroggins et al., 2003). Like Cdc37, Hsp90 binds 
protein clients at a very early stage in their maturation process, associating with them 
as polypeptides in ribosomal complexes, interacting with clients prior to their full 
translation (Shao et al., 2001). Hsp90 is active in promoting the maturation of newly 
synthesised polypeptides to native state proteins of clients such as c-src (Xu et al., 
1999). Hsp90 is also involved in maintaining the protein levels of clients. Under stress 
conditions such as heat shock, Hsp90 stabilises client proteins such as citrate synthase 
by preventing their ability to form thermal insoluble aggregates and sustaining their 
activity (Jakob et al., 1995). 
Hsp90 is an molecular chaperone whose function requires the hydrolysis of ATP 
(Obermann et al., 1998; Panaretou et al., 1998). The addition of the Hsp90 ATP-
hydrolysis inhibitor Geldanamycin (GA) to NIH-3T3 cells reduces the stability of the 
client protein kinase Cdk4, decreasing protein levels 5-fold (Stepanova et al., 1996). 
GA binds Hsp90 in the ATP binding domain, preventing ATP hydrolysis from being 
carried out (Roe et al., 1999). Several co-chaperones of Hsp90 can stimulate its ATP 
activity promoting chaperone function towards client proteins. Ahal interacts with 
Hsp90 and can stimulate its ATPase activity up to 12 times its basal level (Panaretou 
et al., 2002). The ATPase activity of Hsp90 in association with Ahal can be inhibited 
by the presence of other co-chaperones such as Stil/Hop (Panaretou et al., 2002), 
forming a regulatory network for Hsp90 chaperone function. 
1.2.7.3 	Hsp90 associations with co-chaperones 
Hsp90 interacts with a range of co-chaperones forming different heterocomplexes. 
The best characterised model of Hsp90 chaperone activity in association with co- 
chaperones involves the maturation of the steroid hormone receptor (Pain, 2000). The 
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early chaperone complex associated with the steroid hormone receptor involves 
delivery of the client by Hsp40 to Hsp70, forming a heterocomplex that also includes 
Hip. The chaperone Hop acts as a scaffold linking Hsp70 of the early complex and 
Hsp90 of the intermediate complex. The hormone receptor is then passed to the 
intermediate complex which contains Hsp90, Hip and Hop. The final stages of 
maturation of the client protein before release involve the mature complex comprising 
Hsp90 with p23 and different Immunophillin. This model represents just one of the 
pathways in which Hsp90 and co-chaperones interact to carry out appropriate 
chaperone activity towards client proteins. 
1.2.7.4 	Tertiary complex of Hsp90-Cdc37-client protein 
Hsp90 also interacts with the co-chaperone Cdc37 and is believed to form a 
heterocomplex that includes client proteins. Reconstitution in rabbit reticulate lysates 
of the complex between the co-chaperone Hsp90 and the protein kinase client pp60" 
identified the presence of Cdc37, indicating that these proteins form a 
heterocomplex (Hutchison et al., 1992). In addition, Cdc37 and Hsp90 have been 
found in the same 450 kDa high molecular weight complex associated with the client 
Cdk4 in NIH-3T3 cells (Stepanova et al., 1996). Cdc37 and Hsp90 associate at 
stoichiometric levels in the heterocomplexes, but the protein levels of specific clients 
are greatly reduced by comparison (Grammatikakis et al., 1999). It is believed that 
Cdc37 delivers client kinases to the co-chaperone Hsp90, forming a tertiary complex 
(MacLean and Picard, 2003). This concept is supported by the observation that 
associations between the client Raf- 1 and Hsp90 are greatest in the presence of Cdc37 
(Grammatikakis et al., 1999). Furthermore, Cdc37 can compensate for loss of another 
Hsp90 co-chaperone, Sti 1, by restoring Hsp90 binding to the client protein kinase 
Stel 1 when Cdc37 is overexpressed in a S. cerevisiae StilA strain (Lee et al., 2004). 
The addition of Geldanamycin (GA) blocks the interaction between Cdc37 and certain 
client proteins, indicating that interactions with Hsp90 are essential for these 
associations (Hartson et al., 2000; Lange et al., 2002; Rao et al., 2001; Shao et al., 
2003). Formation of the heterocomplex involving both Hsp90 and Cdc37 appears to 
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be crucial for promoting chaperone activity towards certain client proteins such as 
sustaining the activity of Raf- 1 (Grammatikakis et al., 1999). 
1.2.7.5 	The interaction between the chaperones Cdc37 and Hsp90 
Interactions between Hsp90 and Cdc37 have been identified in both lower and higher 
eukaryotic systems, although the interaction has been studied in greater detail in 
higher organisms. The middle domain of human Cdc37 interacts with the co-
chaperone Hsp90 (Scholz et al., 2001). The complex between Hsp90 and Cdc37 was 
purified and subjected to limited proteolysis which identified an extremely stable 16 
kDa unit comprising amino acids 147 to 276 of Cdc37 and amino acids 4 to 261 of 
Hsp90 (Zhang et al., 2004). A complex between these interacting domains of yeast 
Hsp90 and human Cdc37 has been crystallised and its structure determined 
identifying amino acids 164-170 and 204-208 of human Cdc37 that form a 
hydrophobic patch which interacts with the N-terminal region of yeast Hsp90 (Figure 
1.8) (Roe et al., 2004). Human Cdc37 binds both the N-terminal domains and the 
linker regions of Hsp90 (Zhang et al., 2004). Cdc37 binds to Hsp90 as a dimer 
(Siligardi et al., 2002; Zhang et al., 2004) at a 1:1 molar ratio (Zhang et al., 2004). 
Cdc37 preferentially binds a non-ATP bound form of Hsp90, suppressing ATP 
turnover (Siligardi et al., 2002). Consistent with this, Cdc37 forms a stable complex 
with Hsp90 bound to the ATP hydrolysis inhibitor GA (Grammatikakis et al., 1999; 
Siligardi et al., 2002). The Hsp90-binding domain of Cdc37 is better at inhibiting 
ATP turnover by Hsp90 than the full length chaperone protein (Zhang et al., 2004). 
Displacement of Cdc37 from Hsp90 by immunophillin Cpr6/Cyp4O removes the 
suppression of Hsp90 ATP turnover (Siligardi et al., 2002). After Cdc37 has been 
released from the tertiary complex with Hsp90 and the client, ATP turnover by Hsp90 
is carried out as a two step process, promoting conformational changes of the Hsp90-
client complex (McLaughlin et al., 2004). 
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Figure 1.8: A diagram to show the interacting domains of yeast Hsp90 and human 
Cdc37 determined by crystallisation studies. Amino acids 164-170 and 204-208 of 
human Cdc37 were seen to form a hydrophobic patch that interacts with the N-
terminal region of yeast Hsp90 (Roe et al., 2004). 
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At present there is less biochemical evidence of Cdc37-Hsp9O interactions in yeast 
systems than mammalian. A genetic interaction between Cdc37 and Hsp90 was 
observed in S. cerevisiae; strains mutationally compromised for Cdc37 and Hsp90 
were synthetically lethal (Kimura et al., 1997). In yeast systems, Cdc37 interactions 
with clients and co-chaperones are more unstable and harder to detect biochemically 
(Farrell and Morgan, 2000) and human Cdc37 binds Hsp90 tighter than S. cerevisiae 
Cdc37 (Siligardi et al., 2002). The non-specific binding affinity of these co-
chaperones and the stability of the Cdc37 complexes have made identifying 
interactions problematic, and in vitro and mutational analysis has had to be employed 
to identify interactions between Hsp90 and Cdc37 in yeast. In S. cerevisiae, a physical 
interaction between Hsp90 and Cdc37 has been shown using recombinant GST-Cdc37 
in pull-down experiments (Abbas-Terki et al., 2000). The yeast-two hybrid assay also 
indicates an interaction between these co-chaperones, but only when a mutant form of 
Hsp90 was used in which ATP hydrolysis was inhibited (Millson et al., 2004). 
Interestingly, in S. cerevisiae Cdc37 binds both of the Hsp90 isoforms, Hsc82 and 
Hsp82 (Abbas-Terki et al., 2000). 
1.2.8 	Cdc37 is important for maintenance of the cell cycle and 
proliferation 
Cdc37 RNAi treatment of Drosophila cells abrogates proliferation and cells display 
defects in cytokinesis and chromosome segregation (Lange et al., 2002). The 
chaperone function of Cdc37 is important for maintenance of the cell cycle, 
promoting cell proliferation. Consistent with this, Cdc37 expression is elevated in 
proliferative zones of human tissues and embryonic development (Stepanova et al., 
2000). In cancerous cells that undergo uncontrolled proliferation in patients with acute 
myelocytic leukaemia (Casas et al., 2003) and in prostatic tumours, neoplasias and 
pre-malignant tumours (Stepanova et al., 2000) Cdc37 expression is upregulated. 
Cdc37 has oncogenic properties, being able to promote irregular and unchecked cell 
proliferation. Cdc37 overexpression in mammary gland tissues in transgenic mice 
promoted abnormal growth and occasionally necrosis (Stepanova et al., 2000). Cdc37 
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overexpression drives cell proliferation whereas loss of Cdc37 arrests the cell and 
leads to apoptosis (Schwarze et al., 2003). 
Cdc37 is essential for cell viability and maintenance of the cell cycle as cells deleted 
for the CDC37 gene in S. cerevisiae can only produce micro-colonies of 4-60 cells 
which are heterogeneous in phenotype (Gerber et al., 1995). The heterogeneity 
suggests that Cdc37 is involved in a variety of cellular processes. Temperature-
sensitive mutants of CDC37 in S. cerevisiae have been valuable in understanding the 
role of this molecular chaperone in the cell cycle. cdc37 was first isolated in S. 
cerevisiae as two temperature-sensitive mutants, cdc37-1 and cdc37-2, that arrest in 
START of the cell cycle (Reed, 1980; Reed, 1980). Other S. cerevisiae CDC37 
temperature-sensitive mutants identified to date include cdc3 7-1 84 which also arrests 
in START (Valay et al., 1995) and cdc37-34 which arrests with a cell population split 
between Gi and a G2/mitosis arrest (Dey et al., 1996). It is interesting to note that the 
cdc37-1 (Gerber et al., 1995) and cdc37-184 (Valay et al., 1995) mutations are located 
around the joining region of the middle and C-terminal domains, whereas the cdc37-
34 mutation is located at the extreme N-terminus (Dey et al., 1996). Therefore, 
temperature-sensitive mutations in the N-terminal and middle domains of Cdc37 may 
cause different types of cell cycle arrests as they affect different aspects of Cdc37 
function and interactions with different cell cycle clients. 
Cdc37 has chaperone activity towards a range of client protein kinases that are crucial 
for cell cycle progression. These clients include cyclin dependent kinases (Cdk) such 
as Cdk4 (Dai et al., 1996; Lamphere et al., 1997; Stepanova et al., 1996) that is 
essential for GuS-phase transition. The kinase MPSJ is also a client of Cdc37 that is 
involved in spindle pole body duplication and GI control in S. cerevisiae and the 
lethality of the temperature-sensitive mutant mps1-1 is rescued by overexpression of 
Cdc37 (Schutz et al., 1997). These data indicate that the role of Cdc37 as a chaperone 
is of great importance to maintenance of components of the cell cycle. 
1.2.8.1 	The cell cycle 
Cell proliferation occurs by the ordered and regulated progression of the cell cycle, 
enabling a parent cell to duplicate and divide, producing two identical daughter cells. 
The progression of the cell cycle is highly regulated and various checkpoints exist that 
are activated by malfunction of a step in the cell cycle to ensure that cell growth and 
division are accurately executed generating viable progeny. The cell cycle consists of 
four distinct stages; GI, S phase, G2 and mitosis (Figure 1.9). In Gi and G2 the cells 
undergo a period of growth. During S phase the genetic material is replicated and 
mitosis involves the segregation of genetic material, followed by cleavage to generate 
two daughter cells. 
Cells can exit from the cell cycle in either Gi or G2, and cells in multicellular 
organisms that exit the cell cycle in Gi at the restriction point, arrest in a stationary 
phase called GO (Pardee, 1974). If cells do not exit the mitotic cell cycle at this point, 
then they are committed to complete the remaining cell cycle stages. In S. cerevisiae 
the restriction point in called Start (Hartwell, 1974), and occurs in GI which is the 
longest phase in the cell cycle for this organism. In contrast, G2 is the longest phase in 
the S. pombe and higher eukaryotic cell cycle. S. pombe is an ascomycetous fungus 
whose cell division occurs by medial fission, as observed in higher eukaryotes to 
produce two daughter cells of equal size (Figure 1.10). S. pombe cells are rod shaped 
and after division grow by apical extension, initially at the old end and then also from 
the new. The length of the rod shaped S. pombe cells is indicative of the cell cycle 
(Mitchison, 1957; Mitchison, 1990). 
Entry into each phase of the cell cycle is regulated by a family of protein kinases 
known as cyclin dependent kinases (Cdks). To initiate entry into the next cell cycle 
phase, the Cdk must be active which requires its association with an appropriate 
cyclin partner and both positive and negative phosphorylation at specific residues. 
Activation of some cell cycle checkpoints is due to a malfunction that can induce 
inactivation of the Cdk, preventing cell cycle progression until the discrepancy has 
been resolved. 
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Figure 1.9: A schematic of the cell cycle. This schematic is representative of the S. 
pombe cell cycle during which G2 is the longest phase. This is in contrast to S. 









Figure 1.10: A schematic diagram of the S. pombe life cycle. Cells usually divide by 
means of the haploid mitotic cell cycle. Under nutrient deprivation, cells exit the 
mitotic cell cycle, arresting in stationary phase or undergo conjugation to form diploid 
zygotes. The continuation of nutrient starvation of cells results in entry into meiosis, 
resulting in sporulation producing an ascus that contains four spores. If nutrients are 
provided, the spores undergo outgrowth and resume the mitotic cell cycle (MacNeil! 
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In S. cerevisiae and S. pombe, Cdc28 and Cdc2 respectively, are the main Cdks that 
promote the passages between GuS phase and G2/mitosis. The cyclin partner proteins 
are periodically present and rapidly degraded, which modulates their association with 
the Cdk and acts in part to regulate progression of the cell cycle. In S. cerevisiae 
Cdc28 associates with two different types of cyclin. To initiate the transition between 
Gi and S phase, Cdc28 forms an active complex with one of three Cln cyclins and 
one of six different Clb cyclins to modulate the progression between S, G2 and M 
phase (Mendenhall and Hodge, 1998). In S. pombe, two principal cyclin partners have 
been identified, Cdc 13 and Cig2, that associate with Cdc2 and regulate the G2/mitosis 
transition and entry into GI during the cell cycle (Moser and Russell, 2000). In 
contrast to these yeasts, higher eukaryotic cells contain a number of different Cdks to 
regulate the various stages of the cell cycle, including the Cdc2 homologue Cdkl (Lee 
and Nurse, 1987). Other Cdks include Cdk2 that regulates GuS and G2JM transitions, 
Cdk4 and Cdk6 are involved in passage of the restriction point and Cdk7 is important 
for the activation of other Cdks (Pollard and Earnshaw, 2002) 
1.2.8.2 	The cell cycle role of S. pombe cyclin-dependent kinase Cdc2 
In S. pombe, Cdc2 is the Cdk that is crucial for the transitions between G2/mitosis and 
GuS phase. Cdc2 protein levels remain constant throughout the cell cycle (Alfa et al., 
1989). Regulation of cell cycle progression by Cdc2 is controlled by modulating its 
activity at different stages by associating with specific cyclin partners and both 
negative and positive phosphorylation. Prior to the G2/mitosis transition, Cdc2 is 
phosphorylated on threonine 167 (Gould et al., 1991) to promote cyclin association 
and on tyrosine 15 (Gould and Nurse, 1989) to keep the Cdk inactive during 
interphase. Phosphorylation on threonine 167 is carried out by the Cdk-activating 
kinases (CAKs) (Lee et al., 1999) while tyrosine 15 is phosphorylated primarily by 
Weel (Gould and Nurse, 1989). Phosphorylation on threonine 167 allows Cdc2 to 
stably associate with a 482 amino acid B-type cyclin, Cdc13 (Booher and Beach, 
1988; Booher et al., 1989; Hagan et al., 1988). The Cdcl3 protein shows periodic 
changes in abundance (Alfa et al., 1989), accumulating through interphase and then 
being actively degraded at the metaphase-anaphase transition. To initiate mitosis, 
Cdc2 bound to Cdcl3 is activated by dephosphorylation on tyrosine 15 by the 
phosphatase Cdc25 (Nurse, 1997). Active Cdc2 is then localised to the nucleus by 
cyclin Cdcl3 and the active complex promotes mitosis (Alfa et al., 1989). 
1.2.8.3 	Cdc37 and the client Cdc28 
Temperature-sensitive mutants of Cdc37 in S. cerevisiae, cdc37-184 and cdc37-1, 
arrest at Start within Gi phase. As previously stated, the Cdk Cdc28 in S. cerevisiae is 
pivotal at this transitional stage of the cell cycle, and overexpression of Cdc28 rescues 
the lethality of cdc37-184 (Mort-Bontemps-Soret et al., 2002) and partially rescues 
the lethality of cdc37-1 at the restrictive temperature (Gerber et al., 1995). In contrast, 
overexpression of Cdc37 in the S. cerevisiae temperature-sensitive mutants cdc28-1 
and cdc28-4 could not suppress the lethality at the non-permissive temperature (Mort-
Bontemps-Soret et al., 2002). Cdc28 may be a client of Cdc37, as in the S. cerevisiae 
temperature-sensitive mutant cdc37-1 at the restrictive temperature, Cdc28 protein 
levels were dramatically reduced and activity was lowered 5-fold (Gerber et al., 
1995). Cdc37 also aids Cdc28 activation by facilitating its association with its cyclin 
partner, as in the cdc37-1 temperature-sensitive mutant there was a 6-fold drop in the 
amount of cyclin C1n2 associated with Cdc28 (Gerber et al., 1995). Furthermore, the 
N-terminal domain of Cdc28 binds the C-terminal domain of S. cerevisiae Cdc37 as 
determined by yeast-two hybrid (Mort-Bontemps-Soret et al., 2002), showing that 
these two proteins can biochemically interact. 
1.3 	This work 
1.3.1 	The molecular chaperone Cdc37 in S. pombe 
Cdc37 in S. pombe was isolated and found to be essential for cell viability (Westwood 
et al., 2004). Little is known about the molecular chaperone Cdc37 in S. pombe and its 
interactions with the co-chaperone Hsp90 or client proteins. The only client of Cdc3l 
identified in S. pombe to date is the protein kinase Spc 1 with which a biochemical 
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interaction has been detected (Tatebe and Shiozaki, 2003). To study Cdc37 further a 
range of cdc37 temperature-sensitive, 5 amino acid insertion, truncation and point 
mutation mutants were created using both random and directed mutagenesis. Each of 
these mutants was characterised to gain a better understanding of the molecular 
chaperone Cdc37 in S. pombe and the results are presented and discussed in this work. 
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Chapter 2: 
Materials and Methods 
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2.0 	Methods & Materials 
2.1 	General 
2.1.1 	Chemicals and enzymes 
Materials were generally purchased from Sigma-Aldrich, New England Biotech or 
Roche unless otherwise stated. 
2.1.2 	Commonly used reagents 
DNA loading buffer (6x stock): 	0.25% bromophenol blue 
40% sucrose 
PBS (lOx stock): 	 800 mM Na2HPO4 
200 mm NaH2PO4 
1MNaC1 
TBS (lOx stock): 125 mM NaCl 
25 mM Tris-HC1 pH8.0 
PBST/TBST: 1 x PBS/TBS 
0.1% (v/v) Tween-20 
Protein gel running buffer: 25 mM Tris-HCL 
200 mM glycine 
0.1% (w/v) SDS 
2x SDS protein buffer: 100 mM Tris-HCL pH6.8 
200 mM DTT 
4% (w/v) SDS 
0.2% (w/v) bromophenol blue 
sodium phosphate buffer pH5 
7.7 mm Na2HPO4 
42.3 mM NaH2PO4 
TAE (50x): 	 2MTris 
17.5% glacial acetic acid 
50 mM EDTA pH8 
TB (lOx pH8): 	 100 mM Tris-HC1 
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10 mM EDTA 
Transfer buffer: 	 20 mM glycine 
25 mM Tris-HCL 
20% (v/v) methanol 
Semi-dry Transfer Buffer: 	39 mM glycine 
48 mM Tris-HCL 
0.037% (w/v) SDS 
20% (v/v) methanol 
2.2 	DNA techniques 
2.2.1 	Plasmids 
2.2.1.1 	General vectors 
Table 2.1: DNA vectors that were employed for cloning and expression of various 
genes. 
Name Description Reference Use 
PFA6a-kanMX6 S. pombe (Bahler et al., 1998) Construction of 
expression Random Mutagenic 
vector PCR template to 
containing a generate cdc37 
G418 cassette temperature-sensitive 
mutants 
pBDC Yeast two- (Millson et al., Yeast two-hybrid assay 
hybrid vector 2003)  
pADC Yeast two- (Millson et al., Yeast two-hybrid assay 
hybrid vector 2003)  
pGEX- 1 GST fusion Amersham Make recombinant 
vector for p50 proteins with a 
and Cdc37 cleavable N-terminal 
GST tag 
2.2.1.2 	pREP vectors 
In 1990 Maundrell identified a highly expressed S. pombe gene, nmtl (o message in 
thiamine) that in the presence of thiamine was completely repressed at the 
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transcriptional level within 3 hours. The mechanism of repression of the nmt] gene is 
fully reversible. The nmt promoter was sub-cloned, creating an extra-chromosomally 
replicating plasmid for use in S. pombe, pREP3 with nutritional markers for selection 
(Maundrell, 1993). A general map of the pREP vector is shown schematically in 
Diagram 2.1. Deletion of bases in the TATA box of the nmt] promoter was found to 
reduce expression levels (Basi et al., 1993). Two plasmids were subsequently 
generated with reduced expression levels, pREP41 and pREP81, detailed in Table 2.2. 
The pREP vectors that were used in this work are listed in Table 2.3. 
	
2.2.1.3 	Modification of the pREP81 vector for N-terminal HA-tagging of 
proteins 
To N-terminally HA-tag proteins, the promoter region of the pREP8 1 vector was 
modified by PCR amplification using a 3' primer incorporating an HA-tag sequence 
upstream of Ndel. The customized promoter was cloned into pREP81 using 
restriction sites Ndel and Psi']. Cdc37 mutants were cloned into the pREP81-HA 
vector using restriction sites Nde] and Xmal. 
2.2.1.4 	Constructs 
All constructs generated and used in this work are listed in Tables 2.4 to 2.12. For 
expression in S. pombe genes were cloned into pREP vectors. The general cloning 
strategy for genes such as cdc37 into pREP vectors in shown in Diagram 2.2. 
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Table 2.2: pREP vectors with modified TATA box (Basi et al., 1993). Mutations 
within the TATA box of the nmtl promoter enable different levels of expression from 
for pREP vectors. The relative promoter activity was measured as CAT (Cm 
acetyltransferase activity.) 
Relative Promoter Activity 
Vector TATA box - thiamine + thiamine 
pREP3 or 1 ATATATAAA 80 1 
pREP41 IATAAA 1 12 0.06 
pREP81 IAT 1 	1 1 0.004 
Table 2.3: pREP vectors used in this work. 
Name Description Origin 
pREP 1 A high level expression vector with a leucine marker (Maundrell, 
gene 1990) 
pREP41 A pombe expression vector with a leucine marker (Maundrell, 
gene 1993) 
pREP8 1 A pombe expression vector with a leucine marker (Maundrell, 
gene 	 1 1993) 
pREP82 A pombe expression vector with a uracil marker gene 
enables expression at a level equal to pREP8 1  
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Diagram 2.1: A general map of a pREP vector denoting the nutritional marker and 
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Table 2.4: Constructs generated by directed mutagenesis for mutational analysis of 
the conserved N-terminal serine residues of cdc37. 
Name Origin Description 
pREP] -cdc37-S1417A ET Mutate Serine 14 and 17 to alanine 
pREP81-cdc37-S1417A ET Mutate Serine 14 and 17 to alanine 
pREP] -cdc3 7-S6A ET Mutate Serine 6 to alanine 
pREP81-cdc37-S6A ET Mutate Serine 6 to alanine 
pREPJ-cdc37414A ET Mutate Serine 14 to alanine 
pREP8]-cdc37-S]4A ET Mutate Serine 14 to alanine 
pREPJ-cdc37-S14E ET Mutate Serine 14 to glutamic acid 
pREP81-cdc37-S14E ET Mutate Serine 14 to glutamic acid 
pREP]-cdc37-S17A ET Mutate Serine 17 to alanine 
pREP81-cdc37-S17A ET Mutate Serine 17 to alanine 
pREP]-cdc37-S14L ET Recapitulate of cdc37-34 from S. cerevisiae 
pREP81-cdc37-S14L ET Recapitulate of cdc37-34 from S. cerevisiae 
pREP81-HA-cdc37-S14A ET N-terminally HA tag mutate S14 A 
pREP81-HA-cdc37-S14E ET N-terminally HA tag mutate S14 E 
pREP81-HA-cdc37-S14L ET N-terminally HA tag of cdc37-34 
pREP81-HA-cdc37 ET N-terminally tag cdc37 
Origin key: ET: Emma Turnbull 
KS: Katie Single - Honours Student 
IM: ma Martin - Post-doc 
CP: Chris Prodromou 
SM: Stuart MacNeill 
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Table 2.5: Truncation mutants of cdc37 generated by directed mutagenesis. 
Name Origin Description 
pREPJ-cdc37-120 ET Introduce a STOP codon at amino acid 120 
pREP81-cdc37-120 KS Introduce a STOP codon at amino acid 120 
Introduce a STOP codon at amino acid 120 pREPJ-cdc37-120T ET 
and remove remaining sequence 
Introduce a STOP codon at amino acid 120 pREP81-cdc37-120T KS 
and remove remaining sequence 
pREPJ-cdc37-360 ET Introduce a STOP codon at amino acid 360 
pREP41-cdc37-360 ET Introduce a STOP codon at amino acid 360 
pREP81-cdc37-360 ET Introduce a STOP codon at amino acid 360 
pREPJ-cdc37-360T ET 
Introduce a STOP codon at amino acid 360 
and remove remaining sequence 
Introduce a STOP codon at amino acid 360 
pREP41-cdc37-360T ET 
and remove remaining sequence 
Introduce a STOP codon at amino acid 360 
pREP81-cdc37-360T ET 
and remove remaining sequence 
introduce stop codon at amino acid 155 and  
pREPJ-cdc37-155 ET 
remove remaining sequence 
introduce stop codon at amino acid 155 and 
pREP81-cdc37-155 ET 
remove remaining sequence 
introduce stop codon at amino acid 190 and 
pREPJ-cdc37-190 ET 
remove remaining sequence 
introduce stop codon at amino acid 190 and 
pREP81-cdc37-190 ET 
remove remaining sequence 
introduce stop codon at amino acid 220 and 
pREPJ-cdc37-220 ET 
remove remaining sequence 
introduce stop codon at amino acid 220 and 
pREP81-cdc37-220 ET 
remove remaining sequence 
Table 2.6: Cdc37 mutants created by in vitro pentapeptide mutagenesis. 
Name Origin Description 
pREP81-cdc3 7-PA ET Insertion of 5 amino acids at codon 421 
pREP] -cdc3 7-PA ET Insertion of 5 amino acids at codon 421 
pREP81-cdc37-P] ET Truncation, STOP codon at amino acid 61 
pREP1-cdc37-P] ET Truncation, STOP codon at amino acid 61 
pREP81-cdc37-P2 ET Truncation, STOP codon at amino acid 421 
pREPJ-cdc37-P2 ET Truncation, STOP codon at amino acid 421 
pREP81-cdc37-P3 ET Truncation, STOP codon at amino acid 40 
pREPJ-cdc37-P3 ET Truncation, STOP codon at amino acid 40 
pREP81-cdc37-P5 ET Truncation, STOP codon at amino acid 354 
pREP1-cdc37-P5 ET Truncation, STOP codon at amino acid 354 
pREP81-cdc37-P6 ET Insertion of 5 amino acids at codon 252 
pREPJ-cdc37-P6 ET Insertion of 5 amino acids at codon 252 
pREP81-cdc37-P7 ET Truncation, STOP codon at amino acid 273 
pREP]-cdc37-P7 ET Truncation, STOP codon at amino acid 273 
pREP81-cdc37-P8 ET Truncation, STOP codon at amino acid 396 
pREPJ-cdc37-P8 ET Truncation, STOP codon at amino acid 396 
pREP81-cdc37-P9 ET Truncation, STOP codon at amino acid 333 
pREP]-cdc37-P9 ET Truncation, STOP codon at amino acid 333 
pREP81-cdc37-P]] ET Truncation, STOP codon at amino acid 301 
pREP1-cdc37-P11 ET Truncation, STOP codon at amino acid 301 
pREP8]-cdc37-P]5 ET Truncation, STOP codon at amino acid 261 
pREP1-cdc37-P15 ET Truncation, STOP codon at amino acid 261 
pREP81-cdc37-P23 KS Insertion of 5 amino acids at codon 120 
pREP]-cdc37-P23 KS Insertion of 5 amino acids at codon 120 
pREP81-cdc37-P30 KS Insertion of 5 amino acids at codon 386 
pREP]-cdc37-P30 KS Insertion of 5 amino acids at codon 386 
pREP81-cdc37-P35 ET Truncation, STOP codon at amino acid 428 
pREP]-cdc37-P35 ET Truncation, STOP codon at amino acid 428 
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Table 2.7: Constructs generated by directed mutagenesis of N-terminal serine 
residues of cdc37. 
Name Origin Description 
pREPJ-cdc37-S1417A ET Mutate Serine 14 and 17 to alanine 
pREP81-cdc37-S],]7A ET Mutate Serine 14 and 17 to alanine 
pREPJ-cdc3746A ET Mutate Serine 6 to alanine 
pREP81-cdc3746A ET Mutate Serine 6 to alanine 
pREP1-cdc37-SJ4A ET Mutate Serine 14 to alanine 
pREP81-cdc37-S14A ET Mutate Serine 14 to alanine 
pREPJ-cdc37-S14E ET Mutate Serine 14 to glutamic acid 
pREP81-cdc37-SJ4E ET Mutate Serine 14 to glutamic acid 
pREP]-cdc37-S17A ET Mutate Serine 17 to alanine 
pREP8]-cdc374]7A ET Mutate Serine 17 to alanine 
pREP]-cdc37-S14L ET 
Recapitulate temperature-sensitive mutant. 
cdc37-34 from S. cerevisiae mutating Serine 
14 to leucine 
pREP81-cdc37-SJ4L ET 
Recapitulate temperature-sensitive mutant 
cdc37-34 from S. cerevisiae mutating Serine 
14 to leucine 
pREP81-HA-cdc37-SJ4A ET N-terminally HA tag mutate Serine 14 to 
alanine 
pREP81-HA-cdc37-S]4E ET N-terminally HA tag mutate Serine 14 to 
glutamic acid 
pREP81-HA-cdc37-SJ4L ET N-terminally HA tag recapitulated 
temperature-sensitive mutant cdc37-34 from 
S. cerevisiae mutating Serine 14 to leucine 
pREP81-HA-cdc37 ET N-terminally tag cdc37 to compare 
expression levels with N-terminally HA 
 tagged Serine mutants 
Table 2.8: Plasmid used to express S. pombe cdc2 
Name Origin Description 
pIRT2-cdc2 SM For expression of cdc2 
ZE 
Table 2.9: Plasmids used in generating and analyzing cdc37 temperature-sensitive 
mutants. 
Name Origin Description 
Template for Random mutagenic PCR 
PFA6a-kanMX6-cdc37 ET 
incorporating cdc37, G418 cassette and 
cdc37 flanking sequence for homologous 
recombination into the chromosome 
PFA6a-kanMX6-cdc37-184 ET 
Template for introducing cdc37-184 into the 
genome by homologous recombination 
pREP81-cdc37-RMJ3-LH ET Recapitulate both cdc37-13 mutations 
pREPJ-cdc37-RMI3-LH ET Recapitulate both cdc37-13 mutations 
pREP81-cdc37-RM13-L ET 
Recapitulate cdc37-13 mutation glutamic 
acid 237 to lysine 
pREPJ-cdc37-RMJ3-L ET 
Recapitulate cdc37-13 mutation glutamic  
acid 237 to lysine 
pREP81-cdc37-RM13-H ET 
Recapitulate cdc37-13 mutation tyrosine 
261 to histidine 
pREP]-cdc37-RMJ3-H ET 
Recapitulate cdc37-13 mutation tyrosine 
261 to histidine 
Recapitulate cdc374 mutation leucine 286 
pREP81-cdc37-RMJ-1 ET to methionine 
Recapitulate cdc374 mutation leucine 286 
pREPJ-cdc37-RMJ-1 ET to methionine 
Recapitulate cdc3 7-f mutation histidine 305 
pREP81 -cdc3 7-RMJ-2 ET to leucine 
Recapitulate cdc374 mutation histidine 305 
pREPJ-cdc37-RMJ-2 ET to leucine 
pREP81 -cdc3 7.RMJ.3 ET 
Recapitulate cdc3 7-f mutation arganine 314 
to glycine 
Recapitulate cdc374 mutation arganine 314 
pREP1-cdc37-RMJ-3 ET to glycine 
pREP81-cdc37-RMJ-123 ET Recapitulate all 3 cdc374 mutations 
pREP1-cdc37-RMJ-123 ET Recapitulate all 3 cdc374 mutations 
Table 2.10: The cdc37 constructs for use in the yeast two-hybrid. 
Name Origin Description 
cdc37-pADC ET C-Terminal activating domain 
cdc37-pBDC ET C-Terminal DNA binding domain 
pADC-cdc37 ET I N-Terminal activating domain 
pBDC-cdc37 ET I N-Terminal DNA binding domain 
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Table 2.11: Constructs of human cdc37 (p50) generated and used in this work. 
Name Origin Description 
pREPJ-p50 ET For overexpression of p50 in S. poinbe 
pREP81-p50 CP For expression of P50 in S. pombe 
pGEX-lb-GST-p50 ET 
For expression of GST-p50 for GST Pull 
downs 
pREP81-P50-myc ET For size exclusion chromatography and IFs 
pREPJ-P50-myc ET For size exclusion chromatography and IP's 
p50-pADC ET 
C-Terminal activating domain for use in the 
Yeast two-hybrid 
p50-pBDC ET 
C-Terminal DNA binding domain for use in 
the Yeast two-hybrid 
pADC-p50 ET 
N-Terminal activating domain for use in the 
Yeast two-hybrid 
pBDC-p50 ET 
N-Terminal DNA binding domain for use in 
the Yeast two-hybrid 
Table 2.12: Constructs of S. pombe swol (the gene encoding S. pombe Hsp90). 
Name Origin Description 
pREP81-Swo] ET For expression of swol 
pREPJ-Swol ET For overexpression of swol 
pAD C-Swol ET 
N-Terminal activating domain for use in the 
Yeast two-hybrid 
pBDC-Swol ET 
N-Terminal DNA binding domain for use in 
the Yeast two-hybrid 
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2.2.2 	Purification of plasmid DNA using QlAfilter midi kit 
Plasmid DNA from E. co/i was purified using the Qiagen midi kit manufacturer's 
protocol (#12243) for a final yield of up to 100 pjg. 
2.2.3 	Small scale purification of plasmid DNA using QlAprep spin 
miniprep kit 
Up to 20 tg of plasmid DNA was purified from E. co/i using the QlAprep Spin 
Miniprep kit's protocol (#27106). 
2.2.4 	Crude preparation of plasmid DNA from E. coli 
Crude preparations of plasmid DNA for analytical purposes were made by inoculating 
4 ml of LB plus appropriate antibiotics with a single E. co/i colony. Cultures were 
grown overnight at 37 °C shaking at 200 rpm. 3 ml of overnight cell culture was 
harvested by centrifugation at 11,000 xg for 1 minute. Supernatant was removed and 
the pellet was resuspended in 100 j.il of STET by vortexing. 25 tl of Lysozyme buffer 
was added and samples were vortexed. 
STET: 	 8% sucrose 
5% Triton x-100 
50 mM Tris-HCL pH8.0 
5OthMEDTA 
Lysozyme buffer: 	 10 mM Tris-HCL pH8.0 
1rnMEDTA 
10 mg/ml of lysozyme 
Samples were boiled for 45 seconds then allowed to cool on ice for 1 minute. Tubes 
were centrifuged for 15 minutes at 11,000 xg and resulting pellets removed using a 
sterile toothpick. 125 tl of Isopropanol was added to each tube and vortexed. Samples 
were centrifuged for 10 minutes at 11,000 xg, the supernatant was discarded and 
pellets were allowed to air dry for 5 minutes. DNA pellets were resuspended in 30 pA 
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of Tris-RNAase (RNAase 10 mg/ml in Tris-HCL pH8.0). Samples were incubated at 
room temperature for 1 hour and then stored at -20 °C. 
	
2.2.5 	E. coli colony PCR for analysis of plasmid DNA 
Colony PCR was used for crude analysis of plasmid DNA from E. coli. A sterile 
toothpick was dipped into an E. coli colony, streaked on a LB-agar plate containing 
appropriate antibiotics and then swirled in an eppendorf tube containing 10 pd of 
dH20. Tubes were boiled ai 95 °C for 5 minutes, cooled on ice for 2 minutes and then 
spun down at 5000 xg for 2 minutes. 2 j.tl of each preparation was used in a Standard 
PCR reaction (Section 2.3.2.2). Reactions were then run on an agarose gel (Section 
2.2.7) for visualisation of the PCR amplified product. Plates containing streaked E. 
coli candidates were incubated overnight at 37 °C and then used as a source to make a 
clean DNA prep. 
2.2.6 	Restriction digest of DNA 
Restriction digests of DNA were carried out using a 1:10 dilution of appropriate 
buffer, 1 !.d BSA and 0.5-1 tl of restriction enzymes from Promega or NEB. 
Analytical digests were allowed to run at the optimum temperature for 2 hours in a 
total volume of 20 p1. Restriction digests to isolate DNA fragments for cloning were 
carried out overnight in a 50 jil reaction volume. 
2.2.7 	Visualization of DNA by electrophoresis in agarose gel 
DNA samples were run on agarose (Roche #1-388-991) gels for visualization, 0.7% 
agarose in TAE for fragments larger than 1kb and 1% for smaller. Ethidium bromide 
(Sigma-Aldrich #160539) was used at a 1:20,000 dilution to permit fluorescence of 
DNA bands and gels were run using the gel sub-cell (Bio-rad #170-4417). 
ME 
2.2.8 	Purification of plasmid DNA from agarose gels 
DNA plasmids smaller than 4kb that required a concentrated output in a small volume 
were purified using the Minelute TM  gel extraction kit (#28604) following the 
instructions provided by the manufacturer. DNA that was greater than 4 kb was 
cleaned by means of the QlAquick gel extraction kit (#28704) using the kit protocol. 
	
2.2.9 	Purification of DNA by Phenol-chloroform extraction and ethanol 
precipitation 
One volume of 25phenol:24chloroform: lisoamylalcol (phenol chloroform) was added 
to samples and vortexed for 30 seconds. Samples were centrifuged at 11,000 xg for 5 
minutes at room temperature and the upper phase was carefully transferred into a new 
tube. 2.5 volumes of 100% ethanol and 0.1 volume of 3 M NaOAc were added to 
samples and vortexed. Tubes were incubated at -70 °C for 20-30 minutes. Samples 
were spun at 4 °C at 11,000 xg for 10 minutes and ethanol was discarded. One volume 
of 70% ethanol was added to partially re-hydrate the DNA and centrifuged at 11,000 
xg for 5 minutes at 4 °C. The supernatant was removed and DNA pellets allowed to 
air dry. Finally, pellets were resuspended in 50 p.1 of appropriate buffer and stored at - 
20 °C. 
2.2.10 	Quantification of purified plasmid DNA 
The DNA content of samples was quantified using a Hitachi U-2000 
Spectrophotometer. A 1:200 dilution of DNA samples was made into dH 20 and placed 
in a quartz cuvette. Absorbency was determined at OD260 and 0D280. The 
concentration of nucleic acids can be calculated from the 0D260 reading where an OD 
1 corresponds to approximately 50 p.g/p.l assuming that the mass of a nucleotide pair 
is 660 daltons. The purity of nucleic acid can be estimated by the ratio between the 
readings at OD260 and 0D280 . A value of 1.8 for DNA indicates a relatively pure 
sample, lower figures indicate greater contamination. 
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2.2.11 	Ligation of DNA fragments 
Ligation of DNA fragments was carried out using 400 units of T4 DNA ligase (NEB 
#M0202) in a 1:10 dilution of buffer provided by the manufacturer. Ligation of DNA 
fragments with overhang ends were performed at room temperature for 30 minutes. 
Ligation of blunt ended fragments was carried out at room temperature overnight at 
4°C. 
2.2.12 	Phosphatase treatment of DNA fragments 
Vectors cut with a single restriction enzyme were treated with CIP (calf intestinal 
alkaline phosphatase (NEB #M0290)) to reduce plasmid re-ligation during cloning. 
Reactions' were 'carried out at 37 °C for 60 minutes using a 1:10 dilution of buffer 
provided by the manufacturer and 10 units of CIP. DNA was then purified using the 
QlAquick gel extraction kit (Section 2.2.8), substituting Buffer QG for Buffer PBS 
according to the manufacturer's protocol. 
2.2.13 	In vitro pentapeptide mutagenesis 
The GPS-LS linker scanning system (NEB #E7102) was used for in vitro 
pentapeptide transposition as shown in Diagram 2.3. 
Reactions were set up according to manufacturers instructions as shown below. 
Reaction: 	 2 1zi lox GPS Buffer 
1 pd pGPS5 Donor DNA (0.02 jLg) 
0.08 pg Target DNA (variable volume) 
dH2O to a final volume of 18 Al 
1 Al Tn5ABC*  Transposase was added to each reaction, mixed thoroughly and 
incubated for 10 minutes at 37 °C. 1 ttl of Start Solution was added to each sample 
and mixed. Reactions were incubated for 1 hour at 37 °C and then heat inactivated at 
75 °C for 10 minutes. 
Diagram 2.3: A schematic diagram to show how the cdc37 gene was mutagenised by 
in vitro pentapeptide transposition mutagenesis and cloned into pREP vectors. A 
cdc37 was cut from its vector, pREP81, using restriction enzymes NdeJ and Xmal 
and purified. B TnsABC*  Transposase was used to randomly insert a transposon into 
target DNA fragments from the GPS5 Transprimer-5 donor plasmid. C cdc37 
fragments were run on an agarose gel and those fragments containing the 1.7kb GPS5 
insertion were excised and purified using the QlAquick gel extraction kit. D 
Fragments were then ligated into the pREP81 vector using the restriction sites Ndel 
and Xmal. E The transprimer was removed from resulting plasmids by digestion with 
the restriction enzyme Pine]. Plasmids were recircularised in the presence of T4 DNA 
ligase, leaving a 15 bp insertions. Plasmids were then sequenced to identify the 
insertion. 
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All oligonucleotides were purchased from MWG Biotech or Sigma-Aldrich. 
Oligonucleotide pellets were re-hydrated as a 100 pM stock with dH 20 for 1 hour at 
37 °C. PCR amplifications were carried out using 10 jiM oligonucleotides and 3.2 j.tM 
for sequencing reactions. Oligonucleotides designed for Stratagene Quick change TM 
site directed mutagenesis (Section 2.3.5) were diluted to a stock of 100 jig/ml, using 
125 ng/tl per PCR reaction. Oligos used in this work are listed in Tables 2.13 to 2.19. 
Key: 	GCTA 	mutation 
GCTA 	introduced restriction site 
FIR 	Forward or Reverse respectively 
Table 2.13: List of oligonucleotides used for sequencing and amplification of the 
cdc37 gene 
Name Sequence Direction Bps Description 
PW cdc37 #1 CATGCCATGGCAATTGAT F 24 Sequence starting at base 
TACAGC  pair 1 of cdc37 ORF 
PW cdc37 #2 ATCCGAAGGAGATFCCTF R 28 Sequence starting at base 
pair240_of cdc37 0RF 
PW cdc37 #3 AACATAAGGATCCGAAG R 21 Sequence starting at base 
GAA  pair 249 of cdc37 ORF 
PW cdc37 #4 CGATGAATCGTAGGCTCT F 21 Sequence starting at base 
TOT  pair 190 of cdc37 ORF 
PW cdc37 #5 CCGAATTCATATGGCAAT F 28 Sequence starting at base 
TGATACAGC  pair 1 of cdc37 ORF 
PW cdc37 #6 GCAGCCCGGGTAAGACA R 28 Sequence starting at base 
ATTGAGGAAT  pair 1401 of cdc37 ORF 
PW cdc37 #11 GATCGTCGACATGGCAAT F 28 Sequence starting at base 
TGAFACAGC  pair 1 of cdc37 ORF 
PW cdc37 #12 TCCATCACCATCCCGGAG F 18 Sequence starting at base 
pair_1147_ofcdc37ORF 
PW cdc37 #14 TTGGGCTTTGATTCCACC F 18 Sequence starting at base 
pair 526_of cdc37 ORF 
PW cdc37 #15 TCTTCCTCATCTGCCAAG R 18 Sequence starting at base 
______ pair_839_of cdc37 ORF 
Table 2.14: List of oligonucleotides used for mutating the cdc37 gene 
Name Sequence Direction Bps Comments/Purpose 
cdc3 7-1 84 #2 GATGCTATTCFITIGGAA F 41 Overlap PCR to mutate 
GATITI'AATGCTGAACTA alanine 275 to aspartic 
GAAGG  acid 
cdc37-184 #3 CCTFCTAGTTCAGCATFA R 41 Overlap PCR to mutate 
AAATCT11TCCAAAAGAATA alanine 275 to aspartic 
GCATC  acid 
cdc37-J-1 #3 CCCTI'CTAGTFCAGCTT F 28 Overlap PCR to 
AAAGGCTTCC recapitulate cdc37-J 
mutation #1 
cdc37-J-1 #2 GGAAGCC1TFAAçGCTGA R 28 Overlap PCR to 
ACTAGAAGOG recapitulate cdc37-J 
mutation #1 
cdc37-J-2 #3 CAAAAGGGCTT'OMGAA F 30 Overlap PCR to 
CATAT7GF111'GC recapitulate cdc37-J 
mutation #2 
cdc37-J-2 #2 GCAAAACAATATGTTCIT R 30 Overlap PCR to 
CAAGCCCT1TFG recapitulate cdc37-J 
mutation #2 
cdc37-J-3 #3 GGTCCAAGCTGTCçGCAA F 27 Overlap PCR to 
TAGCTGAT recapitulate cdc37-J 
mutation #3 
cdc37-J-3 #2 GATCAGCTA11I'GCGACA R 27 Overlap PCR to 
GCTFGGACC recapitulate cdc374 
mutation #3 
cdc3 7-13-H #3 CCGATGAAGAATATCA R 25 Overlap PCR to 
CCAAAATC recapitulate cdc37-13 
mutation #H 
dc3 7-13-H #2 GATITTGGTGATCATFCT F 25 Overlap PCR to 
TCATCGG recapitulate cdc37-13 
mutation #H 
cdc37-13-L #3 CATCTT'CCGACTTATTCT R 23 Overlap PCR to 
CATTG recapitulate cdc37-13 
mutation #L 
cdc37-13-L #2 CAATGAGAATAAGTCGG F 23 Overlap PCR to 
AAGATG recapitulate cdc37-13 
mutation #L 
cdc37 Ndel 3' GCAGCATATGTTAAGAC R 28 Introduce Ndel site at 3' 
AA1TGAGGAAT  end of cdc37 
cdc37-S14A #2 GGATAAGCTAGAACTTGC F 35 Overlap PCR to mutate 
TGATGACAGTGACATFG  serine 14 to alanine 
cdc37-S14A #3 CAATGTCACTGTCATCAG R 35 Overlap PCR to mutate 
CAAGTFCTAGCTTATCC  serine 14 to alanine 
cdc37- S14E #2 CAATGTCACTGTCATCTF R 35 Overlap PCR to mutate 
GAAGTTCTAGCfl'ATCC  serine 14 to glutamic acid 
cd07414E #3 GGATAAGCTAGAACflTcA F 35 Overlap PCR to mutate 
AGATGACAGTGACATTG  serine 14 to glutamic acid 
rsj 
Table 2.14 continued: List of oligonucleotides used for mutating the cdc37 gene 
Name SEQUENCE Direction Bp's Comments/Purpose 
cdc37417A #2 GAAC'VI'AGTGATGACGCT F 35 Overlap PCR to mutate 
GACATFGAAGTFCATCC  serine 17 to alanine 
cdc37-S17A #3 GGATGAACTrCAATGTCA R 35 Overlap PCR to mutate 
GCGTCATCACTAAG'TTC  serine 17 to alanine 
cdc37-S6A GAATTCATATGGCAATTG F 39 Mutate serine 6 to alanine 
ATITACGCTAAGTGGGATA 
AGC  
cdc37-S1417A GGATAAGCTAGAACTFGC F 44 Overlap PCR to mutate 
#2 IGATGACTGACA11TGA serine 14 and 17 to 
G1TCATC  alanine 
cdc37-S1417A GATGAACTTCAATGTCAG R 44 Overlap PCR to mutate 
#3 CGTCATCAGCAAGTT'CCT serine 14 and 17 to 
AGCfl'ATCC  alanine 
cdc37414L #2 GGATAAGCTAGAAC1Tfl F 35 Overlap PCR to mutate 
AGATGACAGTGACATTG  serine 14 to leucine 
cdc37-S14L #3 CAATGTCACTGTCATCL, R 35 Overlap PCR to mutate 
AAAGTI'CTAGCTITATCC  serine 14 to leucine 
cd37-220 #2 GATTTTCCCGGCGCTTA, F 30 Overlap PCR to introduce 
GAGCAAGC  stop codon to residue 220 
cdc37-220 #3 GC1 FGCTCfAAGCGCCG R 30 Overlap PCR to introduce 
GGAAAATC  stop co on to residue 220 
cdc37-220 xmal CGCGCGCCCGGGTTATT R 34 Introduce 2 stop codons 
AAGCGCCGGGAAAATC and Xmal site at residue 
220 
cdc37-190 #2 GGAGCCTGAAIMCCTA F 24 Overlap PCR to introduce 
AAAAGAC  stop codon to residue 190 
cdc37-190 #3 GTCTTTTAGGtI4JTCA R 24 Overlap PCR to introduce 
GGCTCC  stop codon to residue 190 
cdc37-190 xmal CGCGCGCCCGGGT17A1T R 34 Introduce 2 stop codons 
ATTCAGGCTCCTYVVFC and an Xmal site at 
residue 190 
cdc37-155 #2 GCTAGAAGATGCAIMA F 26 Overlap PCR to introduce 
AGOAGTATG  stop codon to residue 155 
cdc37-155 #3 CATACTCCT1ILTGCAT R 26 Overlap PCR to introduce 
CTTCTAGC  stop codon to residue 155 
cdc37-155 xmal CGCGCGCCCGGGTTATT R 34 Introduce 2 stop codons 
ATGCATCTFCTAGCAAC and Xmal site at residue 
155 
cdc37-360 #2 GCCATCAGCAAATMCA F 28 Overlap PCR to introduce 
AGCTGAAAGCG a stop codon to residue 
120 
cdc37-360 #3 GCTVFCAGCTTGIIATIT R 26 Overlap PCR to introduce 
GCTGATGG a stop codon to residue 
 120 
cdc37-360 xmal GC1TTCCCCGGGITTT7 R 26 Introduce a stop codon 
GCTGATGG and an Xmal site at 
residue 120 
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Table 2.15: List of oligonucleotides used in the construction of the random 
mutagenesis (RM) template to generate temperature-sensitive mutants of the cdc37 
gene 
Name Sequence Direction Bp 's Comments/Purpose 
RM EcoRl 5' GCACGAATTC' 111T1'CTG F 31 Introduce EcoRl site to 5' 
CTI'ACGGGTGTGC of 300bp of cdc37 3' 
flanking sequence 
RM EcoRl 3' GCACGAATTCAGCACTA R 35 Introduce EcoRl site to 3' 
TGGAGTGAAGTTTGAGG of 300bp of cdc37 3 
G  flanking sequence 
RM Bg1H 3' GCCTGTGTAAACCCCGTF R 41 Introduce Bgl II site to 3' 
TCAGATCTATFCCGTI'CA of cdc37 
rrrCC  
RM Pad 5' GAACGGAATI'TAATTAA F 35 Introduce a Pacl site at 
AACGGGG1TT'ACACAGG the 5' of cdc37 plus 300 
C  bp of 5' flanking sequence 
HRC RM cdc37 GGTTTACACAGGC'ITII'G F 19 PCR amplification of 
5' G fragments for homologous 
recombination 
HRC RM cdc37 GGCCATVFGGACTACATA R 20 PCR amplification of 
3' IT fragments for homologous 
recombination 
G-418 13795' TTVI'CGCCTCGACATCAT F 20 Sequence staring at 1379 
CT  in template from 5' 
ET Seq 1 cdc37 GTACTCCAATCAAAGGCA R 20 Sequence starting at base 
TC pair 21013 of cdc37 
cosmid c9b6 
ET Seq 2 cdc37 CTATTCTITI'GGAAGCCT F' 23 Sequence starting at base 
ITAAT pair 22107 of cdc37 
cosmid c9b6 
ET Seq 3 cdc37 GTTAGGAGGAAAAGACT R 23 Sequence starting at base 
CAAAAG pair 22464 of cdc37 
cosmid c9b6 
ET Seq 4 cdc37 AAATATTACGCGTTFATF F 23 Sequence starting at base 
GTAGC pair 20412 of cdc37 
cosmid c9b6 
ET Seq 5 cdc37 GTGGGAAGTAATAGAGT F 24 Sequence starting at base 
ATTCGT pair 20332 of cdc37 
cosmidc9b6 
PW cdc37 #16 GTCAAATCGACGAGAAT F 18 Sequence starting at base 
A pair 20751 of cdc37 
cosmid c9b6 
PW cdc37 #17 AAATCAATAAATAAAATT R 21 Sequence starting at base 
TCA pair 22758 of cdc37 
cosmid c9b6 
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Table 2.16: List of oligonucleotides used for amplifying, mutating and sequencing of 
the p50 gene 
Name Sequence Direction Bps Comments/Purpose 
GST-p50 GCATGGATCCATGGTGG F 26 Introduce 5' BamHl site 
BamHl 5' ACTACAGCG to p50 to clone into 
pGEX6P- 1 
GST-p50 Xhol GCATCTCGAGCACACTG R 28 Introduce 3' Xhol site to 
3' ACATCCTTCTC p50 to clone into 
pGEX6P- 1 
mycx6 3' GCATGGATCC'VI'ACTATF R 33 Introduce BamHl site into 
BamHl used ACAAGTCCTCTFCAG myc tag to insert into 
pREP 
mycx6 5' GCATGGATCCATGGAGC F 25 Introduce BamHl site into 
BamHl AAAAGCTC myc tag to insert into 
pREP 
p50 BamHl GCATGGATCCCACACTG R 28 Introduce BamHl site into 
3'(minus STOP ACATCCTTCTC p50 and remove 3' stop 
codon)  codon to insert myc tag 
p50 Forward GTAAATACCAAGCCCGA F 23 Sequence from bp 384 of 
primer 2 GAAGAC  p500RF 
p50 Reverse CTGTC'TTAATCTI'AGTGA R 26 Sequence from bp 704 of 
primer 1 AGAACTGC p50 ORF 
TabIe12.17: List of oligonucleotides used for work with pREP vectors 
Name Sequence Direction Bp's Comments/Purpose 
pREP81 HA 5' GCTGCATGCCTGCAGGTC F 34 introduce N-terminal HA 
GATCGACTCTAGAGG tag and retain Ndel at 5' of 
pREP81 
pREP81 HA 3' GCATCATATGAGCGTAG R 62 introduce N-terminal HA 
TCTGGGACGTCGTATGGG tag and retain Ndel at 3' of 
TAATFAACAAAGCGACTA pREP8 1 
TAAGTCAG  
nmt 3' GCAGCTGAATGCCCATAG R 20 Sequence starting at bp 100 
T  from Ndel site 
nmt 5' GGAATCCGCAATCATCAA F 22 Sequence starting at bp 100 
TTG  from Ndel site 
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Table 2.18: List of oligonucleotides used for amplifying, mutating and sequencing of 
the swol gene 
Name Sequence Direction Bp's Comments/Purpose 
swol Ndel 5' GATGCTAGCATATGTCG F 28 Introduce Ndel at 5' of 
AACACAGAAAC  p50 
swol Xmal 3' CTGACCCGGG'VI'AATCG R 29 Introduce Xmal at 5' of 
ACTI'CCTCCATC  p50 
Table 2.19: List of oligonucleotides used in the construction of plasmids for the yeast 
two-hybrid 
Name Sequence Direction Bp's Comments/Purpose 
pADC Y211 CP OAAATFCGCYFATVITAGA R 24 Colony PCR of swol in 
AGTGTC pADC vectors, sequence 
starting at bp 189 from 
PvuII_site 
pBDC Y211 CP GATGGGCATT'AATTCTAG R 22 Colony PCR swol in pBDC 
TCAT vectors, sequence starting at 
bp_207_  from _PvuIlsite 
cdc37 Y2H CTGACCCGGGATGGCAA F 28 Introduce Smal at 5' of 
Smal-5' 1TGATTACAGC cdc37 to insert into yeast  
two-hybrid vectors 
Cdc37 Y211 ACGTCCCGGGAGACAAT R 29 Introduce Smal and remove 
Smal-3' minus TGAGGAATAGTC STOP codon at 3' of cdc37 
STOP codon to insert into yeast two- 
hybrid_vectors 
Y2H swol Smal CTAGCCCGGGATGTCGAA F 23 Introduce Smal at 5' of 
5' CACAO swol to insert into yeast 
two-hybrid_vectors 
Y2H swol Smal CTGACCCGGGATCGACTF R 26 Introduce Smal and remove 
3' minus STOP CCTCCATC STOP codon at 5' of swol 
codon to insert into yeast two- 
hybrid_vectors 
Y2H p503' GCATCCCGGGCACACTGA R 28 Introduce Smal and remove 
Smal minus CATCCTTCTC STOP codon at 3' of p50 to 
STOP codon insert into yeast two-hybrid 
vectors 
Y2H p503' GCATCCCGGGTCACACAC R 31 Introduce Smal at 3' of p50 
Smal plus TGACATCCfl'CTC to insert into yeast two- 
STOP codon  hybrid vectors. 
Y2H p50 5' GCATCCCGGGATGGTGG F 26 Introduce Smal at 5' of p50 
Smal ACTACAGCG to insert into yeast two- 
________________  hybrid vectors 
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2.3.2 	PCR reactions 
2.3.2.1 	Sequencing PCR reactions 








to a total volume of 20 p1 
Reaction: 	Step 1 94 °C 
Step 2 96 °C 
Step 3 50°C 
Step 4 60 °C 
Repeat Steps 2 to 4 30 times 






2.3.2.2 	Standard PCR amplification reactions 
Add in reaction: 	DNA 50 ng 
Primer 1 1 p1 of 10 jiM stock 
Primer 2 1 p1 of 10 jiM stock 
Buffer 2 jfl of lOx stock 
dNTPs 0.4 p1 of 100 tM stock 
Polymerase 0.1 p1 taq/0.2 p1 Pfu 
dH20 add to total volume of 20 p1 
Reaction: 	Step 1 94 °C 	3 minutes 
Step 2 94 °C 	90 seconds 
Step 3 variable variable 
Step 4 72°C 	3 minutes 
Repeat Steps 2 to 4 30 times 
Extension 72 °C 	3 minutes 
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2.3.3 	PCR polymerase 
For analytical applications Taq DNA polymerase (Roche #1-146-173) was used. Pfu 
DNA polymerase (Promega #M7741) was used for proofreading ability during PCR 
reactions where accurate replication of sequence was essential. 
2.3.4 	Directed mutagenesis 
Directed mutagenesis was used to change specific base pairs to substitute codons, 
utilizing the most frequently occurring arrangement of base pairs for that residues in 
S. pombe according to (Forsburg, 1994). Oligos were designed incorporating the 
desired mutation. Standard PCR reactions were carried out using designated oligos. 
Products were purified (Section 2.2.8), restriction digested (Section 2.2.6) and ligated 
into appropriate vectors. 
2.3.5 	Site directed PCR mutagenesis 
The Stratagene Quick change TM  site directed mutagenesis XL (#200517) kit was used 
to introduce specific mutations by following the protocol provided by the 
manufacturer. 
2.3.6 	Directed mutagenesis by overlap PCR 
Site directed mutagenesis to change specific codons was performed by overlap PCR 
as shown schematically in Diagram 2.4. 
2.3.7 	PCR purification 
PCR amplified fragments were purified using the QlAquick gel extraction kit (# 
28704) substituting Buffer QG for Buffer PBS according to the instructions by the 
manufacturer. 
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Diagram 2.4: Directed mutagenesis by overlap PCR; A Standard PCR reactions were 
carried out with primer combinations 1 & 3 and 2 & 4 using pfu polymerase. The red 
star indicates the mutation being introduced. B PCR products were run on a DNA gel 
and bands cut out manually. C PCR products from both reactions were transferred 
into a single tube and covered with dH 20. Samples were incubated for 30 minutes at 
37 °C. The eppendorf was inverted to mix contents. D & E 15 .tI was used as a 
template for a second Standard PCR reaction with oligonucleotides 1 and 4. The final 
product was run on a DNA gel, purified and then cloned as appropriate. 










2.3.8 	Purification of DNA sequencing reactions 
To purify DNA sequencing reactions for analysis, 3 tl 3 M sodium acetate pH5.8, 
62.5 j.tl ethanol and 14.5 pi dH20 were added to samples once the PCR sequencing 
reaction had been carried out. Reactions were incubated at —80 °C for 15 minutes. 
Samples were then centrifuged at 4 °C for 30 minutes at 11,000 xg and then rinsed 
with 70% ethanol. DNA was dried in a speed vacuum for 10 minutes then sent for 
sequence analysis. 
2.4 	Bacterial Methods 
2.4.1 	E. coli Strains 
The E. coli strain DH5a was used for general molecular cloning and the strain BL21 
for the expression of GST fusion proteins. 
2.4.2 	Media 
Luria Broth (LB): 	 10 g/l bacto-tryptone 
5 g/l bacto-yeast extract 
5 g/l NaCl 
pH7 (NaOH) and stored at room temperature 
Solid LB: 
	




100 mg/mI in dH 20 (Sigma-Aldrich #A9518) 
Working concentration 0.5 pJ/ml 
Kanamycin stock 
	
50 mg/ml in dH20 (Sigma-Aldrich #0879) 
Working concentration 0.5 pd/ml 
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2.4.4 	Blue-white selection of E. coli colonies using x-gal 
Identification of positive clones from the Stratagene Quick change TM  site directed 
mutagenesis by blue-white selection required the addition of 5-bromo-4-chloro-3-
indolyl-3-D-ga1actosidase (x-gal) (Amersham #US 10077) to media of -60 °C. A 
stock solution of 50 mg/ml was added to media to a final concentration of 40 tg/ml. 
2.4.5 	Making and transforming competent E. coli 
2.4.5.1 	Making E. coli competent for heat shock transformation 
Retransformation of plasmids was carried out by heat shock transformation of DH5a 
as described by (Inoue et al., 1990). Competent E .coli stocks were made by 
inoculating 250 ml of SOB media in a 2 litre conical flask and incubating overnight at 
18 °C shaking at 200 rpm. 
SOB: 	 2% tryptone 
0.5% yeast extract 
10 mM NaCl 
2.5 mM KC1 
10 MM MgC12 
10 MM MgSO4 
At an OD600 of 0.6 the culture was placed on ice for 10 minutes. Cells were 
centrifuged at 4 °C for 10 minutes at 5000 xg. The pellet was then resuspended in 80 
ml of ice cold TB and incubated on ice for 10 minutes. Cultures were then spun down 
at 5000 xg at 4 °C for 10 minutes and resuspend in 18.6 ml of ice cold TB and 1.4 ml 
of DMSO. The cells were then distributed out as 200 xl aliquots in eppendorfs which 
were snap frozen in liquid nitrogen and store at -80 °C. 
TB: 	 l0mMPipes 
15 mMCaCl2 
250 mM KC1 
55 mM MnC12 
2.4.5.2 	Heat shock transformation of DNA plasmids into competent E. coli 
To transform plasmids by heat shock, aliquots of competent DH5a were thawed on 
ice and 100 p.1 of E. co/i were added to DNA. Samples were mixed well and incubated 
on ice for 30 minutes. Aliquots were heat shocked at 42 °C for 90 seconds and then 
kept on ice for 2 minutes. 1 ml of LB was added to each reaction which was then 
incubated at 37 °C shaking at 200 rpm for 30-45 minutes. 200 p.1 of cells were then 
plated on LB agar plus appropriate antibiotics and incubated overnight at 37 °C. 
	
2.4.5.3 	Making competent E. coli for transformation by electroporation 
Electroporation was used for DNA requiring high efficiency transformation. 
Competent DH5a or BL21 E. coli were made by picking 10 individual colonies from 
a freshly streaked plate and inoculating a 10 ml LB culture. Cells were shaken at 200 
rpm overnight at 37 °C. The 10 ml cell culture was then used to inoculate 1 litre of 
LB. The culture was allowed to grow up to an 0D6 00 of 0.35-0.4. E. coli were then 
incubated on ice for 1 hour. All of the following steps were carried out at 4 °C. The 
cell culture was centrifuged for 15 minutes at 5000 xg, supernatant was discarded and 
the pellet was resuspended in 2 ml of ice cold 10% glycerol. Cells were spun at 5000 
xg for 15 minutes and resuspended in 25 ml of ice cold 10 % glycerol. This step was 
then repeated twice. Cells were resuspended in 1 ml of ice cold 10% glycerol and 
centrifuged at 5000 xg for 15 minutes. This step was repeated a second time. 50 p.1 
aliquots were made, snap frozen in liquid nitrogen and store at —80 °C. 
2.4.5.4 	Electroporation transformation of DNA plasmids and ligations 
into competent DH5a or BL21 E. coli 
For electroporation transformation, aliquots were thawed on ice and 50 p.1 of ice cold 
10% glycerol was added. An appropriate amount of target DNA was placed into a 
pre-chilled electroporation cuvette with cells and mixed thoroughly. Cuvettes were 
chilled on ice for 5 minutes then shocked at 1.8 kV, 25 p.Fd capacitance, 200 
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resistance on a Bio-Rad Gene-Pulser. 900 tl of LB was immediately added to each 
sample. Cells are transferred to eppendorfs and grown up over 1 hour at 37 °C. 
Bacteria were then plated onto LB-agar plates plus appropriate antibiotics and 
incubated at 37 °C overnight. 
2.5 	Yeast 
2.5.1 	S. pombe stains 
A list of the S. pombe strains used in this work are shown in Table 2.20. 
2.5.2 	S. pombe media for vegetative growth 
S. pombe strains were grown on Yeast Extract (YE) a complex medium containing all 
necessary amino acids and that inhibits conjugation and sporulation. YE media 
contains thiamine which represses the nmtl promoter of pREP vectors. 





ED1090 ura4-D18 leul-32 h 
ED1526 ade6-M21 ura4-D]8 leul-32 his]-102 cdc37::his] pREP82-cdc37 
ED1537 swol-2HA ura4-D18 leu]-32 (Munoz and Jimenez, 1999) 
leu]-32 ura4-D]8 h cdc37-681 (temperature-sensitive mutant) (Tatebe 
ED1538 and Shiozaki, 2003) 
leul-32 h 	swo]-26 (Hsp90 temperature-sensitive mutant) (Aligue et al., 
ED1560 
1994) 
ura4-D18 leu]-32 G-418 h 	cdc37::G4]8 cassette 
ED1565 
(cdc37-]84_  temperature-sensitive _mutant) 
ED1566 
ura4-D18 leu]-32 G-418 h 	cdc37::G4]8 cassette 
(cdc37-]3_  temperature-sensitive _mutant) 
ura4-D18 leu]-32 G-418 h 	cdc37::G418 cassette 
ED1567 
(cdc3 7-J temperature-sensitive_mutant) 
ED0824 I Cdcl0-129 leul-32 h 	(temperature-sensitive mutant) (Nurse et al., 1976) 
Mi 
YE: 	 5 gIl Oxoid yeast extract 
30 g/l glucose 
120 mg/i adenine, histidine, leucine, lysine 
hydrochloride and uracil 
For vegetative growth Edinburgh Minimal Media (EMM) was used which enabled 
selective growth of strains by the addition of appropriate amino acids and expression 
of pREP plasmids due to the absence of thiamine. 
Emm: 	 3 g/l potassium hydrogen phthalate 
2.2 g/l Na2HPO4 
5 g/l NaC1 
2% (w/v) glucose 
20 mi/i salts (from a 50x stock) 
1 mi/i vitamins (1000x stock) 
0.1 mi/i minerals (10,000x stock) 
Salts (50x): 	 52.5 g/l M902 6H0 
0.735 mg/i CaC12 2g/1H20 
50 g/l KC1 
2 g/l Na2SO4 
Vitamins (1000x): 	 1 gli panthothenic acid 
10 g11 nicotinic acid 
10 g/1 myo-inositoi 
10 mg/i biotin 
Minerals (10,000x): 	 5 g/i boric acid 
4 g/l MnSO4 
4 g/l ZnSO4 . 7H20 
2 g/l FeC12 . 6H20 
0.4 g/i molybdic acid 
1 gIl KI 
0.4 g/i CuSO4 • 5H20 
10 g/l citric acid 
2.5.3. 	Amino acids 
Table 2.21: Amino acids added to EMM in this work are outlined below: 




Adenine A-9126 3.75 gIL 
Leucine U-0750 7.5 gIL 
Uracil H-8125 3.75 g/L 
Histidine L-8000 7.5 g/L 
Thiamine T-4625 15 g/L 
	
2.5.4 	5FOA media 
In the presence of 5' fluoro-2'-deoxyuridine (5FOA), Ura strains generate a toxic 
metabolite which is lethal and results in cell death (Grimm et al., 1988). 5FOA 
(Toronto Research Chemicals Inc. #595000) was added to melted EMM-agar media at 
55 °C at 1 mg/ml to make plates for the plasmid shuffle assay (Section 2.7.1). 
2.5.5 	G418 
The PFA6a-kanMX6 plasmid (Bahier et al., 1998) contains a G418 cassette that 
expresses resistance in S. pombe against Geneticin (G418 sulphate) (Gibco #11811-
031). G418 was dissolved into molten YE media (-60 °C) at a concentration of 1 g/L. 
2.5.6 	Phloxin-B 
S. pombe cells that are dead are permeable to Phioxin B which stains them red. 
Phioxin B (Sigma-Aldrich #P-2759) was added to melted agar media (-60 °C) at a 
final concentration of 1.75 tg/ml. 
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2.5.7 	Storage of S. pombe strains 
Yeast strains were stored in the short term on plates at 4 °C sealed with paraflim. S. 
pombe strains were stored for the long term by mixing 1.4 ml of cells grown in 
selection media with 0.6 ml of autoclaved glycerol. Samples were frozen at —80 °C in 
1.8 ml Nunc CryotubeTM Vials (#368632). 
2.5.8 	Waking up S. pombe strains 
S. pombe strains were woken up by scraping a small amount of frozen stock onto a 
sterile pipette tip. Samples were then placed on a plate containing media that would 
select for its growth and incubated at a suitable temperature for 2-3 days. Using a 
toothpick, cells were streaked out to enable single colony formation. Three single 
colonies per strain were then patched onto different selection media and incubated at 
appropriate temperatures for growth to ensure correct genotype. 
2.6 	Transformation of DNA into S. pombe protocols 
2.6.1 	Transformation by electroporation of plasmid DNA into S. pombe 
DNA plasmids were transformed into S. pombe strains by electroporation. 10 ml of 
appropriate media was inoculated with a swab of cells on a sterile toothpick. 
Precultures were incubated at an appropriate temperature for 2 days. A suitable 
amount of preculture was used to inoculate 200 ml of liquid media. Cultures were 
incubated at a given temperature, shaking at 200 rpm overnight. At an 0D 600 of 0.4-
0.5 cells were harvested by centrifugation at 5000 xg for 5 minutes. Cells were then 
washed 3 times with 20 ml ice cold 1.2 M Sorbitol, spinning at 5000 xg for 3 minutes 
between steps and consolidating each culture. Finally, the pellet was resuspended in 2 
ml of ice cold 1.2 M sorbitol. 0.2 ml of cells was added to approximately 0.5 tg of 
plasmid DNA in a sterile cuvette and stored on ice. Each cuvette was pulsed at; 2.25 
kV, 200, 25 uF. 0.5 ml of ice cold 1.2 M Sorbitol was immediately added to the 
transformation. 0.2 ml of transformed cells was spread on EMM plates plus suitable 
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amino acids for selection. Plates were incubated at an appropriate temperature for 3-4 
days until single colonies were formed. 
2.6.2 	Lithium acetate based transformation for PCR based gene 
targeting in S. pombe 
Transformation of PCR fragments for homologous integration into the chromosomal 
DNA was performed using the Lithium Acetate method as described by Bahier., et al 
(1998). Precultures were grown for two days in suitable media at an appropriate 
temperature. A 200 ml culture was inoculated with preculture and grown at an 
appropriate temperature shaking at 200 rpm overnight. At an 0D 600 of 0.4-0.5 cells 
were harvested at 5000 xg for 5 minutes. Supernatant was discarded and the pellet 
was washed in an equal volume of dH 20. Cells were then spun down at 5000 xg for 5 
minutes and pellets were resuspended in 1 ml of dH 20 by vortexing. Samples were 
transferred to a 1 .5ml eppendorf and spun for 5 minutes at 5000 xg. 1 ml of LiAc/TE 
was added, cells were then spun down at 5000 xg for 5 minutes. 600 jil of LiAc/TE 
was added to resuspend the pellet. 100l of cells were added to 2 jil sheared Herrings 
Testes DNA (lOmg/ml) and 10 pl of target DNA for transformation. Mix was left to 
stand at room temperature for 10 minutes. 260 p1 of 40% PEG/LiAc/TE was added 
and mixed gently. Samples were incubated at 32 °C for 30-60 minutes. 43 tl of 
DMSO was then added and samples were heat shocked for 5 minutes at 42 °C. Cells 
were then spun down at room temperature for 5 minutes at 5000 xg and washed once 
with dH20. The pellet was resuspended in 0.5 ml of dH20 and plated on YE. Plates 
were incubated for 18 hours at an appropriate temperature, and then replicated onto 
selection media. New replica plates were incubated at an appropriate temperature for 
3-4 days until single colonies appeared. 
lOx LiAc: 	 1 M LiAc pH7.5 
lOx TE: 	 0.1 M Tris-HC1 pH7.5 
0.01 M EDTA 
LiAc/TE: 	 10 ml lOxLiAc 
10 ml 1OxTE 
80 ml dH2O 
40%PEGILiAc/TE: 	 16 ml 50% PEG 4000 
2 ml lOxLiAc 
2 ml 1OxTE 
10 ml dH2O 
2.7 	Experimental techniques with S. pombe 
2.7.1 	Plasmid shuffle assay 
ED1526 is a strain deleted for the endogenous cdc37 gene and cell viability is 
maintained by the presence of wildtype cdc37 on pREP82 that contains the ura4 
gene. The ability of different alleles and cdc37 mutants to sustain cell viability was 
determined by expression from pREP 1, 41 or 81 in ED 1526 by plasmid shuffle assay 
as shown in Diagram 2.5. 
2.7.2 	Serial dilutions of S. pombe 
S. pombe precultures in suitable media were incubated overnight at an appropriate 
temperature. Precultures were adjusted to a final 0D 600 of 0.5 in either dH 20, YE or 
EMM. 1:4 serial dilutions were made of cells to a total of 5 dilutions which were then 
spotted as 5 /Ll onto appropriate media and incubated at a suitable temperature for 4 
days. 
2.7.3 	Preparation of chromosomal DNA from S. pombe 
A preculture was set up for 2 days, then used to inoculate a 100 ml culture which was 
grown to stationary phase (0D 5 95 2 or 3). Cells were centrifuged at 5000 xg for 10 
minutes. Pellets were resuspended in 1.5 ml of CPS buffer. 
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Diagram 2.5: Plasmid shuffle assay to determine the ability of cdc37 mutants to 
sustain cell viability. A ED1526 cdc37::his1 ade6-M21 ura4-D18 leul-32 hisi -102 
pREP82-cdc37"' was B transformed with 1eu plasmids (pREP1, pREP41 or pREP81) 
expressing wildtype or mutant cdc37. Cells were precultured overnight in EMM 
containing uracil to promote loss of the ura4 plasmid pREP82-cdc37. 0D 600 was 
adjusted to 0.5 and serial dilutions were carried out and spotted onto 
MM+adenine+uracil plates with and without 5FOA. Plates were incubated at 25, 28 
32 and 36 °C for 4 days. C 5FOA selects against ura4+ cells but allows ura4 cells to 
grow. Strains carrying a functional cdc37 construct expressed from pREP 1 or pREP81 
are able to grow in the absence of pREP82-cdc37' and are 5FOA resistant. Strains 
with a non-functional cdc37 construct cannot loose the pREP82-cdc37' are lethal on 
5FOA. 
A 
cdc3 7 i 
pURA-cdc37+  
B 
pLEUcdc37* [ 	I 
Plated on 
C. 
 [ J 5FOA  L G I 
Dead 	 Viable 
CPS buffer: 	 50 mM citrate phosphate buffer pH5.6 
1.2 M sorbitol 
0.1% (v/v) 3-mercaptoethanol 
15 mg of zymolyase-20T (ICN #320921) was added and samples were incubated at 
37 °C for 5-30 minutes, until cell walls were fully digested. Cells were centrifuged at 
5000 xg for 5 minutes and pellets were resuspended in 15 ml of 5x TE buffer (50 mM 
Tris-HCL pH7.0, 5 mM EDTA). 1.5 ml of 10% SDS was added and mixed 
thoroughly. Samples were then incubated 65 °C for 5 minutes. 5 ml of 5 M KOAc 
pH5.6 was added and incubated on ice for 30 minutes. Preps were then centrifuged for 
15 minutes at 8000 xg. 1 ml of ice cold ethanol was added for every 20 ml of cells and 
mixed. Centrifugation was carried out for 10 minutes at 4 °C at 11,000 xg and pellets 
were resuspended in 3 ml of 5x TE buffer. RNase A was added to a final 
concentration of 100 g/ml and incubated at 37 °C for 2 hours. Phenol-chloroform 
extraction (Section 2.2.9) was then used to purify DNA which was resuspended in a 
final volume of 200 tl of dH20. 
2.7.4 	Crossing of S. pombe strains 
Strains of opposite mating types, h and h, were grown on selective media plates. 
Each strain was patched independently and in combination of Spa plates containing 
leucine and mixed with a drop of dH20. Plates were incubated at a suitable 
temperature (usually 28 °C) for 1-2 days. Spa plates starve the cells of nitrogen and 
induce sporulation. 
Spa media: 	 1% (w/v) glucose 
7.3 mm KH2PO4 
1 mlfl vitamins (1000x stock) 
45 mg/l adenine, histidine, lysine hydrochloride, 
uracil and leucine 
For solid Spa media for plates: 	3% Difco Bacto Agar 
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2.7.4.1 	Random sporulation analysis of crosses .between S. pombe strains 
Successful crosses were incubated in a 1:50 dilution of Helicase, a snail gut digestive 
enzyme, from a 1:10 stock solution overnight at 28 °C. Helicase acts to enzymatically 
break down the asci wall and release the spores. Spores were centrifuged at 11,000 xg 
for 20 seconds, resuspended in 1 ml of dH 20, spun again and resuspended in 500 p1 of 
dH20. 50jtl of each sample was plated and streaked into appropriate media and 
incubated at a suitable temperature for 2 days to observe growth. Plates were then 
replicated to selection media and different temperatures to determine the genotype of 
progeny. 
	
2.7.4.2 	Dissection of S. pombe tetrads derived from crosses 
Asci are composed of 4 spores that can be dissected so that the genotype of each 
individual spore can be determined. A swab of the cross material was patched onto a 
thinly poured YE plate and then streaked using a sterile loop and dH 20. Asci were 
picked using the tetrad dissector and placed at designated locations. Asci were 
incubated overnight at 4 °C and then shift to 28 °C for 3 to 4 hours. Using the tetrad 
dissector, each of the four spores from the asci were isolated and placed at designated 
locations. Spores were then incubated at an appropriate temperature for 2-3 days and 
then replicated to appropriate temperatures on suitable selection media to determine 
genotypes. 
2.7.4.3 	Culturing S. pombe temperature-sensitive mutant strains 
S. pombe Temperature-sensitive mutant strains were cultured as 200 ml YE cultures 
shaking overnight at 28 °C. Cultures were diluted to an 0D600 of 0.1 with media pre-
warmed at 28 °C. Cell cultures were then split into two separate flasks and incubated 
shaking at 28 and 36 °C. 
2.8 	S. pombe cytology and immunofluorescence 
2.8.1 	Staining of S. pombe cells with calcofluor 
Calcofluor was used to stain the walls and septa of S. pombe cells. 1 ml of cell culture 
(0D600 0.4-0.5) were added to 100 j.tl of formaldehyde and incubated on a rotating 
wheel for 15 minutes at room temperature. Cells were then washed three times in 250 
j.il of dH20 spinning at 10,000 xg at each step for 1 minute. Finally, cells were 
resuspended in 50 .tl of dH 20. 2 p1 of cells were mixed with 1 tl of Calcofluor 
(Sigma-Aldrich F3543) (1 mg/mi) on a microscope slide and sealed with a cover slip 
and nail varnish. Cells were visualized immediately under a 63x oil objective 
Axioskop 2 lens. 
2.8.2 	Staining of S. pombe cells with DAPI 
The DNA content of S. pombe cell culture (0D600 0.4-0.5) was visualized by staining 
with 4',6-Diamidino-2-phenylindole (DAPI). 100 p1 of formaldehyde was added to 1 
ml of cells and incubated at room temperature for 15 minutes on a rotating wheel. 
Cells were then washed three times in 1 ml of dH 20 spinning each step at 11,000 xg 
for 1 minute. Cells were resuspended in a final volume of 50 .tl of dH20. 2 tl of cells 
were mixed on a slide with 1 tl of DAPI (50 jig/ml) (Sigma-Aldrich D9542) and 
covered with a cover slip which was sealed nail varnish. Cells were viewed 
immediately under a 63x oil Axioskop 2 objective lens. 
2.8.3 	Staining of S. pombe cells with Phalloidin-conjugated Rhodamine 
Phalloidin-conjuagted rhodamine was used for staining actin in S. pombe cells 
according to (Chang et al., 1996). 1 ml of cell culture (0D6 00 0.4-0.5) was mixed with 
100 p1 of formaldehyde and placed on a rotating wheel for 10 minutes at room 
temperature. Cells were washed 3 times with 1 ml of PEM spinning cells at 5000 xg 
for 10 seconds between washes. 1 ml of PEM plus 1% Triton-X-100 was then added 
and incubated at room temperature for 2 minutes. Cells were resuspended in a final 
volume of 50 pJ of PEM. 2 gl of cells were mixed with 1 tl of 1:15 dilution of 
Phalloidin-TRITC (Sigma-Aldrich P1951). Phalloidin-TRITC is a fluorescent that 
enables visualisation of actin under UV. 
PEM: 	 100 mM Pipes (pH7) 
1 mMMgSO4 
1 mM EGTA 
2.8.4 	Immunofluorescence staining of S. pombe cells 
Staining of S. pombe cells using antibodies was carried out by harvesting 40 ml of 
cells at an 0D595 of 0.5-0.8 by filtration onto Millipore HVLP 0.45m membranes 
(Fischer #FDR-295-050Q) and fixed by submerging into -80°C chilled 100 % 
methanol and shaking vigorously. Tubes were incubated at -80°C and for more than 2 
hours. Filters were removed and cells pelleted by centrifugation for 5 min at 5000 xg. 
Cells were resuspended in 1 ml of 100% methanol and stored at -80 °C. 50-100 jl of 
fixed cells were transferred into a fresh eppendorl tube. Cells were washed twice in 1 
ml of PEM, using spinning at 5000 xg for 1 minute. Pellets were resuspended in 1 ml 
of PEMS with 0.2 mg/ml zymolyase-20T and incubated at 37 °C for 1 hour. Samples 
were washed twice with 1 ml of PENIS, spinning 5000 xg for 1 minute and 
resuspended in 1 ml PEMS/1% Triton X-100 for 30 seconds. Cells were then 
harvested at 5000 xg for 1 minute and washed twice in 1 ml of PEM. The cells were 
then resuspended in 1 ml of PEMBAL and incubated at room temperature on a 
rotating wheel for >30 mm. Approximately 5 ttl of cells were removed and 
resuspended in 30 jtl PEMBAL plus an appropriate dilution of primary antibody. 
Primary antibody incubation was carried out overnight rotating at room temperature. 
Cells were then washed three times; harvesting cells at 5000 xg for 1 minute and 
incubating for 10 minutes in 1 ml PEMBAL. The pellet was finally resuspended in 30 
l of PEMBAL containing a 1:300 dilution of appropriate Alexa 2° antibody and 
incubated at room temperature for> 6 hours. Cells were washed 3 times in 1 ml of 
PEMBAL being resuspended in a final volume of 50 p1. 2-3 p1 of cells are placed on a 
slide and sealed with a cover slip and nail varnish for immediate observation under an 




1.2 M sorbitol in 1X PEM 
to 200 ml final with sterile dH20 
PEMBAL: 	 1 % BSA (Sigma-Aldrich A7638, globulin free) 
0.1 %NaN3 
100 mM lysine hydrochloride 
in PEM 
2.8.5 	Measuring Cell Length of S. pombe 
Cells were stained with calcofluor and viewed under Axioskop 2 fluorescent 
microscope (Zeiss) with a 63x objective lens. Photographs were taken of fields of 
cells with a digital camera (Princeton Instruments) and a minimum of 200 cells per 
sample were measured using the IPLab scientific imaging software (scanalytics). 
2.8.6 	Counting S. pombe cell number by Coulter Counter 
The number of S. pombe cells in a sample can be determined using a Coulter counter. 
A preculture was incubated for 2 days and used to inoculate a 200 ml culture that was 
incubated overnight at an appropriate temperature shaking at 200 rpm. 100 p.1 of cells 
were placed into a sterile Coulter counter vial containing 10 ml of filtered Isoton II 
and were mixed. Samples were sonicated at 5% for 10 seconds and then mixed 
thoroughly. Vials were placed into the Coulter counter and 500 p.1 of each sample was 
counted twice and the average number of cells per ml was calculated. 
2.8.7 	Analysis of DNA content of S. pombe by FACS 
Flow cytometry by Fluorescent activated cell sorting (FACS) was used to determine 
whether cells contain a replicated or unreplicated genome by staining the DNA 
content with propidium iodide (Alfa et al., 1993). Stains were grown up at a suitable 
temperature and harvested at 2000rpm for 5 minutes to yield 5 x 106  cells per sample. 
Pellets were resuspended in 1 ml of cold 70% ethanol and stored at 4 °C. For each 
sample the cell number per ml was determined by Coulter counter Section 2.8.6 
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An appropriate number of cells were spun down at 5000 xg for 5 minutes and 
resuspended in 1 ml of 0.1 M HC1 plus 2 mg/ml pepsin. Samples were incubated at 
room temperature for 1 hour. Cells were centrifuged at 5000 xg for 5 minutes and 
washed in 1.5 ml 50 mM sodium citrate (pH7). Pellets were resuspended in 500 tl of 
50 mM sodium citrate (pH7) containing 0.1 mg/ml RNase A. Cells were incubated at 
37 °C overnight. 500 p1 of 50 mM Na citrate containing 4jig/ml propidium iodide 
(Sigma-Aldrich #P4864) was added to each sample. Cells were sonicated at 5% for 10 
seconds and immediately processed in a FACScan (Becton Dickson). 
2.9 	Protein extraction from S. pombe 
2.9.1 	Small scale protein extraction using a Ribolyser 
A preculture was used to inoculate a 200 ml culture of S. pombe cells that was 
cultured to an 0D6 00 of 0.4. 40m] of cells were harvested by centrifugation at 5000 xg 
for 3 minutes. Pellets were resuspended in 10 ml of ice-cold STOP buffer or dH 20, 
centrifuged at 5000 xg for 3 minutes and the supernatant was discarded. 
For denatured protein extracts pellets were resuspended in 100 tl of Buffer A and 
for native extracts pellets were resuspended in 100 p.1 of buffer B. 
STOP buffer: 	 150 mM NaCl 
50 mM NaF 
10 mM EDTA 
1 mM NaN3 
Buffer A: 	 10 mM sodium phosphate buffer pH7.0 
100 41 of Complete Inhibitors (xl0stock) 
(Roche #187-3580) 
1% Triton X-100 
0.1% SDS 
1 mM EDTA 
150 mM NaCl 
1 mM PMSF 
dH20 to a total volume of lml 
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Buffer B: 	 Buffer A 
No SDS 
100 m NaCl 
Cells were added to pre-cooled ribolyser matrix tubes (HYBAID #RYM-601 1) and 
vortexed for 2 seconds. Samples were then placed into a ribolyser machine and set to 
run for 20 seconds at 4.0 g. 
For denatured extracts, 100 j.il of 2x SDS loading buffer was added and vortexed for 
2 seconds. Tubes were heated to 95 °C for 5 minutes and allowed to cool for 1 
minute. The tube bottom was pierced with a hot needle and the contents were drained 
into a fresh 1.5 ml eppendorf by centrifuging at 5000 xg for 1 minute. Protein preps 
were stored at -80 °C and spun for 3 minutes at 11,000 xg prior to loading on gel. 
For native extracts, 100 tl of buffer B was added to the tubes and vortexed for 2 
seconds. The base of the tubes was punctured, placed in a 1 .Sml eppendorf and spun 
at 5000 xg for 1 minute. Samples were then centrifuged at 11,000 xg for 15 minutes at 
4 °C to generate low speed soluble extracts. The supernatant was transferred to a new 
eppendorf and stored at -80 °C. 
2.9.2 	Small scale native protein extraction using glass beads 
This protocol was used to make protein from S. pombe to look at protein-protein 
interactions. 50 ml of cell culture of 0D 600 0.4 were harvested at 5000 xg and washed 
once in 20 ml of STOP buffer. Supernatant was removed and pellets were 
resuspended in 100 t1 of appropriate lysis buffer. Two samples were added to 1 ml of 
autoclaved acid washed 425-600 micron glass beads (Sigma-Aldrich G8772). Tubes 
were vortexed three times for 20 seconds with 1 minute breaks on ice. The bottom of 
the tubes were punctured, placed in an eppendorf and spun at 5000 xg for 1 minute. 
200 p1 of lysis buffer was added to the beads and vortexed for 2 seconds. Samples 
were then centrifuged again at 5000 xg for 1 minute and the supernatant was 
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transferred to a new tube. Samples were centrifuged at 11,000 xg to remove insoluble 
material, placed into a fresh chilled tube and stored at -80 °C. 
	
2.9.3 	Small scale native protein extraction using filtration and glass 
beads 
Protein preparation for size exclusion chromatography were made by harvesting 50 
ml of cell culture of an 0D 600 0.4 by filtration over a 0.45 pm milipore filter (Fisher 
#FDR-295-050Q). Filters were placed in an eppendorl and washed with 1 ml of cold 
dH20. Tubes were then spun at 12,000 xg for 10 of seconds. The filter paper was 
removed and centrifuged again at 8000 xg for 1 minute. The supernatant was removed 
and pellets were resuspended in 100 p1 of appropriate lysis buffer. Two samples were 
added to 200 p1 of autoclaved acid washed 425-600 micron glass beads (Sigma-
Aldrich G8772). Samples were then treated as described in 2.5.3. 
2.9.4 	Quantification of protein concentration using the Bio-Rad protein 
assay 
The protein concentration of S. pombe protein preparations was determined using the 
Bio-Rad protein assay kit (#500-0006) following the manufacturers instructions. 
2.9.5 	Immunoprecipitation (IP) 
Protein A Sepharose CL-4B beads (Amersham 17-0780-01) were rehydrated with 1 
ml of lysis buffer and incubated for 10 minutes on ice. Beads were centrifugation at 
5000 xg for 3 minutes at 4 °C, washed three times in 1 ml of lysis buffer and then 
finally resuspended in an equal volume of buffer to beads. For each IP, 30 jii of beads 
were transferred into a chilled eppendorf. An appropriate amount of antibody was 
added and the volume in each tube was adjusted to 500 tl using lysis buffer. Samples 
were incubated for 1 hour at 4 °C on a rotating wheel. Samples were then spun down 
at 5000 xg at 4 °C for 1 minute and washed 3 times with 1 ml of lysis buffer. Two 
protein preparations (Section 2.9.2) added to each IP, adjusting the volume to lml 
with lysis buffer. 50 tl of native protein prep is retained as an input control for 
analysis of IPs by SDS PAGE and western blot. Samples were incubated for 1 hour on 
a rotating wheel at 4 °C. IP's were washed by centrifugation at 5000 xg for 1 minute 
at 4 °C, resuspended in lml of lysis buffer and transferred to a new chilled tube. 
Beads were washed another three times and transferred to a new tube on the fourth 
wash. Supernatant was discarded and 30 RI of 2x SDS loading buffer was added to 
each IP and boiled for 5 minutes. Samples were stored at -80 °C. 
2.9.6 	Treatment of protein preparations with phosphatase 
For treatment of S. pombe Cdc37 with phosphatases, Cdc37 was immunoprecipitated 
(IP) as described in Section 2.9.5, using 2.5tl of Cdc37 .antibody and 500 .tg of S. 
pombe whole cell protein extracts. All IN were pooled and divided into 4 separate 
eppendorfs. Samples were treated in a total liquid volume of 40 j.tl with either Lambda 
protein phosphatase X-PPase (#P0753S NEB) or Calf intestinal phosphatase (CIP) 
(NEB #M0290) as shown below: 
lx buffer and 2 mM MnC1 2 
lx buffer, 2 mM MnC1 2 and 800 units of Lambda phosphatase or CIP 
lx buffer, 2 mM MnC1 2, 800 units of Lambda phosphatase or CIP and 
phosphatase inhibitors (250 mM NaF, 4 mM Na-orthovanadate, 10 
niM EDTA (Watson et al., 2001)) 
lx buffer, 2 mM MnC1 2, 800 units of Lambda phosphatase or CIP and 
heat inactivated at 65°C for 1 hour in the presence of 50 mM EDTA 
The first three conditions were incubated at 30 °C for 1 hour. Samples were 
centrifuged at 5000 xg and supernatant removed. The beads were washed 4 times with 
appropriate lysis buffer and boiled for 5 minutes in 2x SDS loading buffer. Samples 
were then analysed by SDS PAGE. 
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2.9.7 	Size exclusion chromatography (SEC) 
Protein samples of S. pombe were made as described in Section 2.9.3. Small scale size 
exclusion chromatography was carried out using 250 .tg of protein at a 1 jig/pi 
concentration on a superpose 6 column (Amersham). Large scale size exclusion 
chromatography used 12 ml of protein sample at a 1 .ig/.tl concentration on a 
sephacryl s-300 HR 26/60 column (Amersham). Small scale size exclusion 
chromatography was run at a rate of 0.2 ml per minute giving 0.5 ml fractions, while 
large scale ran at 0.5 ml per minute resulting in 3 ml fractions. The following buffer 
was used to run the columns: 
SEC Buffer: 	 20 mM Hepes KOH pH7.9 
3 MM MgCl2 
150 mM KC1 
10% glycerol 
1 m Dlii' 
20 mM molybdate 
Fractions were collected and run on large acrylamide gels for western blot or 
Coomassie staining analysis. 
2.9.8 	TCA Precipitation of size exclusion chromatography fractions 
Protein samples were concentrated after size exclusion chromatography by TCA 
precipitation. 200 p1 of TCA was added to each sample on ice. Tubes were vortexed 
and incubated on ice for 30 minutes. Samples were centrifuged at 4 °C at 11,000 xg 
for 15 minutes. Supernatant was removed by aspiration and pellets resuspended in 1 
ml of acetone chilled at -80 °C. Samples were vortexed and centrifuged at 4 °C at 
11,000 xg for 15 minutes. Supernatant was discarded and pellets were allowed to air 
dry for 15-30 minutes. 50 p1 of 2x SDS Sample Buffer was added to run on SDS 
PAGE for analysis by western blot or Coomassie staining. If samples turned orange 
then 1-2 p1 of 1.5 M Tris was added to adjust the pH. 
2.9.9 	GST pull-down 
2.9.9.1 	Making recombinant GST protein 
The E. coli strain BL21 was transformed (Section 2.4.5.3) with constructs of the 
pGEX- 1 vector. Single colonies were picked and precultured in 25 ml of LB plus 
ampicillin at 37 °C shaking at 200 rpm overnight. A 500 ml culture of LB plus 
ampicillin was inoculated with the preculture and incubated at 37 °C shaking at 200 
rpm for approximately 1.5 hours until 0D600 0.5 was obtained. Isopropyl-beta-D-
thiogalactopyranoside (IPTG) was added to the culture to a final concentration of 1 
mlvi to induce expression of the pGEX-1 construct. The culture was incubated at 30 
°C shaking at 200 rpm for 3.5 hours. Cells were harvested by centrifugation at 4 °C at 
8000 xg for 10 minutes. Pellet was resuspended in 5 ml of ice cold lysis buffer. 
Lysis Buffer: 	 500 mM NaCl 
0.5% NP-40 
50 mM Tris-HC1 pH7.6 
5 mM EDTA 
5 mM EGTA 
lx Complete Inhibitors 
Cells were sonicated at Drive 20.5, auto 4.9, 6 times for 30 seconds with 30 second 
breaks. Sonicated cells were spun down at 16,000 xg for 15 minutes at 4 °C. 
Supernatant was transferred to a new tube and incubated with 200 p1 of glutathione-
sepharose 4B (Amersham 17-0756-01) beads being rocked gently at 4 °C for 10 
minutes. Samples were pelleted by spinning at 5000 xg for 1 minute, supernatant was 
removed and beads were washed twice with 1 ml of lysis buffer and twice with 1 ml 
of cold TEE buffer. 
TEE Buffer: 	 200 mM Tris pH8 
5 mM EDTA 
5 mM EGTA 
A volume of cold elution buffer was then added and mixed thoroughly by inverting. 
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Elution Buffer: 	 200 mM Tris-HC1 pH8 
5 mM EDTA 
5 mM EGTA 
50 mM Glutathione 
Samples were centrifuged at 5000 xg for 1 minute and supernatant was transferred to 
a fresh tube. This was repeated a total of three times, combining each elution step. An 
aliquot of the GST (fusion) protein was then run against a known amount of BSA for 
quantification on SDS PAGE and stained with Coomassie. 
Dialysis was carried out to remove the glutathione b placing samples in snake skin 
dialysis tubing (Pierce 68035 3500 MWCO) and incubated at 4 °C in Dialysis buffer 
being gently rotated in solution with a stirrer. Dialysis was carried out for 4 hours, 
after which the dialysis buffer was replaced and incubated for another 4 hours. 
Dialysis Buffer: 	 150 mlvi NaC1 
20 mM Tris-HC1 pH7.6 
1mMEDTA 
1 mM EGTA 
Samples were placed into new eppendorfs, sterile glycerol was added to a final 
concentration of 20% and stored at -80 °C. All samples were then quantified using the 
Bio-rad protein assay (Section 2.9.4). 
2.9.9.2 	GST pull-down experiment 
Glutathione-sepharose 4B beads were washed three times in appropriate buffer, e.g. 
PBS, Buffer R or TEG, and centrifuged at 5000 xg for 1 minute. 1-3 .tg of GST or 
GST fusion protein was incubated with glutathione-sepharose 4B beads in 500 tl of 
appropriate buffer at 4 °C on a rotating wheel for 30 minutes. Beads were washed 
twice in designated buffer, centrifuging samples at 5000 xg for 1 minute. 500 tg of 
native S. pombe protein extract was added to each tube and samples were incubated at 
4 °C for 2 hours on a rotating wheel. Samples were washed 4 times with appropriate 
buffer centrifuging at 5000 xg for 1 minute. Beads were then either treated with 
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PreScissionTM Protease (Section 2.9.9.3) or resuspended in 40 p.1 of 2x SDS loading 
buffer and boiled for 5 minutes prior to loading on SDS PAGE. 
Buffer R: 	 20 mM Hepes 
150 mM NaCl 
0.5 mM EDTA 
10% glycerol 
0.1% Triton-X 100 
1mMDYF 
lOx Complete Inhibitors (100 p.1 per ml) 
TEG: 	 25 mM Tris pH 7.4 
15 mM EGTA 
10% glycerol 
1 mMDTT 
2.9.9.3 	PreScissionTM Protease treatment of GST fusion proteins 
PreScissionTM Protease (Amersham #27-0843-01) was used to cleave recombinant 
protein from its' GST tag. GST fusion protein bound to glutathione-sepharose 4B 
beads were resuspended in 50 p.1 of cleavage buffer and 1 p.1 of P reScissionTM 
Protease (2 units). Reactions were allowed to run for 4 hours at 5 °C. 
Cleavage Buffer: 	 50 mM Tris pH7 
150 mMNaC1 
1 mM dithiothreitol 
Samples were centrifuged at 5000 xg for 3 minutes and the supernatant was 
transferred to a new tube. 40 p.1 of 2x SDS loading buffer was added to both the beads 
and the supernatant. Samples were boiled for 5 minutes, centrifuged at 5000 xg and 
loaded onto SIDS PAGE. 
2.9.10 	 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS PAGE gels were made as shown in Table 2.22 and run in Running buffer in Bio- 
Rad cells. High percentage separating gels were used for observing proteins of low 
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molecular weight and low percentage gels gave better resolution for higher molecular 
weight proteins. 
Running Buffer: 	 25 mM Tris 
250 mM Glycine 
0.1% SDS 
Table 2.22: Components used to pour SDS PAGE gel for analysis of protein 
Separating Gel Separating Gel Stacking Gel 
7% 12% 5% 
1.5 M Tns-HCL pH8.8 2.5 ml 2.5 mt - 
0.5 M Tris-HCL pH6.8 - - 2.5 ml 
Acrylamide 	solution 
(30%)  
2.5 ml 4 ml 1.33m1 
10% (w/v) SDS 100 p.1 100 p.1 100 p.1 
dH20 4.85 ml 3.35 ml 6.1 ml 
10% (w/v) AMPS 50 p.1 50 p.1 50 p.1 
TEMED (add last) 5 p.1 5 j.il 10 p.1 
10 ml 10 nil lOml 
For protein gels a SDS-PAGE standards broad range marker was used (Bio-Rad 161-
0317) and for western gels a broad range pre-stained protein marker (NEB P7708) 
was used. Protein samples were treated as follows prior to loading on gels: 
Denatured: 	Centrifuge for 3 minutes at 12,000 xg and load 10 p.1 
Native: 	Add equal quantities of 2x SDS loading buffer and protein 
extract. 
Heat at 95 °C for 5 minutes then spin for 3 minutes at 12,000 
xg load 10 p.1. 
2.9.11 	Coomassie Staining of Protein Gels 
For visualisation of protein on a SDS PAGE gel directly, gels were stained with 
Coomassie for 1 hour. 
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Coomassie: 	 0.1% Brilliant Blue R250 
(Sigma-Aldrich B7920) 
50% Methanol 
10% Acetic Acid 
Gels were destained by incubating for 1-2 hours on a shaker at room temperature. 
Destain: 	 10% Acetic Acid 
30% methanol 
dH2O. 
2.9.12 	Western blotting and immunoprobing of SDS PAGE gels 
The stacking gel was removed and the separating gel was placed in chilled transfer 
buffer on a shaker for 10 minutes. A PVDF membrane (Bio-Rad PVDF #162-0177) 
was dipped in methanol for a few seconds, submerged in dH 20 for 1-2 minutes then 
incubated in chilled transfer buffer on a shaker for 10 minutes. The transfer of protein 
from small gels was carried out according to manufacturer's instructions and run for 1 
hour at 100 volts. The transfer of large gels was carried out using the Bio-rad semi-
dry transfer system as set out by the manufacturers manual and run for 1 hour at 20 
milliamps. Membranes were then placed into 100 ml of PBST/5% "Marvel" dried 
milk powder on a shaker for 1 hour at room temperature. 
Membranes were rinsed with 2 changes of PBST, then 1 x 15 minutes PBST and 2 x 5 
minutes PBST at room temperature on a shaker. The membrane was then incubated 
with 10 ml of PBST plus primary antibody for one hour at room temperature or 4 °C 
overnight. Membrane was washed in PBST as previously described and incubated in 
10 ml of PBST plus secondary antibody on a shaker for 1 hour at room temperature. 
PBST washes were then repeated again. ECL Detection solutions I and II (Amersham 
#RPN2 108) were added in equal volumes and placed on the membrane for 1 minute. 
Membranes were then exposed to Hyperfilm ECL (Amersham RPN3103k) and 
developed. 
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2.9.13 	Assay for Cdc2 kinase activity 
The kinase activity of Cdc2 was assayed in temperature-sensitive mutants by its 
ability to phosphorylate Histone Hi in vitro. 2.5 x 108  cells were harvested by 
centrifugation at 5000 xg for 5 minutes at 4 °C. Pellets were washed once with 20 ml 
of STOP buffer and resuspended in 20 t1 of HB 15 buffer by vortexing. Samples were 
added to iml of ice cold acid washed glass beads and vortexed for 20 seconds 4 times 
with 1 minute breaks on ice. 500 il of ice-cold HB15 buffer was added, mixed well 
and 500 1d of supernatant was removed and placed into a new eppendorf. Extracts 
were centrifuged at 12,000 xg for 1 minute at 4 °C. The supernatant was placed into a 
fresh chilled tube and the protein concentration of each sample determined by 
Bradford assay (Section 2.9.4) and adjusted to 0.5 j.tg/.tl with ice cold HB15 buffer. 
Cdc2 was immunoprecipitated from native S. pombe protein extracts using 10 tl of 
13SUC1 beads (Upstate 14-122) (1:1 v/v ratio with lysis buffer) per sample. Beads 
were washed twice in HB 15 buffer and resuspended in 250 tl of HB 15 buffer. 70 .tg 
of S. pombe protein was transferred to each tube and IPs were incubated at 4 °C for 30 
minutes. Beads were washed four times with 1113 15 buffer and resuspended in 6 p1 of 
HB5 buffer and mixed. Samples were incubated at room temperature for 15 minutes. 
10 p1 of KIN buffer was then added and mixed gently. Reactions were incubated at 
room temperature for 10 minutes and stopped by the addition of 2x SDS loading 
buffer. Samples were then run on a 12% SDS PAGE, stained with Coomassie and 
then dried. The dried gel was place din a phosphor-imager cassette overnight and 
processed using the STORM phosphor-imager. 
HB15 buffer: 	 1 x Complete 
60 mM -glycerophosphate 
15 mM p-nitrophenylphosphate 
25 mM MOPS(pH7.2) 
15mM EGTA 
15 MM MgCl2 
1mM Dlii' 
0.1 mM Na3VO4 (pH8) 






Plus 5 mM EGTA 
200 iM ATP 
2 mg/ml of histone Hi 
40 j.tCi of [y- 32P] ATP 
2.9.14 Antibodies 
 
Antibodies used in this work are listed in Table 2.23. 
2.10 	Protocols for S. cerevisiae 
2.10.1 	Media 
2.10.1.1 	YPD medium and YPD agar medium 
YPD: 	 20 gIL Difco peptone 
10 gIL Yeast extract 
20 g/L Agar (for plates only) 
pH was adjusted to 5.8 and autoclaved. Once cooled to 55 °C, dextrose was added to 
2%. 
2.10.1.2 	SD Medium and SD medium plates 
SD: 	 6.7 g yeast nitrogen base without amino acids 
20 g agar (plates only) 
850mIH20 
100 ml of appropriate sterile i0x drop out 
solution 
pH was adjusted to 5.8 and allowed to cool to 55 °C before adding the appropriate 
sterile carbon source usually dextrose to 2%. 
103 
Table 2.23: Antibodies used in this work are listed below. 
Name Poly/monoclonal Origin Reference 
Anti-S. pombe polyclonal Raised against full 
Cdc37 antibody length S. pombe Cdc37  
in Rabbit  
12CA5 Monoclonal Raised in mouse Roche #1-583- 
Anti-HA  816 
Anti-PSTAIR Monoclonal Raised in mouse Sigma-Aldrich 
against synthetic 16 #P7962 
amino acid 
oligopeptide containing 
the p34" 2 (cdkl) 
PSTAIR_sequence  
Anti-phosphor- Polyclonal Raised in rabbits with a NEB #9111 
tyrosine 15 cdc2 synthetic phospho- 
peptide (KLH-coupled) 
corresponding 
to residues surrounding 
Tyr15_of human_cdc2.  
anti-cdc2 Y63.2 Monoclonal Raised in mice against kind gift from 
S. pombe Cdc2 Paul Nurse lab 
anti-cdcl3 6F Monoclonal Raised in mice against kind gift from 
10/11  S. pombe Cdcl3 Paul Nurse lab 
anti—rabbit IgG For Molecular 
antibody immunofluorescence Probes 
Alexfluor 680 
Anti-mouse IgG HRP linked Amersham 
NA931V 
Anti-rabbit IgG HRP linked Amersham 
NA935V 




2.10.2.1 	Carbon Sources 
Added to SD media: 	 40% dextrose 
20% glucose 
2.10.2.2 	Dropout supplements 
Table 2.24: Amino acids used to supplement media for growth of S. cerevisiae 
Supplement Sigma-Aldrich # Working 
concentration 
L-Histidine H-9511 20 mgfL 
L-Leucine L- 1512 100 mg/ml 
L-Tryptophan T-0254 20 mg/ml 
L-Uracil U-0750 20 mg/ml 
L-Adenine  20 mg/ml 
2.10.3 	Transformation of S. cerevisiae 
2.10.3.1 	Lithium Acetate transformation of plasmid DNA into S. cerevisiae 
S. cerevisiae was transformed using the Lithium acetate based method (Gietz et al., 
1992). A preculture was grown in 50 ml of YPD, 30 ml of which was used to 
inoculate 300 ml of YPD and was cultured at 30 °C overnight shaking at 230-270 
rpm. At an 0D600 of 0.4-6 cells were centrifuged at 5000 xg for 5 minutes at room 
temperature and supernatant was removed. Pellets were washed in an equal volume of 
dH20 or lx TE and mixed by vortexing. Samples were centrifuged at 5000 xg for 5 
minutes and resuspended in 1.5 ml of lx TE/LiAc. 0.1 .tg of plasmid and 0.1 mg of 
sheared ss herring DNA was added to 0.1 ml of yeast cells in a new tube. 0.6 ml of 
sterile TE/PEG/LiAc was added and samples were incubated at 30 °C for 30 minutes 
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shaking at 200 rpm. 70 pJ of DMSO was added and cells were heat shocked for 15 
minutes at 42 °C. Tubes were then placed on ice for 1-2 minutes. Cells were then 
centrifuged at 11,000 xg at room temperature for 5 seconds. Supernatant was 
discarded and pellet was resuspended in 0.5 ml of sterile lx TE buffer. 100 tl of 
transformed cells were plated on SD-agar media with appropriate nutrients and 
incubated at 30 °C until single colonies appeared. 
2.10.4 	Maintaining S. cerevisiae strains 
2.10.4.1 	Storage of S. cerevisiae 
Strains of S. cerevisiae were stored on selection plates at 4 °C for the short term. For 
long term storage of S. cerevisiae strains were mixed with 1.4 ml of preculture grown 
in selection media with 0.6m1 of autoclaved glycerol. Samples were frozen at to —80 
°C in 1.8m1 Nunc Cryotube TM Vials (#368632). 
2.10.4.2 	Waking up S. cerevisiae strains 
S. cerevisiae strains were woken up by scraping up a small amount of frozen stock 
with a sterile pipette tip and placing it on a selection plate. Plates were incubated at a 
suitable temperature for 2-3 days. Cells were then streaked out using a sterile 
toothpick and incubated at an appropriate temperature until single colonies had 
appeared. Single colonies were patched out on to different selection media and 
incubated at an appropriate temperature for growth to ensure correct genotype. 
106 
2.10.4.3 	S. cerevisiae strains used 
AH 109: 
System 	 GAL4 2H-3 
Genotype 	 MATa, trpl-901, leu2-3, 112, ura3-52, his3-200, gal4L\, 
gla80E, LYS2.. GAL] uAs-GALJ TATA -HIS3, MEL] GAL2 
UASGAL 2 TATAADE 2, URA3.:MEL] uAs -MELJ TATA -IaCZ 
Reporters: 	 H153, ADE2, lacZ, MEL1 
Transformation Markers: 	trpl, leu2 
Source: 	 Holtz unpublished 
2.10.5 	Yeast two-hybrid assay 
The Yeast two-hybrid system was used to study protein-protein interactions and is 
detailed schematically in Diagram 2.6. 
2.10.5.1 	Colony lift filter yeast two-hybrid assay 
Strains were grown up as patches overnight on selective agar plates. An autoclaved 
Whatmann #5 (7cm diameter) filter paper (#1005070) was pre-soaked in 2.5-5m1 of Z 
buffer and X-gal in a Petri dish. Another sterile filter paper was placed over the yeast 
colonies to transfer cells and then submerged in liquid Nitrogen for 10 seconds. The 
filter was removed and allowed to thaw at room temperature. The filter paper was 
then placed colony side up into a Petri dish on top of a filter paper pre-soaked in Z 
buffer. Samples were incubated at 30 °C for 20 minutes to 1 hour. If colonies turned 
blue this would suggest an interaction between the two candidate proteins. 
Z-Buffer: 	 16.1 gIL Na2HP04 7H20 
5.5 gIL NaH2PO4 H20 
0.75 gILKC1 
0.246 g/L MgS04 7H20 
X-gal stock: 	 20 mg/ml 
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Z-Buffer/X-gal Solution: 	100 ml Z-Buffer 
0.27 ml 3-mercaptoethano1 
1.67 ml X-gal stock 
Diagram 2.6: The yeast two-hybrid system is used to identify protein-protein 
interactions between candidate proteins, shown here as A and B. A The candidate A 
protein is tagged with a GALA DNA binding domain and B candidate B with the 
GALA activation domain. C If the two candidate proteins physically bind, then the 
DNA binding domain and activating domain come together and enable expression of 
the reporter gene. 
A 
Candidate Protein A 
DNA-binding domain 
C) 
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Chapter 3: 
Identification of the essential domains of 
the molecular chaperone protein Cdc37 
in S. pombe 
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3.0 	Identification of the essential domains of S. yombe 
Cdc37 
3.1 	Introduction 
The expression of mutant alleles in a cell lacking the endogenous gene to determine 
their ability to sustain cell viability is a valuable tool for identifying essential domains 
of a candidate protein. The S. pombé cdc37 gene was mutagenised both randomly and 
by directed mutagenesis to generate various mutants to identify which domains are 
crucial for cell viability. Three domains have been identified in the human Cdc37 
homologue using limited proteolysis and peptide analysis: an N-terminal region 
consisting of amino acids 1-126, a middle region composed of residues 128-282 and a 
C-terminal portion of amino acids 283-378 (Shao et al., 2003). By aligning human 
and S. pombe Cdc37 sequences these three domains were mapped onto the S. pombe 
protein as indicated in Figure 3.1. Crystallisation studies of the human Cdc37 protein 
comprising amino acids 148 to 347 identified structural features of the middle and C-
terminal domains (Roe et al., 2004). A 6-helix bundle (amino acids 148-245) was 
identified, connected to a small 3-helix bundle (residues 316-347) by a long single 
helix (residues 246 to 286) and a disordered polypeptide chain (amino acids 309-3 15) 
(Roe et al., 2004). These features have also been mapped onto S. pombe Cdc37 as 
shown in Figure 3.2. 
At present there is no known role for the C-terminal domain of Cdc37, although 
functions for the N-terminal and middle regions have been identified. The N-terminal 
domain of human, rat and S. cerevisiae Cdc37 contains conserved serine residues that 
are important for function and are phosphorylated by casein kinase II (Bandhakavi et 
al., 2003; Miyata and Nishida, 2004; Shao et al., 2003). Phosphorylation of these 
conserved serine residues is important for the binding of client proteins by the 
molecular chaperone Cdc37 (Miyata and Nishida, 2004). The N-terminal, domain of 
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Figure 3.1: The protein sequence of A Human Cdc37 was aligned with B S. pombe 
Cdc37. Domains identified in human Cdc37 by limited proteolysis and peptide 
analysis (Shao et al., 2003) and the Hsp90-binding (purple) and homodimerisation 
(blue) domains (Roe et al., 2004) were mapped onto the S. ponbe Cdc37. These 
represent the domains referred to for S. pombe Cdc37 in this Chapter. 
A Human 
126 	 282 	378 
EIIW 	II 	1 
I 	 I 	 I I I 	I 
0 100 200 	 300 	400 466 
B S. pombe 
180 	 367 
II 	I_Il 	II 	I 
	
I 	 I 	 I I 	I 
0 	 100 200 300 	 400 466 
Figure 3.2: Alignment of the structures identified in the human Cdc37 protein with 
the S. ponbe Cdc37 protein. Amino acids 148 to 347 of human Cdc37 were 
crystallized and the structural features determined for this region (Roe et al., 2004). 
These features were mapped onto the S. pombe Cdc37 protein sequence by alignment. 
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Small 3-helix 
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Cdc37 binds client proteins as shown for the eIF2a kinase interacting with human 
Cdc37 (Shao et al., 2003). The middle domain of human Cdc37 contains the 
homodimerisation binding domain (amino acids 218 to 255) and the regions 
responsible for interactions with the co-chaperone Hsp90. A complex between the 
interacting domains of yeast Hsp90 and human Cdc37 has been crystallised and its 
structure determined (Roe et al., 2004). Amino acids 164-170 and 204-208 of human 
Cdc37 were found to form a hydrophobic patch that interacts with the N-terminal 
region of yeast Hsp90 (Roe et al., 2004). The Hsp90-binding and homodimerisation 
binding sites identified in human Cdc37 have also been mapped by alignment onto the 
S. pombe Cdc37 protein as shown in Figure 3.1. 
This chapter describes the creation and analysis of a range of cdc37 mutants with the 
aim of identifying the essential domains of this molecular chaperone that are essential 
for cell viability. Mutants of cdc37 were generated by in vitro pentapeptide 
transposition random mutagenesis and directed mutagenesis to produce a range of 
truncation and five amino acid in-frame insertion mutants throughout the Cdc37 
protein. These cdc37 mutants were expressed in the S. pombe strain ED 1526, deleted 
for the endogenous gene and kept alive by expression of the plasmid pREP82-cdc37. 
The ability of these cdc37 mutants to substitute for wildtype Cdc37 and to sustain cell 
viability in S. pombe was assessed in ED 1526 using the plasmid shuffle assay. 
3.2 	Random mutational analysis of S. pombe cdc37 using in vitro 
pentapeptide transposition 
3.2.1 	In vitro pentapeptide transposition of cdc37 
Random mutagenesis by in vitro pentapeptide transposition was carried out using the 
GPSTMLS Linker Scanning System from NEB to generate a range of S. pombe cdc37 
mutants (described in detail in Materials and Methods: Section 2.2.13). A 
transposonitransprimer is randomly inserted by In vitro pentapeptide transposition 
mutagenesis and its subsequent removal leaves a 15 bp insertion in the target DNA, 
producing an in-frame insertion of five codons. Insertion into the target DNA of less 
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than 15 bp, results in a frameshift and/or the introduction of a stop codon which 
creates a truncation mutant. 
The target DNA, the cdc37 gene, was restriction digested with Ndel and Xmal and 
purified from the pREP8 1 vector. Removal of the vector ensured that in vitro 
pentapeptide transposition insertions only occurred in the target gene to improve 
mutagenesis efficiency. The small scale individual analysis protocol, as described by 
the manufacturer, was carried out using the GPS5 donor DNA and the T nsABC* 
Transposase to randomly insert a Tn7-based Transprimer into cdc37 DNA fragments. 
Once fragments containing insertions had been identified and ligated into the pREP8 1 
vector, the transprimer was removed by digestion with the restriction enzyme Pmel, 
leaving only the in vitro pentapeptide transposition insert. Plasmids were allowed to 
recircularise in the presence of DNA ligase and were then sequenced to determine the 
pattern of inserted nucleotides. 
	
3.2.2 	Mutations obtained by in vitro pentapeptide transposition 
A total of 14 cdc37 mutants were generated by in vitro pentapeptide mutagenesis. A 
summary of the mutants detailing their insertions is given in Table 3.1; Figure 3.3 is a 
schematic diagram to show the location of the insertions within the cdc37 gene. Three 
categories of mutations were identified; in-frame insertions of five codons, in-frame 
stop codons and insertions that produced frameshifts leading to a stop codon. Two of 
the mutants, 1120 and 1386, were obtained by an Honours student, Katie Single. 
3.2.3 	Directed mutagenesis to generate truncation mutants of cdc37 
A range of cdc37 truncation mutants had been generated by in vitro pentapeptide 
transposition mutagenesis. To generate even coverage of truncation mutants across 
the Cdc37 protein, directed mutagenesis was carried out. Overlap PCR and site-
directed mutagenesis were employed to create truncation mutants introducing stop 
codons at specific locations in the full length cdc37 gene as detailed in Table 3.2. 
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Table 3.1: Table of cdc37 mutations generated by in vitro pentapeptide mutagenesis 
detailing the insertion size, location and type of mutant generated. 














37 14 37 Stop codon 40 RQRDGVOT 
60 14 60 Stop codon 61 MAMV°TP]IRRL 
1120 15 120 In-frame IKDACLNNAE 
250 13 250 Frameshift 260 EDGGLNIQEVCQY• 
1252 15 252 In-frame GKKCLNKKVANI 
264 14 264 Frameshift 272 SSSGFKPTKSF• 
273 16 273 Frameshift 282 HLNCLNIKYLGR' 
321 13 321 Frameshift 332 NGLRCLN]INIFSKN• 
351 14 351 Stop codon 354 VRIQYV°T 
385 13 385 Frameshift 395 S1TVFKHHPGRFY' 
1386 15 386 In-frame SITIPVFKHPEA 
412 13 412 Frameshift 422 NLQMFKHTSSYDQ• 
428 13 428 Stop codon 429 KINVOTYC 
1422 15 422 In-frame LDKMFKHKIVVL 
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Figure 3.3: A schematic diagram to illustrate the location of mutations obtained by in 
vitro pentapeptide mutagenesis and directed mutagenesis within the Cdc37 protein. 
J7 \7 
0 	 100 	200 	 300 	400 	466 
Li Insertions introducing a frame-shift and resulting in a stop codon 
LII Insertions introducing a stop codon 
U In-frame insertions of 5 amino acids 
LI Directed mutagenesis introducing a stop codon 
420 	Denotes the codon location of the insertion 
Table 3.2: Truncation mutants generated by directed mutagenesis. 
Name Method STOP codon location 
cdc37-120 Site directed 120 
cdc37-155 Overlap PCR 155 
cdc37-190 I Overlap PCR 190 
cdc37-220 I Overlap PCR 220 
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These truncation mutants were also generated by directed mutagenesis using standard 
PCR amplification with a mutagenised 3' primer that introduced a stop codon 
followed by an Xmal restriction site for cloning, to remove all downstream cdc37 
sequence. This was to ensure that read-through of the stop codon did not occur and 
that a truncated Cdc37 protein was produced. 
3.3 	Ability of cdc37 mutants to sustain cell viability 
A range of cdc37 mutants had been generated, described in the previous section, and 
their ability to sustain cell viability in S. pombe was assayed by plasmid shuffle in the 
strain ED1526. All cdc37 mutants were expressed from pREP81. Expression of 
wildtype Cdc37 from pREP81 produces the Cdc37 protein at a level very similar to 
endogenous Cdc37 (Figure 3.4). This system was therefore used to test the ability of 
cdc37 mutants to sustain viability in the plasmid shuffle assay. 
3.3.1 	Ability of cdc37 in-frame insertion mutants to sustain cell viability 
In vitro pentapeptide mutagenesis of the cdc37 gene generated four mutants with in-
frame insertions of five amino acids. These mutants were expressed from pREP8 1 in 
the plasmid shuffle assay to determine their ability to support growth and to see 
whether any mutant phenotypes resulted. Expression of cdc374120, cdc374386 and 
cdc37-1422 resulted in cells that were wildtype in appearance, supporting growth as 
well as pREP81-cdc37 expression (Figure 3.5). The five amino acid insertions in 
cdc374120, cdc37-1386 and cdc37-1422 start at codons 120, 422 and 386 
respectively. These data show that insertions in the N- and C- terminal domains do 
not dramatically affect essential Cdc37 function in S. pombe. In contrast, the mutant 
cdc37-1252 was unable to sustain cell viability and no growth was observed at any 
temperature in the plasmid shuffle. Cells were heterogeneous in phenotype, being 
elongated, round, small and bowling pin shaped, all characteristic of depletion of 
Cdc37 from cells as described by (Westwood et al., 2004). The cdc37-1252 mutant 
has a five amino acid insertion in the middle domain starting at residue 252 which 
disrupts the essential function of the molecular chaperone Cdc37, so that it could not 
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Figure 3.4: Comparison of Cdc37 protein levels of endogenous Cdc37 in the cdc37' 
strain ED1022 and expression of pREP81-cdc37 in the cdc37A strain ED1526. 
Western blots were carried out with anti-S. pombe Cdc37 antibody to determine 
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Figure 3.5: A schematic diagram of the location of the five amino acid insertion sites 
within the Cdc37 protein. Cdc37 mutants were expressed from pREP81 in ED 1526 to 
determine their ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 
and 36 °C (shown here at 28 °C, behaviour did not differ at other temperatures). 
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be substituted for wildtype Cdc37. According to the alignment of the human and S. 
pombe Cdc37 proteins shown in Figures 3.1 and 3.2, the five amino acid insertion of 
cdc374252 is located at the edge of the postulated Hsp90 binding domain, within the 
6-helix bundle of the middle domain (Roe et al., 2004) and may disrupt structure in 
this region abrogating Cdc37 function. 
3.3.2 	Ability of cdc37 truncation mutants to sustain cell viability 
Truncation mutants of cdc37 were generated as previously described, and their ability 
to sustain cell viability was assayed using the plasmid shuffle system. All truncation 
mutants were expressed in the S. pombe strain ED1526 from pREP81. Expression of 
Cdc37 mutants, cdc37-428, cdc37-412, cdc37-385, cdc37-360 (formally called cdc37-
1) and cdc37-351, truncated in the C-terminal domain, were able to sustain cell 
viability supporting growth as well as expression of pREP81-Cdc37 (Figure 3.6). 
These data indicate that the C-terminal domain is not essential for Cdc37 function and 
cell viability in S. pombe. Shorter truncation mutants of Cdc37, cdc37-321, cdc37-
273, cdc37-264 and cdc37-250, deleted in the middle domain, were unable to 
compensate for loss of full length Cdc37 and could not sustain growth at any 
temperature (Figure 3.6). Cells phenotypically resembled those observed with 
expression of only the pREP8 1 vector consisting of morphologically heterogeneous 
non-dividing cells. Interestingly, Cdc37 truncation mutants cdc37-190 and cdc37-220 
were able to support a low level of growth when expressed from pREP81 (Figure 3.6). 
This result was surprising, considering cdc37-190 and cdc37-220 only express 40% 
and 47% of full length Cdc37 protein respectively. These Cdc37 truncation mutants 
lack the majority of the middle and all of the C-terminal domains, indicating that 
these domains are not essential for Cdc37 function and cell viability. Expression from 
pREP81 of Cdc37 mutants, cdc3 7-3 7, cdc37-60, cdc37-120 and cdc37-155, truncated 
in the N-terminal domain, were unable to sustain growth. 
Figure 3.6: A schematic diagram of the Cdc37 truncation mutants expressed from 
pREP8 1 in the cdc37A strain ED 1526. Strains were plated onto 5FOA to determine 
their ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 and 36 °C 
(shown here at 28 °C, behaviour did not differ at other temperatures). 
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Figure 3.7: Western blot of S. pombe cdc37 strain Ed1090 expressing truncation 
mutants from pREP8 1. Protein levels of truncations compared to endogenous Cdc37 
were ascertained by western blot with anti-S. pombe Cdc37 antibody. * indicates 
proteolytic truncation of endogenous Cdc37. 
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The protein levels of Cdc37 truncation mutants expressed from pREP8 1 were studied 
to determine whether reduced protein levels might be the cause for the observed 
phenotypes in the plasmid shuffle assay. Reduced protein levels have been observed 
in S. cerevisiae for the Cdc37 truncation mutant cdc37-1, which is truncated at codon 
360 (Gerber et al., 1995). S. pombe Cdc37 truncation mutants were expressed from 
pREP81 in the cdc37 strain ED1090 for comparison by western blot analysis to full 
length endogenous Cdc37. Whole cell protein extracts were made for each mutant and 
loaded equally onto SDS polyacrylamide gels. Western blot analysis was carried out 
using the anti-S. pombe Cdc37 antibody. All Cdc37 truncation mutants yielded a 
truncated protein that was detected by western blot except for cdc37-155 (Figure 3.7). 
Mutants truncated within the C-terminal and middle domains produced protein at 
levels very similar to endogenous Cdc37. Mutants cdc37-190 and cdc37-220 were the 
only truncations that were detected by western blot at reduced levels compared to 
endogenous Cdc37. This may be due to low expression levels, reduced stability of 
mutant protein or poor recognition by the anti-S. pombe Cdc37 antibody whose 
recognition epitopes have not been fully characterised. 
3.3.3 	Ability of cdc37 truncation mutants to sustain cell viability when 
overexpressed 
Cdc37 truncation mutants were overexpressed in the plasmid shuffle assay from the 
pREP 1 vector to determine the effect of increasing mutant protein levels on cell 
viability. Overexpression of the Cdc37 mutants cdc37-321, cdc37-273, cdc37-264 and 
cdc37-250, truncated in the middle domain, supported growth as well as expression of 
pREPJ-cdc37 (Figure 3.8). This was a surprising result as these mutants were unable 
to maintain cell viability in the plasmid shuffle when expressed from pREP8 1. Cdc37 
truncation mutants, cdc37-190 and cdc37-220, which lack the majority of the middle 
and all the C-terminal domains, were able to sustain growth when overexpressed 
(Figure 3.8). With expression from pREP81, these two Cdc37 truncation mutants only 
supported limited growth, most likely due to their reduced protein levels (Figure 3.8). 
The Cdc37 mutant cdc37-155, truncated in the N-terminal domain was unable to 
support growth even when overexpressed (Figure 3.8). 
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The protein levels of Cdc37 truncation mutants overexpressed from pREP 1 were 
assayed against endogenous Cdc37 protein levels to determine whether the resulting 
phenotypes were due to dramatically increased mutant protein levels. Overexpression 
of the truncation mutant's cdc37-155, cdc37-190 and cdc37-220 yielded protein that 
was detected by western blot with the anti-S. pombe Cdc37 antibody (Figure 3.9). 
These data indicate that the Cdc37 S. pombe antibody does recognise the cdc3 7-1 55 
protein sequence. Cdc37 truncation mutants were all expressed at a level much greater 
than endogenous Cdc37. The truncation mutants cdc37-190 and cdc37-220 may be 
able to support cell viability when overexpressed because protein levels were greater 
than endogenous Cdc37 protein levels; whereas protein levels were reduced compared 
to the endogenous Cdc37 protein when these mutants were expressed from pREP8 1. 
The mutant cdc37-155 is expressed at a level much greater than the endogenous but 
cannot sustain cell viability, indicating that the essential function of Cdc37 is 
abolished in this mutant. Proteolysis of Cdc37 was observed in these experiments, 
most notably for cdc37-190 and cdc37-220 (Figure 3.9). This phenomenon may be a 
reflection of the stability of the truncation mutant when overexpressed in this S. 
pombe strain. 
3.4 	Cdc37 mutants do not exhibit any dominant negative effect 
All cdc37 mutants previously described were overexpressed from pREP 1 in the S. 
pombe cdc37 strain ED 1090 to look for any dominant negative effect. A dominant 
negative effect may occur when a mutant version of a protein inhibits the endogenous 
protein in some manner negatively affecting the cell. Overexpression in ED1090 of 
the Cdc37 truncation and in-frame insertion mutants did not negatively effect growth 
or alter morphology at 25, 28, 32 and 36 °C, except for the mutant cdc37-321, whose 
overexpression resulted in slightly elongated cells (data not shown). The cdc37-321 
truncation mutant is truncated in the 6-helix bundle around the homodimerisation 
domain identified in human Cdc37 (Roe et al., 2004). A truncation in this region may 
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Figure 3.8: A schematic diagram of the Cdc37 truncation mutants overexpressed 
from pREP1 in the cdc37A strain ED1526. Strains were plated onto 5FOA to 
determine their ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 



















Figure 3.9: Western blot of S. pombe wildtype strain Ed 1090 overexpressing 
truncation mutants pREP] -cdc37- 155, pREP] -cdc3 7-190 and pREP] -cdc3 7-220. 
Protein levels of truncations were compared to endogenous Cdc37 by western blot 
with Cdc37 antibody. * indicates proteolytic truncation of endogenous Cdc37. 






negatively affect structure and function of Cdc37, but still permit a level of 
dimerisation, titrating endogenous Cdc37 away and preventing proper function. 
3.5 	Discussion 
A range of truncation and in-frame insertion mutants of cdc37 were generated using 
in vitro pentapeptide transposition mutagenesis and directed mutagenesis and were 
tested for their ability to support cell viability. The aim of these experiments was to 
identify the domains essential for Cdc37 to sustain cell viability in S. pombe. The 
domains identified in human Cdc37 (Shao et al., 2003) were mapped onto S. pombe 
Cdc37 and used as a guide line for the predicted domains of the S. pombe Cdc37 
protein. 
The in-frame insertion of five amino acids into the C-terminal or N-terminal region in 
mutant's cdc374120, cdc37-1386 and cdc374422 did not negatively affect Cdc37 
function. The mutant cdc37-1252 containing an in-frame insertion at residue 252 in 
the middle domain abolished Cdc37 function and was unable to sustain viability. The 
introduction of five extra amino acids in cdc374252 may have significantly altered 
the conformation of Cdc37, inhibiting function of the molecular chaperone, as the 
insertion lies in the large 6-helix bundle (Roe et al., 2004). An insertion at this point 
in Cdc37 may prevent proper folding and conformation from being achieved thus 
abrogating function. Alternatively, the insertion may lie in or near to an essential 
functional domain that is negatively affected by the presence of five extra amino 
acids. The alignment of human and S. pombe Cdc37 indicates that the cdc37-1252 
insertion is located between the two regions identified as important for Hsp90 
binding, just upstream of the putative dimerisation region (Roe et al., 2004) and may 
negatively affect these interactions. 
In accordance with observations in S. cerevisiae (Lee et al., 2002), the C-terminal 
domain of S. pombe Cdc37 was found to be dispensable for essential function. In S. 
cerevisiae the Cdc37 truncation mutant Cdc37 1388 , which lacks the C-terminal 
domain, was able to restore v-src activity as well as full length Cdc37 in the S. 
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cerevisiae stilA mutant (Lee et al., 2002). Interestingly, the shorter truncation mutant, 
cdc37-1, truncated at codon 360, supports cell viability in a cdc37A in a temperature 
dependent manner (Gerber et al., 1995). Overexpression of this S. cerevisiae 
truncation mutant is able to support a greater level of growth at the restrictive 
temperature (Gerber et al., 1995). 
In S. cerevisiae the truncation mutant Cdc37 1355 which lacks the latter part of the 
middle domain and the entire C-terminal domain was unable to restore cellular 
viability in a cdc37A strain whether expressed at low or high level (Lee et al., 2002). 
In contrast, the equivalent S. pombe mutants, cdc37-321, cdc37-273, cdc37-264 and 
cdc37-250, which are truncated within the middle domain, around the putative Hsp90-
binding and homodimerisation domains, were able to sustain cellular viability, but 
only when overexpressed. These mutants were lethal in the plasmid shuffle with 
expression from pREP8 1, most likely due to reduced function as protein levels were 
very similar to endogenous Cdc37. Increasing the protein level of these truncation 
mutants, may raise the overall function above a threshold level so that cell viability is 
maintained. Reduced function of these Cdc37 truncation mutants may be because the 
N-terminal domain is titrated away from carrying out essential roles by the aberrant 
middle domain attempting, for example to interact with Hsp90 or homodimerise. 
Alternatively, the folding of Cdc37 may be perturbed, as these mutants are truncated 
in the 6-helix bundle identified in human Cdc37 (Roe et al., 2004), which could 
negatively affect protein structure. Disruption of the protein structure in this region 
might affect essential functions and/or interactions of Cdc37, possibly disrupting the 
N-terminal domain and its interactions with client proteins. 
Truncation mutants cdc37-190 and cdc37-220, which lack the majority of the middle 
and all of the C-terminal domains which include the Hsp90-binding and 
homodimerisation regions, were able to sustain cell viability when overexpressed. 
Expression of these mutants from pREP81 supported limited growth, but 
overexpression of cdc37-190 and cdc37-220 was able to sustain growth as well as 
expression of pREPJ-cdc37. These results differ from observations in S. cerevisiae 
which showed that overexpression of the truncation mutants Cdc37 1148 and Cdc37 1 
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239, also truncated around the N-terminal and middle domain boundary, permitted 
slow growth in a temperature dependent manner in a cdc37i\ strain (Lee et al., 2002). 
Protein levels of S. pombe cdc37-190 and cdc37-220 expressed from pRP81 were 
reduced compared to endogenous Cd'c37, which may explain why these mutants could 
only support limited growth. Growth was fully restored when these Cdc37 truncation 
mutants were overexpressed, increasing protein levels above endogenous Cdc37. 
These data indicate that only the N-terminal domain is required for the essential 
function of Cdc37 in S. pombe, providing their protein levels are high enough. 
Expression of Cdc37 mutants truncated within the N-terminal domain from pREP81 
were unable to sustain cell viability. Cell viability could not be maintained by cdc37-
155, even when protein levels were greater then endogenous Cdc37. Truncations from 
the C-terminus into the N-terminal domain of Cdc37 completely abolish essential 
function. The N-terminal domain appears to be the domain essential for Cdc37 
function to sustain cell viability. N-terminal truncation mutants of S. pombe Cdc37, 
lacking the first 20 or 40 amino acids, were unable to maintain cell viability even 
when over-expressed on pREP 1 in a plasmid shuffle (from Dr ma Martin personal 
communication). The highly conserved N-terminal domain is essential for Cdc37 
function as it interact directly with the client proteins (Shao et al., 2003). 
In summary, the middle and C-terminal domains of S. pombe Cdc37 are completely 
dispensable for growth, when protein levels are not a limiting factor. Expression of 
only the N-terminal domain is sufficient to maintain essential Cdc37 function. This is 
surprising as these mutants do not contain the Hsp90-binding or homodimerisation 
domains, indicating that these functions may not be essential for Cdc37 in S. pombe. 
Truncations within the N-terminal domain were unable to sustain growth at low or 
high expression levels. 
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Mutational Analysis of the N-terminal 
Domain of S. pombe Cdc37 
126 
4.0 	Mutational Analysis of the N-terminal Domain of 
S. pombe Cdc37 
4.1 	Introduction 
The first 40 amino acids of Cdc37 are the most highly conserved across species 
(Figure 4.1) and have been the focus of many mutational studies. Mutation of serine 
14 in S. cerevisiae to a leucine gave rise to cdc37-34 a temperature-sensitive mutant 
(Dey et al., 1996). Further mutational analysis of the conserved N-terminal serine 
residues identified serines 14 and 17 of S. cerevisiae (Bandhakavi et al., 2003) and 
serine 13 of rat (Miyata and Nishida, 2004) and human (Shao et al., 2003) (equivalent 
to S. cerevisiae serine 14) as important sites of phosphorylation. 
Human Cdc37 is phosphorylated in vivo and mutating serine 13 to alanine inhibits this 
(Shao et al., 2003). A recombinant C-terminal truncation of human Cdc37 was 
phosphorylated in vitro by casein kinase II (CKII) (Shao et al., 2003). However, CKII 
was unable to phosphorylate N-terminal deletions of cdc37 in vitro (Miyata and 
Nishida, 2004) or mutant versions of human Cdc37 where serine 13 was substituted 
with an alanine (Miyata and Nishida, 2004). Cdc37 serine 13 in rat and human and 
serines 14 and 17 in S. cerevisiae are the major sites of phosphorylation by CKII. 
Phosphorylation of these N-terminal serine residues is important for Cdc37 function 
(Bandhakavi et al., 2003; Miyata and Nishida, 2004; Shao et al., 2003). This has lead 
to the formation of the hypothesis that CMI and Cdc37 are involved in a feedback 
loop of activation, whereby CKJI activates Cdc37 by phosphorylation and Cdc37 
maintains CMI activation (Bandhakavi et al., 2003). When cells were treated with 
TBB, a specific inhibitor of CKII, Cdc37 phosphorylation was reduced and protein 
levels of the Cdc37 clients MOK and Raf-1 decreased (Miyata and Nishida, 2004). 
The non-phosphorylated form of human Cdc37 was also found to have reduced 
binding affinity for clients Akt, aurora-B, cdk4 and MRK (Miyata and Nishida, 2004). 
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Figure 4.1: An alignment of the first 40 amino acids of human, S. cerevisiae and S. 
poinbe Cdc37. Serine residues that are conserved among Cdc37 homologues and sites 
of phosphorylation in human and S. cerevisiae Cdc37 are highlighted in pink. 
I 	N-terminus 	I 	Middle Domain 	I C-terminus I 
-MVDYSVWDH- 1EV DDED-ETHPN-IDTASLFRWR - - - -HQARVERM Human 
MAIDYSKWDK-IEL DD DVEVHPN-VDKKSFIKWKQQSIHEQRFKRN S. cerev,siae 
MAIDYSKWDK - LEL DD DIEVHPN -VDKXSFIRWRQRDIHEKRAVRX 5 t,ombe 
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This chapter describes how a mutation, equivalent to the S. cerevisiae temperature-
sensitive mutation cdc37-34, was introduced into the S. pombe cdc37 gene with the 
aim of generating a temperature-sensitive mutant. However, this mutation proved to 
be lethal in S. pombe and this prompted a more detailed investigation of the conserved 
N-terminal serine residues of Cdc37 with the aim of identifying putative 
phosphorylation sites. Further work was also carried out to develop an assay to 
determine the phosphorylation status of S. pombe Cdc37. 
4.2 	Mutational analysis of the N-terminal serine residues of S. pombe 
cdc37 
4.2.1 	Generating a S. pombe mutation equivalent to the S. cerevisiae 
temperature-sensitive mutant cdc37-34 
The temperature-sensitive mutant cdc37-34 in S. cerevisiae was isolated by its ability 
to relieve the toxic effect of over-expressed pp60 ' (Dey et al., 1996). The 
temperature-sensitive mutant cdc37-34 contains a single point mutation of serine 14 
to leucine (Dey et al., 1996). Mutation of the equivalent serine 14 in S. pombe to 
leucine was carried out using Stratagene Quick change TM  site directed mutagenesis 
(Section 2.3.5) on the cdc37 gene in the vector pREP8 1 generating the mutant cd07-
S14L. The mutant cdc37414L was expressed from pREP81 by plasmid shuffle assay 
to determine its ability to sustain cell viability at different temperatures. pREP81-
cdc37414L was unable to promote growth at 25, 28, 32 or 36 °C (Figure 4.2), and 
cells were morphologically heterogeneous, being long, rounded and bowling pin 
shaped, characteristic of depletion of Cdc37 from cells as described in (Westwood et 
al., 2004). 
Lethality of the cdc37414L mutant expressed from pREP8 1 may be due to instability 
of the mutant protein, as observed with some truncation mutants described in Chapter 
3. Therefore Cdc37-S]4L was overexpressed from pREP1 in the S. pombe strain 
ED1526 and assayed by plasmid shuffle to determine whether increasing the level of 
129 
Figure 4.2: Expression of the mutants cdc37-SJ4L and cdc37-S1417A from pREP81 
to determine their ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 
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Figure 4.3: Overexpression of the mutants cdc37-SI4L and cdc37-S14A from pREPI 
to determine their ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 
and 36 °C. A Strains were plated as serial dilutions and incubated at different 
temperatures for 4 days and B the cellular morphology of those strains on 5FOA. 
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mutant protein could sustain cell viability. Overexpression of cdc37-S14L by plasmid 
shuffle assay resulted in a weak temperature-sensitive phenotype (Figure 4.3). A low 
level of growth was observed at 25, 28 and 32 °C but not at 36 °C. At all temperatures 
cells were morphologically heterogeneous, displaying phenotypes characteristic of 
depletion of Cdc37 from cells as described in (Westwood et al., 2004). These data 
indicate that Cdc37 function is not completely abolished by the mutation of serine 14 
to leucine. Increasing the protein levels of this mutant, raising the level of activity 
above a threshold in the cell can sustain viability in a temperature dependent manner. 
4.2.2 	Mutational analysis of the extreme N-terminal serine residues of 
Cdc37 
The first two N-terminal serine residues (6 and 14) are conserved in all Cdc37 
homologues, and yeasts contain a third conserved serine residue at amino acid 17. The 
S. cerevisiae serine residues 14 and 17 and the rat and human serine 13 are 
phosphorylated by CKJI and are important for Cdc37 function (Bandhakavi et al., 
2003; Miyata and Nishida, 2004; Shao et al., 2003). To investigate further the role of 
N-terminal serine residues in S. pombe Cdc37, mutational studies were carried out to 
determine whether these serine residues are of functional importance. Site directed 
mutagenesis by overlap PCR (Section 2.3.5) was used to mutate serines 14 and 17 to 
alanine, both independently and together. The mutation of serine 6 to alanine was 
introduced using a modified 5' oligonucleotide in a standard PCR reaction (Section 
2.3.3.2). Mutants were transformed into the S. pombe strain ED1526 and expressed 
from pREP81 to determine their ability to sustain cell viability by plasmid shuffle 
assay. Independent mutations of serine residues 6 and 17 to alanine did not affect cell 
viability at any temperature (Figure 4.4) and cells were phenotypically wildtype in 
appearance. cdc37-S1417A (Figure 4.2) and cdc37414A (Figure 4.4) were unable to 
maintain cell viability at 25, 28, 32 and 36 °C. Both of these mutants gave rise to a 
population of cells that were either small and round or 4-5 fold longer than wildtype 
cells. These data indicate that serine 14 is important for Cdc37 to maintain cell 
viability in S. pombe, but serines 6 and 17 are not. 
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Figure 4.4: Expression of cdc37 mutants ccIc37-S6A, cdc37-S14A and ccIc37-SJ7A 
from pREP8 1 to determine their ability to sustain cell viability by plasmid shuffle 
assay at 25, 28, 32 and 36 °C. 
2C 
	
32'C 	 3C 
pREP81-cdc3 7 
pREP 
pREP8I-cdc3 7 So..:  
pREP81-cdc37-S141 
pREP8J-cdc3 7-Si 74 
pREP8I-cJc3 7 
pREP I 
pREP8 / -ccic3 7-S64 
pREP8 /-cdc3 7-Si 44 






Cdc37-S14A was overexpressed to establish whether raising mutant protein levels 
could sustain cellular viability by plasmid shuffle assay, as overexpression of cdc37-
S14L by plasmid shuffle enabled growth in a temperature dependent manner. 
Overexpression of cdc37-S14A from pREP1 in ED1526 was able to support growth as 
well as expression of pREPJ-cdc37 and cells were phenotypically wildtype in 
appearance at 25, 28, 32 and 36 °C (Figure 4.3). Therefore, mutating serine 14 to 
alanine, does not completely abrogate Cdc37 function, as increasing the mutant 
protein level which raises the overall cellular level of Cdc37-SJ4A activity sustains 
cell viability. 
4.2.3 	Mimicking phosphorylation of Cdc37 by mutating serine 14 to 
glutamic acid 
Phosphorylation of rat Cdc37 by CKII in vitro was inhibited by mutating serine 13 
(Miyata and Nishida, 2004). CMI preferentially phosphorylates motifs that are 
enriched up to four codons away on either side of. the phosphorylatable residue with 
glutamic acid and aspartic acid (Kuenzel et al., 1987; Songyang et al., 1996). 
Specifically, CKII was found to favour peptides with aspartic acid at positions —3 and 
+2 (Songyang et al., 1996). Serine 14 in S. pombe aligns with S. cerevisiae serine 14 
and rat and human serine 13, residues known to be phosphorylated by CMI. S. pombe 
Cdc37 serine 14 is a candidate for CKII phosphorylation as this codon is flanked on 
either side by acidic residues. Serine 14 has a glutamic acid at -2 and 3 aspartic acid 
amino acid residues at +1, +2 and +4. 
Serine 14 was substituted for a negatively charged glutamic acid residue which can in 
some instances mimic for a phosphoserine, as seen with Wisi (Samejima et al., 1997). 
Overlap PCR was used to mutate Serine 14 to glutamic acid producing pREP81-
cdc37-514E. This mutant allele was expressed from pREP81 by plasmid shuffle assay 
to determine its ability to sustain cell viability. Expression of cdc37-S]4E from 
pREP8 1 was able to support a low level of growth, greater than observed for the 
expression of just the pREP81 vector (Figure 4.5A). Expression of the mutant cdc37-
S14E in the plasmid shuffle produced cells that were phenotypically heterogeneous at 
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all temperatures, being elongated, rounded and bowling pin shaped cells (Figure 
4.513). Although cells were morphologically aberrant in appearance, the mutation of 
serine 14 to glutamic acid supported a greater level of growth than observed with 
cdc37414L and cdc37-S14A expressed from pREP81 in the plasmid shuffle assay. 
Glutamic acid may not be an effective mimic for phosphoserine which is why cells 
expressing the c&37-S]4E mutants are phenotypically abnormal in appearance. These 
data indicate that Cdc37 serine 14 may be a site of phosphorylation in S. pombe. 
The effect of increasing cdc37-SJ4E protein levels was investigated, as it had been 
previously shown that increasing the levels of certain Cdc37 mutant proteins within 
the cell can promote a greater level of growth. cd67414E was over-expressed from 
pREP 1 in ED 1526 by plasmid shuffle to observe the ability of this mutant construct to 
sustain cell viability with increased protein levels. Expression of pREPJ-cdc37-S14E 
was able to support growth in the plasmid shuffle as well as expression of pREP]-
cdc37 (Figure 4.6). Cells were phenotypically aberrant compared to those expressing 
pREPJ-cdc37, being slightly rounder and smaller in appearance compared to a 
wildtype cell. Overexpression of cdc37-S14E does not affect the level of growth but 
does negatively affect cell morphology. These data indicate that glutamic acid may be 
a poor mimic for Cdc37 phosphoserine at residue 14 in this instance, inhibiting 
optimum function of this molecular chaperone. 
4.3 	Overexpression of Cdc37 serine mutants to test for any dominant 
negative effect 
c&37-SJ4A, cdc37414E, cdc37-S14L and cdc37-S1417A, described collectively as 
serine 14 mutants, were overexpressed in the cdc37 strain ED1090 to observe 
whether they produced a dominant negative effect. Serine 14 mutants were expressed 
from pREP1 in ED1090 and incubated at 28 and 36 °C. All strains were able to 
promote growth and did not exhibit any dominant negative effect. All strains were 
phenotypically wildtype in appearance at both temperatures. 
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Figure 4.5: Expression of the mutant cdc37-S14E from pREP81 to determine its 
ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 and 36 °C. A 
Growth of strains plated as serial dilutions on media with and without 5FOA and B 
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Figure 4.6: Overexpression of the mutant cdc37-SJ4E from pREP 1 to determine its 
ability to sustain cell viability by plasmid shuffle assay at 25, 28, 32 and 36 °C. 
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4.4 	Protein levels in Cdc37 serine 14 mutants 
The protein levels of serine 14 mutants of Cdc37 expressed from pREP81 were 
assayed to test whether phenotypes observed in the plasmid shuffle were due to 
specific mutations or reduced expression of Cdc37 mutants. Cdc37 and serine 14 
mutants were N-terminally tagged with HA to assay protein levels by western blot, as 
serine mutants are single point mutations that cannot be distinguished by 
electrophoretic mobility from endogenous Cdc37. Whole cell extracts of denatured 
protein were made of each mutant and run on SDS PAGE. Western blot with an anti-
HA antibody was carried out to observe Cdc37 serine mutant protein levels. The 
TAT1 antibody was also used in western blots to detect for S. pombe tubulin as a 
loading control. Western blot results indicate that serine 14 mutants do not differ in 
protein level from wildtype Cdc37 (Figure 4.7) indicating that observed phenotypes 
are not due to reduced mutant protein. 
To verify that the N-terminal HA-tag did not have any negative effect on Cdc37 and 
serine 14 mutants, constructs were tested in the plasmid shuffle assay expressed from 
pREP81 to observe their affect on cell viability. pREP81-HA-cdc37 behaved like 
wildtype in the plasmid shuffle with no obvious defects in phenotype (Figure 4.8). At 
25, 28, 32 and 36 °C expression of pREP81-HA-cdc37-SJ4A and pREP81-HA-cdc37-
S14L was unable to support growth and cells were heterogeneous in phenotype as 
previously described for these mutants without the N-terminal tag (data not shown). 
pREP81-HA-cdc37-S14E was able to support a low level of growth consisting of cells 
that were heterogeneous in phenotype as was previously observed for this mutant 
without the HA-tag. The phenotypes observed by plasmid shuffle for these mutants 
are the same as those seen in the absence of an N-terminal HA tag, indicating that the 
tag has no negative effect on Cdc37 function. 
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Figure 4.7: Comparison of protein levels of N-terminally HA-tagged Cdc37 and 
serine 14 mutants expressed from pREP81 in ED1526 at 28 °C. Whole cell extracts 
were made, run on SDS PAGE and western blot were carried out with anti-HA 
antibody and the TAT  antibody as a loading control. 
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Figure 4.8: Expression of N-terminally HA-tagged cdc37, S14A, S14L and S14E from 
pREP8 1 to determine their ability to sustain cell viability by plasmid shuffle assay at 
28, 32 and 36 °C. 
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4.5 	The mobility of Cdc37 and serine mutant proteins do not differ on 
SDS PAGE gels as a method of assaying phosphorylation status 
To investigate further phosphorylation of Cdc37 in S. pombe a biochemical approach 
was taken. Phosphorylation can alter the mobility of a protein by gel electrophoresis 
by SDS PAGE, as has been shown for CMI (Litchfield et al., 1992). To date, no 
difference in mobility by gel electrophoresis due to phosphorylation has been reported 
for Cdc37 from rat, human and S. cerevisiae by western blot analysis. To determine 
whether the mobility of Cdc37 differed by gel electrophoresis due to phosphorylation, 
serine 14 mutants and wildtype Cdc37 protein samples were run by SDS PAGE for 
comparison. Wildtype Cdc37 and serine mutants cdc37-514A, cdc37414L, cdc37-
S14E and cdc37-S1417A were expressed from pREP! in the cdc37 strain ED1090. 
Whole cell protein extracts were made and run on large SDS PAGE gels overnight at 
4 °C to obtain high resolution. Western blot analysis was carried out using the anti-S. 
pombe Cdc37 antibody. The observed migration of Cdc37 and serine mutants did not 
differ as judged by western blot (Figure 4.9). 
4.5.1 	Treatment with phosphatase does not alter molecular weight of 
Cdc37 
Overexpression of Cdc37 and serine 14 mutants is a crude technique to identify 
differences in mobility due to phosphorylation. A more elegant approach was 
undertaken, treating endogenous Cdc37 with phosphatase to determine whether 
dephosphorylation of Cdc37 can be observed by differences in mobility by SDS 
PAGE. Previously whole cell protein extracts were treated with both Lambda 
phosphatase and Calf intestinal phosphatase (CIP) and samples were run by SDS 
PAGE to look for any differences in mobility by gel electrophoresis due to 
phosphorylation. However, these experiments were unsuccessful in detecting any 
difference in mobility and were further complicated as CIP runs at exactly the same 
place as Cdc37 by SIDS PAGE. To eliminate these issues and other factors in crude 
protein extracts that could affect the phosphatase reaction, Cdc37 was 
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Figure 4.9: Western blot with anti-S. pombe antibody of wildtype Cdc37 and serine 
mutants expressed from pREP1 in the S. pombe strain ED1090 to look at differences 
in mobility due to phosphorylation. SDS polyacrylamide gel was stained with 
Coomassie as a loading control. 
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immunoprecipitated (Section 2.5.7) using the anti-S. pombe Cdc37 antibody and then 
treated with either Lambda phosphatase or CIP (Section 2.5.6). All samples were 
loaded onto a 10% polyacrylamide gel interspersed with untreated native protein 
extracts from ED1090 for accurate comparison of Cdc37 mobility. Gels were run 
overnight at 4 °C for high resolution and western blots were carried out with the anti-
s. pombe Cdc37 antibody. No difference in the mobility of phosphatase treated Cdc37 
compared to the endogenous Cdc37 was observed under any phosphatase treatment 
conditions (Figure 4.10 A & B). These data indicate that dephosphorylation of Cdc37 
in S. pombe cannot be detected by differences in mobility by electrophoresis on SDS 
PAGE gels. 
4.6 	Discussion 
Mutational analysis of serine 14 in S. pombe Cdc37 has shown that this residue is 
important for Cdc37 function to maintain cell viability. However, it has not been 
established how this amino acid contributes to Cdc37 function. Theses data indicate 
that phosphorylation of serine 14 in Cdc37 might occur as pREP81-cdc37-SJ4E was 
able to support a low of level of growth whereas pREP81-cdc37414A and pREP81-
cdc37414L could not. The mutation of serine 14 to glutamic acid to mimic 
phosphorylation may not be a complete substitute and overexpression of this mutant 
was still unable to rescue the morphologically aberrant appearance of the cells. 
Attempts to determine the phosphorylation status of Cdc37 by SDS PAGE were 
unable to identify any difference in mobility between wildtype Cdc37 and serine 
mutants. Treatment of endogenous Cdc37 with phosphatases did not produce any 
difference in mobility by SDS PAGE. 
Mutational analysis of the conserved N-terminal residues serines 6 and 17 to alanine 
did not affect cell viability in S. pombe, indicating that serines 6 and 17 did not affect 
Cdc37 function in vivo. In accordance with findings in S. cerevisiae, the S. pombe 
mutant cdc37-S1417A was unable to support growth by plasmid shuffle assay. In S. 
cerevisiae, cdc37-S]41 7A exhibited reduced growth with a doubling time of 10 hours 
compared to 90 minutes for a wildtype strain (Bandhakavi et al., 2003). The S. pombe 
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Figure 4.10 A: Lambda phosphatase treatment of immunoprecipitated endogenous 
Cdc37 from the cdc37' strain ED 1022 using anti-S. pombe Cdc37 antibodies. Western 
blot analysis was carried out with the anti-S. pombe Cdc37 antibody. 
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Figure 4.10 B: CIP phosphatase treatment of immunoprecipitated endogenous Cdc37 
from the cdc37' strain ED1022 using anti-S. pombe Cdc37 antibodies. Western blot 
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mutant pREP81-cdc37-S1417A cannot maintain cell viability by plasmid shuffle due 
to the mutation of serine 14 and not serine 17, as expression of pREP81-cdc37-S17A 
maintains cell viability by plasmid shuffle in S. pombe but pREP81-cdc37414A 
cannot. In S. cerevisiae cdc37-S14A had more severe growth and morphological 
defects than cdc3 7-Si 7A, although both are important sites of phosphorylation by 
CKII (Bandhakavi et al., 2003). 
Consistent with findings in S. cerevisiae (Bandhakavi et al., 2003), mutating serine 14 
to alanine of S. pombe Cdc37 abrogated function so that this mutant could not sustain 
cell viability in the plasmid shuffle when expressed from pREP81. Expression of 
cdc37-S14A in S. pombe was unable to sustain cell viability unless over-expressed 
from pREP1, when it could support growth as well as expression of pREP] -cdc37. 
Expression of Cdc37 with serine 14 substituted for leucine to recreate S. cerevisiae 
mutation cdc37-34 in S. pombe, was lethal when expressed from pREP81, but 
supported growth in a temperature dependent manner when overexpressed. These 
findings indicate that serine 14 to alanine or leucine does not completely abolish 
Cdc37 function and overexpression of these Cdc37 mutants raises the level of mutant 
protein, increasing overall cellular activity which can sustain cell viability. 
These data indicate that Serine 14 is important for Cdc37 function in vivo. The 
mechanism by which serine 14 is important for Cdc37 function to sustain cell 
viability is not understood, but there is a high probability from data in other systems 
that it is a vital site of phosphorylation (Bandhakavi et al., 2003; Miyata and Nishida, 
2004; Shao et al., 2003). Alternatively, mutating serine 14 to alanine or leucine may 
alter conformation, possibly causing instability of the chaperone protein. This may 
reduce Cdc37 function to a very low level that cannot sustain cell viability, unless the 
mutant is overexpressed raising essential function above a threshold level. 
Expression of cdc37-S14E from pREP8 1 only partially restored the essential function 
required by Cdc37 to sustain cell viability. Over-expression of Serine 14 to glutamic 
acid is able to support significant growth but cells are morphologically aberrant. The 
equivalent S. cerevisiae Cdc37 mutant S]4] 7E has a significantly greater growth rate 
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with a doubling time of 4 hours compared to 10 hours for S1417A (Bandhakavi et al., 
2003). In S. pombe pREP81-cdc37-SJ4E was able to support greater growth than 
pREP81-cdc37-S14A and pREP81-cdc37-S14L. These data imply that glutamic acid 
can partially substitute for phosphoserine when cdc37414E is expressed from 
pREP81. This has also been observed in S. cerevisiae where morphological defects 
for cdc37414,17E were significantly fewer than observed for cdc37-S14,17A 
(Bandhakavi et al., 2003). However, in S. pombe overexpression of cdc37-S14A 
results in viable cells that were wildtype in appearance, but overexpression of cdc37-
S14E supported growth of cells that are morphologically abnormal. Glutamic acid 
may not be a complete substitute for mimicking phosphorylation of Cdc37 serine 14 
in vivo and is therefore unable to restore full function to the molecular chaperone. 
However, the ability of cdc37-S14A to support a wildtype phenotype in the plasmid 
shuffle when overéxpressed indicates that if this amino acid is phosphorylated in S. 
pombe, it is not essential for Cdc37 function and cell viability. 
Development of an assay to determine phosphorylation status of Cdc37 by SDS 
PAGE gel was not accomplished. No difference in Cdc37 mobility was observed 
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5.0 	Temperature-sensitive mutants of S. pombe cdc37 
5.1 	Introduction 
The concept of a temperature-sensitive mutant was first presented by (Horowitz and 
Leupold, 1951) for Neurospora. The first temperature-sensitive conditional lethal 
mutants identified in S. pombe were generated by mutagenic treatment with nitrous 
acid resulting in strains that grew at 25 but not at 37 °C (Bonatti et al., 1972). 
Temperature-sensitive generally refers to a heat-sensitive mutant with a low 
permissive temperature and a higher restrictive temperature, but cold-sensitive 
mutants also exist whose restrictive temperatures are lower then their permissive. 
Temperature-sensitive mutants contain a mutation within a gene that permits protein 
function at permissive temperatures but not at restrictive by causing instability and/or 
inactivation of the protein. Temperature-sensitive mutants are valuable tools for 
studying the cellular role of a protein by carrying out detailed analysis of the defects 
that arise at the restrictive temperature. Temperature-sensitive mutants of CDC37 
have been generated in S. cerevisiae and have been valuable in gaining a better 
understanding of the Cdc37 molecular chaperone in this system (Dey et al., 1996; 
Gerber et al., 1995; Mort-Bontemps-Soret et al., 2002; Reed, 1980; Reed, 1980; Valay 
et al., 1995). 
Previous studies of Cdc37 in S. pombe showed that depletion of the Cdc37 protein in 
shut-off experiments resulted in a phenotypically heterogeneous cell population that 
ceased to divide after -36 hours (Westwood et al., 2004). The aims of the present 
study were to generate cdc37 temperature-sensitive mutants to observe the effect of 
rapid loss of Cdc37 function in S pombe. In this study three cdc37 temperature-
sensitive mutants, cdc37-184, cdc37-13 and cdc374, were generated and analysed in 
parallel with a fourth, cdc37-681, which was a kind gift from the Shiozaki Lab 
(Tatebe and Shiozaki, 2003). The mutant cdc3 7-1 84 was generated by introducing the 
equivalent mutation to the S. cerevisiae temperature-sensitive mutant cdc3 7-1 84 into 
the S. pombe cdc37 gene. cdc374 and cdc37-13 were generated by random mutagenic 
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PCR of the cdc37 gene. Detailed characterisation of these four temperature-sensitive 
mutants was carried out to determine the defects that occur in cells at the restrictive 
temperature and the findings are described in this Chapter. 
5.2 	Generating cdc37 temperature-sensitive mutants in S. pombe 
5.2.1 	The temperature-sensitive mutant cdc3 7-681 
The S. pombe temperature-sensitive mutant cdc37-681 was a kind gift from the 
Shiozaki lab. This cdc37 mutant was isolated as a suppressor of hyperactivation of the 
stress-activated MAP kinase pathway involving Spcl (Tatebe and Shiozaki, 2003). 
Sequencing of cdc37-681 identified the mutation of a proline substituted for a leucine 
at codon 285. 
5.2.2 	Random mutagenesis of cdc37 by PCR to generate temperature- 
sensitive mutants 
Random mutagenic PCR was used as an unbiased method of creating mutations in the 
cdc37 gene that may yield proteins whose ability to function properly is temperature 
dependent. In order to facilitate mutagenesis of the cdc37 gene that could then be 
substituted for the endogenous copy, a template was constructed for PCR 
amplification incorporating the S. pombe cdc37 gene upstream of a G418 resistance 
cassette for selection (Bahler et al., 1998). This was flanked at either end by 300 bp of 
chromosomal cdc37 flanking sequence for efficient homologous recombination into 
the S. pombe genome. The technique used is shown schematically in Figure 5.1. PCR 
amplification reactions (Section 2.3.2.2) were carried out on the template using a 
range of mutagenic PCR conditions to randomly introduce mutations throughout the 
cdc37 gene with the aim of generating temperature-sensitive mutants. The mutagenic 
PCR conditions that were employed in reactions included varying the ratio of dNTPs, 
adding MnC12  and incorporating both variables in combination. 
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Figure 5.1: Random mutagenesis of the cdc37 gene using mutagenic conditions in 
PCR reactions to generate cdc37 temperature-sensitive mutants. A The cdc37 gene 
plus 300 bp of the chromosomal flanking sequence at the 5' end was amplified by 
PCR using pfu polymerase from the cosmid c9b6 (Sanger Centre) introducing new 
restriction sites, PacI at the 5' and BglII at the 3' end. B PCR amplified fragments 
were cloned into the PFA6a-KanMX6 vector (Bahler et al., 1998) upstream of the 
G418 resistance cassette. 300 bp of cdc37 3' chromosomal flanking sequence was 
amplified by PCR introducing EcoRI restriction sites at both ends and was cloned 
downstream of the G418 cassette. C Mutagenic PCR amplification was carried out on 
the entire cdc37-G418 construct. D PCR amplified fragments were integrated into the 
genome of S. poinbe by homologous recombination. E Stable transformants were 
selected on YE media containing G418 and temperature-sensitive mutants were 
identified by incubation of resulting colonies at different temperatures. 
C 	Amplification of the 
template under different 
mutagenic PCR conditions 
300bp 
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Altering the ratio of dNTPs in a PCR reaction can enhance the level of mutagenesis. 
For example, 10-fold higher levels of dGTP in the dNTP pool results in a more error 
prone PCR reaction (Takashi Toda, personal communication). By using this ratio of 
dNTPs there is a bias towards the incorrect incorporation of dGTP (Fromant et al., 
1995). However, increasing any single dNTP in a PCR reaction above 4mM results in 
a significant reduction in product yield (Fromant et al., 1995). To generate cdc37 
temperature-sensitive mutants, PCR reactions were optimised to obtain sufficient 
yield in the presence of mutagenic ratios of dNTPs. 
An alternative mutagenic procedure is the inclusion of MnC1 2 in reactions. MnC12 
concentrations of 0.5mIvl (Cadwell and Joyce, 1992) and 0.25mM (Lin-Goerke et al., 
1997) have been found to be mutagenic in PCR reactions, reducing the fidelity of the 
polymerase to introduce random nucleotide changes in PCR amplified fragments. 
These levels of MnC1 2 in a PCR reaction significantly reduce the amplification yield 
(Fromant et al., 1995), making optimization of the technique essential. MnC1 2 was 
used at concentrations considered mutagenic while generating a workable amount of 
PCR product in order to obtain cdc37 temperature-sensitive mutants. 
Oligonucleotides were designed to amplify by PCR from the outermost sequence of 
the template for optimum efficiency homologous recombination. Taq polymerase 
which has no proofreading capacity was used in PCR reactions to increase mutation 
frequency. 10g of PCR amplified mutagenic DNA was produced for efficient 
transformation and recombination into the S. pombe genome (Bahler et al., 1998). 
5.2.3 	The generation of cdc37 temperature-sensitive mutants by random 
mutagenic PCR 
A total of three screens were carried out with the aim of generating temperature-
sensitive mutants of cdc37 in S. pombe by PCR amplification of the template (Section 
5.2.2) under a range of mutagenic conditions detailed in Table 5.1. Mutagenic PCR 
reactions were purified by phenol-chloroform extraction and ethanol precipitation 
(Section 2.2.9), and resuspended in a final volume of lOpi dH20. 10 tg of amplified 
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DNA was transformed into the haploid S. pombe strain ED 1090 using the lithium 
acetate transformation protocol (Bahier et al., 1998), to replace the endogenous cdc37 
gene. Transformed cells were plated directly onto YE media and incubated at 28 °C 
for 18 hours. Plates were then replicated onto YE plus G418 and incubated at 28 °C 
until stable single colony transformants appeared. Candidate temperature-sensitive 
mutants of cdc37 were identified by replicating plates onto YE+G418 incubated at 28 
°C and YE+G418+Phloxin-B plates incubated at 36 °C for 24 hours. Phloxin-B is 
only permeable to dead cells, staining them deep red for easy identification. Colonies 
were screened by eye for growth on plates at 28 °C and for dead, dark red Phloxin-B 
stained colonies at 36 °C, characteristic of temperature-sensitive mutant lethality. 
The stability of candidate cdc37 temperature-sensitive mutants was verified by 
patching mutants onto YE media and incubating at 28 °C, then replicating back onto 
YE media containing G418 and allowing stable transformants to grow up at 28 °C. 
All G418 resistant candidate cdc37 temperature-sensitive mutants were then crossed 
with the temperature-sensitive mutant cdc37-681 (Tatebe and Shiozaki, 2003) to 
determine whether the integration location of the mutagenic PCR fragment was at the 
cdc37 locus (Section 2.7.4). The spores were pooled and treated with Helicase 
(Section 2,7.4.1), plated onto YE+G418 and incubated at 36 °C to observe whether 
wildtype colonies formed. Recombination events during meiosis mean that if cells 
contain a random insertion in an incorrect location, i.e. not at the cdc37 locus, then a 
proportion of wildtype spores will result. 
A total of 11,750 stable colonies were obtained from all three screens, from which 
two cdc37 temperature-sensitive mutants were isolated, cdc37-13 and cdc374. Both 
of these mutants were generated by the inclusion of MnC1 2 in PCR reactions. cdc37-
13 was obtained from a PCR reaction containing 0.1 mM MnC1 2 and cdc37-J from 
PCR reactions with the inclusion of 0.05 mM MnC1 2 . 
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Table 5.1: Number of stable transformants and cdc37 temperature-sensitive mutants 
obtained from different mutagenic PCR conditions during Screens 1, 2 and 3 to 
generate cdc37 temperature-sensitive mutants by random mutagenic PCR. 









lOx dGTP 1 1050 0 
0.3niMMnC12 1 7 0 
1 0.3 mM MnC12 
and 1 Ox dGTP 
1 33 0 
No mutagen 1 1425 0 
1OxdGTP 4 303 0 
2 0.2mMMnC12 2 84 0 
0.1 mM MnC12 2 126 cdc37-13 
0.2mMMnC12 3 317 0 
0.15mMMnC12 3 931 0 
3 0.1 mM MnC12 3 940 0 
0.05 mM MnC12 3 1826 cdc374 
0.025 mM MnC12 4 4708 0 
Totals 28 11750 2 
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The low yield of cdc37 temperature-sensitive mutants generated in these three screens 
might be due to inefficient targeting into the cdc37 locus of DNA fragments amplified 
by random mutagenic PCR or inefficient mutagenic PCR conditions. To test the first 
possibility, the efficiency of homologous recombination into the cdc37 locus was 
determined. 25 G418' colonies were picked at random from Screen 2 and crossed 
with the temperature-sensitive mutant cdc37-681. Random spore analysis was carried 
out and resulting progeny were, plated on YE and incubated at 28 °C. 20 single 
colonies were picked per cross, and their genotype determined by replicating onto YE 
media plus and minus G418 and incubating at 28 and 36 °C. Correct insertion of the 
cdc37 PCR amplified fragment will result in spores being either cdc37' and G-418 
resistant or cdc37-681 and G-418 sensitive. Incorrect insertion will produce progeny 
with other types of genotypes, including cdc37-681 which is G-418 resistant and 
cdc37 that is G-418 sensitive. Homologous integration of the PCR fragments into the 
cdc37 locus occurred in 23 out of 25 colonies giving 92% efficiency of correct 
integration for this method and indicating this is not a limiting factor in generating 
cdc37 temperature-sensitive mutants. 
5.2.4 	Directed mutagenesis to generate cdc37 temperature-sensitive 
mutants 
The temperature-sensitive mutant cdc37-184 was identified in S. cerevisiae and 
arrests in START when incubated at the restrictive temperature (Valay et al., 1995). 
The mutant cdc37-184 has a mutation of alanine at amino acid 275 to aspartic acid 
(Mort-Bontemps-Soret et al., 2002). Alanine 275 in S. cerevisiae aligns with alanine 
287 in S. pombe. Directed overlap PCR mutagenesis was carried out on the S. pombe 
cdc37 gene in the vector pREP81, to introduce the equivalent mutation to S. 
cerevisiae cdc37-184 into the S. pombe cdc37 gene. The ability of the S. pombe 
cdc37-184 mutant expressed from pREP81 to sustain cell viability at different 
temperatures was determined by plasmid shuffle assay in the cdc37iX strain ED 1526 
(Section 2.7.1). Expression of cdc37-184 from pREP81 in the cdc3 7/i strain sustained 
growth in a temperature dependent manner (Figure 5.2A). Cells expressing the S. 
pombe cdc37-184 mutation were able to maintain growth at 25, 28 and 32 °C 
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Figure 5.2: Expression of the S. pombe cdc37-184 mutant from pREP81 in the strain 
ED1526 by plasmid shuffle assay to determine its ability to sustain cell viability at 
different temperatures. A Serial dilutions were plated on 5FOA media and incubated 
at different temperatures for 4 days. Cells at 36 °C expressing B pREP8I-cdc37-184 
and C pREP81-cdc37. 
A 	 B 
1,REP8I-ccJc37 	 : 
pREP8 / -cdc3 7-184 hI 
pREP8 I -cdc3 




producing cells which were wildtype in appearance. At 36 °C, cdc37-184 was unable 
to support growth in the plasmid shuffle assay. The cell population was heterogeneous 
in phenotype, consisting of elongated, short, rounded and bowling pin shaped cells 
(Figure 5.2B) characteristic of depletion of Cdc37 from cells (Westwood et al., 2004). 
5.2.5 	Integration of cdc37-184 into the S. pombe chromosome 
To study further the temperature-sensitive mutant cdc37-184, the mutation was 
introduced into the random mutagenesis PCR template so that it could be integrated 
into the chromosomal cdc37 locus using the technique shown schematically in Figure 
5.3. PCR amplification of the template was carried out with Pfu polymerase to 
minimise the occurrence of undesired mutations. PCR reactions were purified and 
transformed into S. pombe (described in Section 5.2.3) and a total of 815 stable 
transformants were obtained which were then replicated and incubated at 28 and 36 
°C to identify colonies with a temperature-sensitive phenotype. Four candidate 
colonies were identified as possible temperature-sensitive mutants and were crossed 
with cdc37-681 for verification of correct integration of cdc37-184. All four strains 
had correct integration of the cdc37-184 fragment. These four cdc37 temperature-
sensitive mutants were able to form single colonies by streaking on YE plates and 
incubating at 25, 28 and 32 °C for 4 days, but not at 36 °C. Morphologically cells 
were elongated at 36 °C compared to the lower temperatures. 
5.3 	Characterisation of cdc37 temperature-sensitive mutants 
5.3.1 	Identification of cdc37 temperature-sensitive mutations 
The S. pombe temperature-sensitive mutants cdc374 and cdc37-13 generated by 
random PCR mutagenesis were sequenced to identify the location and nature of their 
mutations within the cdc37 gene. The mutant cdc37-184 was also sequenced to verify 
the introduction of the mutation within the cdc37 gene and to ensure the absence of 
other undesired mutations that might have occurred during PCR amplification. 
Genomic DNA was prepared from the temperature-sensitive mutants (Section 2.7.3) 
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Figure 5.3: Integration of the cdc37-184 mutation into the S. pombe genome. The 
cdc37-184 mutation was introduced into the random mutagenesis template A by 
restriction digestion from the pREP81-cdc37-184 plasmid using unique restriction 
sites Bipi and Swal and ligating into the equivalent restriction sites in the random 
mutagenesis template. B Standard PCR amplification was carried out and C 
fragments were then integrated into the genome of S. pombe by homologous 
recombination. D Stable transformants were selected for on media containing G418 
and temperature-sensitive mutants were identified by incubation of resulting colonies 
at different temperatures. 
C:: 	Cdc37 
A 	insertion of the cdc37- 
184 mutation 	into 
the Template for PCR. 
A 
Bipi • Swal 
B 	PCR amplify fragments 
under standard PCR 
conditions 
C 	PCR fragments 
transformed into S. pombe. 
Selected for stable 
homologous recombination 
on YE-G418 media 
D 	Temperature-sensitive 
mutants were identified by 
observing growth and 
phenotype at different 
temperatures 
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and each section of the cdc37 gene was amplified in 3 separate PCR reactions. The 3 
PCR reactions were then combined to reduce the possibility of a mutation introduced 
during one PCR reaction biasing sequencing results. Fragments were sequenced in the 
forward and reverse direction for precision over the entire cdc37 gene and flanking 
sequence in duplicate to determine accurately the genomic sequence of each 
temperature-sensitive mutant. 
The mutations identified in the S. pombe cdc37 temperature-sensitive mutants cdc37-
184, cdc37-13 and cdc374 are shown in Figure 5.4 with the cdc37-681 mutation 
(Tatebe and Shiozaki, 2003) for comparison. Sequence determination of cdc37-184 
verified the substitution of an alanine at codon 275 to aspartic acid. No other 
mutations were identified in the cdc37 gene or flanking regions for the cdc37-184 
mutant. Two mutations were identified in the open reading frame (ORF) of cdc37-13. 
Codon 237 had been mutated from glutamic acid to lysine and amino acid 261 was 
changed from a tyrosine to a histidine. Cdc374 was found to contain three mutations 
in the ORF. Amino acid 286 had been mutated from leucine to methionine, residue 
305 from histidine to leucine and codon 314 from arginine to glycine. 
5.3.2 	Identifying the mutations in cdc37-J and cdc37-13 responsible for 
the temperature-sensitive phenotype 
Temperature-sensitive mutants cdc374 and cdc37-13 each contain more than one 
nucleotide change. To determine which mutations were responsible for producing a 
temperature-sensitive phenotype, mutations were introduced into the cdc37 gene both 
individually and in combination by overlap PCR. Each mutant was expressed from 
pREP81 in the cdc37L strain to observe their ability to sustain cell viability at 
different temperatures. However, the expression of all cdc37-13 or cdc374 (Figure 
5.5) mutants at 25, 28, 32 and 36 °C was able to support growth as well as expression 
of pREP81-cdc37 and cells were phenotypically wildtype in appearance. None of the 
cdc37-13 or cdc374 mutations, individually or in combination, permitted growth in a 
temperature dependent manner. These data show that the effect on growth and cell 
morphology of expression of integrated mutants cdc37-13 and cdc374 differs from 
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Figure 5.4: A schematic diagram to show the location of cdc37 temperature-sensitive 
mutant mutations identified in S. poinbe temperature-sensitive mutants cdc37-681, 
cdc37-184, cdc37-13 and cdc374. 
cde37-184 : Alanine 287 to aspartic acid 
A ck37-J : mutation ii: Leucine 286 to methionine, J2: Histidine 305 to leucine, J3: Arganine 314 to glycine 
cdc37-13 : mutation L: Glutamic acid 237 to lysine, mutation H: Tyrosine 261 to histidine 
Q cdc37-681 : Leucine 285 to proline 
Postulated Hsp90 binding region 
LII Putative dinierisation domain 
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Figure 5.5: Expression of the cdc37 gene containing mutations L and H identified in 
cdc37-13 and mutations Ji, J2 and J3 identified in cdc374 from pREP81 by plasmid 
shuffle assay. The location and nature of these mutations identified in cdc37-13 and 
cdc374 are shown in Fiure 5.4. 
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Figure 5.6: Expression of the cdc37 gene containing mutations L and H identified in 
cdc37-13 and mutations Ji, J2 and J3 identified in cdc37-J from pREP1 by plasmid 
shuffle assay. 
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their expression from pREP81. This has also been seen with cdc37-184 whose 
expression from pREP8 1 in the plasmid shuffle assay supports a morphologically 
heterogeneous cell population at the restrictive temperature, but the integrated 
mutation produces highly elongated cells. These experiments were unable to identify 
the mutations that cause the temperature-sensitive phenotype of cdc374 and cdc37-
13, possibly because Cdc37 protein levels from pREP8 1 may be greater than when the 
same mutant proteins were expressed as single copy integrants. This may raise the 
level of mutant protein and overall function above a threshold that can sustain cell 
viability. However, in Chapter 3, wildtype Cdc37 expressed from pREP81 produced 
protein at a level very similar to endogenous Cdc37, although subtle differences in 
protein levels may not be easily detectable by western blot. 
The cdc374 and cdc37-13 mutant alleles described above were overexpressed from 
pREP1 in the cdc37L strain to examine the effect of increasing mutant protein levels 
on cell viability at different temperatures. Expression of mutants containing cdc37-13 
mutations and cdc3741 and cdc342 permitted growth as well as expression of 
pREPJ-cdc37 at 25, 28, 32 and 36 °C and cells were morphologically wildtype in 
appearance (Figure 5.6). Expression of the mutants cdc3743 and cdc374123 from 
pREP1 were unable to sustain growth (Figure 5.6) at all temperatures and cells were 
heterogeneous in phenotype as observed in Cdc37 depletion experiments (Westwood 
et al., 2004). Overexpression of wildtype Cdc37 does not compromise cell viability, 
but overexpression of the mutants cdc3743 and cdc374123 results in lethality. 
Overexpression of certain alleles in S. pombe can be lethal, as observed with 
overexpression of nda3 and ubc4, which encode for beta-tubulin and an ubiquitin 
conjugating enzyme respectively (Javerzat et al., 1996). 
5.3.3 	Overexpression of cdc37 mutants to look for any dominant 
negative effect in the presence of endogenous Cdc37 
Cdc37-184 and all cdc37-13 and cdc374 mutants described in the previous section 
were overexpressed from pREP1 in the cdc37' strain ED 1090 to look for any 
dominant negative effects. Mutants were transformed into S. pombe strain ED 1090 
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and stable transformants were incubated at 28 and 36 °C. No dothinant negative effect 
was observed for any mutant at either temperature. All cells were morphologically 
wildtype in appearance and successfully formed colonies (data not shown). 
5.3.4 	The ability of cdc37 temperature-sensitive mutants to support 
growth at different temperatures 
To determine accurately the permissive and restrictive temperature ranges of all four 
cdc37 temperature-sensitive mutants, their ability to form single colonies at different 
temperatures was investigated. The cdc37 temperature-sensitive mutant strains and a 
cdc37 strain ED1022 were streaked onto YE plates and incubated at 25, 28, 32 and 
36 °C for 4 days. The cdc37 strain was able to form single colonies at all 
temperatures. All four cdc37 temperature-sensitive mutants were able to form single 
colonies when incubated at 25, 28 and 32 °C (Figure 5.7). However, these mutant 
strains were unable to form single colonies at 36 °C. 
The ability of cdc37 temperature-sensitive mutants and the cdc37 strain to grow on 
media containing different chemical inhibitors was investigated using DL-methionine 
methylsolfonium chloride (MMS) (Sigma 64382) that induces DNA damage and 3-
AT and Canavanine, that inhibit amino acid synthesis. Inhibitors of amino acid 
synthesis were used as it has previously been reported that Cdc37 is required for the 
amino acid starvation response in S. cerevisiae involving Gcn2 (Donze and Picard, 
1999). 3-AT (Sigma A-8056) is an inhibitor of histidine biosynthesis and Canavanine 
(Sigma C1625) is a toxic analogue of arganine. Strains were streaked onto plates 
containing different concentrations of each inhibitor and incubated at different 
temperatures, but mutants showed equal sensitivity to chemical inhibitors as cdc37 
strain ED 1022. 
Figure 5.7: cdc37 temperature-sensitive mutants and the cdc37 strain ED 1022 were 
streaked on YE plates and incubated at 25, 28, 32 and 36 °C for four days to 
determine whether these mutants could form single colonies. 








Figure 5.8: cdc374 was plated as serial dilutions, diluted in dH 20, on different media 
with and without G418 and incubated for 4 days at 36 °C. 
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As previously stated, the mutant cdc374 did not form single colonies when streaked 
on YE at 36 °C in the absence of G418, but it did support growth when plated as 
serial dilutions under these conditions, although cells were morphologically 
elongated. The ability of cdc374 to form colonies when plated as serial dilutions may 
be due to the greater cell density, as a low level of colony formation is apparent on the 
initial inoculation line from streaking at 36 °C. Serial dilutions of cdc374 at 36 °C 
did not grow successfully on media containing G418 (Figure 5.8) which binds the 80S 
ribosome complex and inhibits eukaryotic protein synthesis by disturbing its 
proofreading ability resulting in early termination and mistranslation. All subsequent 
characterisation studies of cdc374 described here were carried out in the absence of 
G418. 
To determine how quickly cell proliferation was affected in cdc37 temperature-
sensitive mutants after shift to the restrictive temperature of 36 °C, the increase in cell 
number in liquid cultures at 28 and 36 °C over a time course was investigated. cdc37-
681, cdc37-184, cdc374, cdc37-13 and the cdc37 strain ED1022 were cultured at 28 
°C, then split and kept at 28 °C or shifted to 36 °C, as described in Section 2.7.4.3. At 
set time points, two 100 pd samples were taken from each cell culture and processed 
for counting in a Coulter electronic particle counter (Section 2.8.6). The number of 
cells in cultures increased over the.time course for the cdc37 strain ED1022 at both 
28 and 36 °C and for all four cdc37 temperature-sensitive mutants at 28 °C (Figure 
5.9). However, at 36 °C the rate of cell division for all cdc37 temperature-sensitive 
mutants was dramatically reduced within 2 hours of the shift. Cell number for cdc37 
temperature-sensitive mutants stabilised after 2 hours at 36 °C and remained fairly 
constant thereafter. 
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Figure 5.9: Analysis of cell number of cdc37 temperature-sensitive mutant and 
cdc37 cells of ED1022 by Coulter electronic particle counter. Strains were cultured 
at 28 and 36 °C and cell number was determined for the cdc37 strain ED 1022 and all 
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Figure 5.10: Comparison of Cdc37 protein levels in cdc37 temperature-sensitive 
mutants and the cdc37 strain ED1022 after 8 hours at 28 and 36 °C. Western blot 
analysis were carried out on whole cell protein extracts using the anti-S. pombe Cdc37 
and TAT! antibodies as a loading control. 
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5.3.5 	Cdc37 protein levels in cdc37 temperature-sensitive mutants 
The reason why cdc37 temperature-sensitive mutant cells stop dividing after 2 hours 
at the restrictive temperature might be due to loss of Cdc37 function or reduced 
Cdc37 protein levels. To investigate the latter possibility, cdc37 temperature-sensitive 
mutant strains and the cdc37' strain ED1022 were cultured as described in Section 
2.7.4.3 at 28 and 36 °C over an 8 hour time course. Denatured protein extracts were 
made and run by SDS PAGE for visualisation by western blot which with the anti-S. 
pombe Cdc37 antibody and TAT1 antibody as a loading control. Western blot 
analysis revealed that Cdc37 protein levels were not reduced in the cdc37 
temperature-sensitive mutants incubated at 36 °C (Figure 5.10). However, cdc37-13 
and cdc374 mutant Cdc37 protein levels were slightly reduced compared to other 
strains but this was not temperature related. These data indicate that loss of cell 
viability in cdc37 temperature-sensitive mutants is not due to lowered protein levels 
but presumably to reduced Cdc37 function. 
5.3.6 	Cell morphology of cdc37 temperature-sensitive mutant cells 
The cell morphologies of cdc37 temperature-sensitive mutants and the cdc37 strain 
ED 1022 were examined after incubation for 24 hours on YE plates at a range of 
temperatures between 25 and 36 °C. At 25, 28 and 32 °C cdc37 and cdc37 
temperature-sensitive mutant cells were morphologically wildtype in appearance. At 
36 °C all cdc37 temperature-sensitive mutant cells were elongated (Figure 5.11), 
characteristic of the cell division cycle (cdc) phenotype. The cdc phenotype indicates 
that cells are unable to progress through the cell cycle and divide, but growth is less 
compromised and the cells continue to elongate. 
To quantitate this observed cell elongation, cell length was measured for cdc37 
temperature-sensitive mutant and cdc37 strains, cultured as described in Section 
2.7.4.3 over an 8 hours time course. Samples were taken from cultures at 0 hours and 
then at subsequent 2 hour intervals, fixed with formaldehyde and stained with 
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Figure 5.11: Cell morphology of cdc37 temperature-sensitive mutants and the cdc374 
strain ED 1022 on YE plates incubated at 25, 28, 32 and 36 °C for 24 hours. Bar is 10 
tm. 
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Calcofluor (Section 2.8. 1) which is a fluorescent brightener that efficiently binds the 
yeast cell wall and septum (Streiblova et al., 1984). The lengths of 200 cells were 
measured for each strain at each time point (Section 2.8.5). 
At 28 °C, the average cell length for cdc37 and cdc37 temperature-sensitive mutant 
cells did not differ dramatically (Figure 5.12). Cells of the cdc37, cdc37-184, cdc37-
681 and cdc37-13 strains at 28 °C had an average cell length of 9.8 tm, 9.1 tm, 8.1 
pm and 10 jim respectively. The average cell length for cdc374 at the permissive 
temperature was 12.3 jim, slightly longer than for cdc37 strain. At the restrictive 
temperature, the average cell length of cdc37 cells was equal to those observed at 28 
°C and did not change over the 8 hour time course. In contrast, the average cell length 
for all cdc37 temperature-sensitive mutants increased with time at 36 °C (Figure 
5.12). Table 5.2 shows the average cell lengths for cdc37 temperature-sensitive 
mutants at 28 °C and after 8 hours at 36 °C. cdc374 cells displayed the greatest 
elongation, increasing by approximately 3-fold in length over 8 hours at the restrictive 
temperature. 
5.3.7 	Identification of the cell cycle stage in which cdc37 temperature- 
sensitive mutant cells arrest 
Previous data indicate that cdc37 temperature-sensitive mutant cells arrest the cell 
cycle, but continue to elongate producing a cdc phenotype. To identify the stage in the 
cell cycle at which the cdc37 temperature-sensitive mutants arrest, flow cytometry 
(FACS) (Section 2.8.7) analysis was carried out. This technique determines whether 
cells contain a 1C (unreplicated) or a 2C (replicated) DNA content by staining of the 
cellular DNA content with propidium iodide. The level of fluorescence from a 1C 
DNA content is half that of a 2C, and this allows cells with replicated and 
unreplicated DNA to be distinguished. In a wildtype S. pombe population very few 
cells contain a 1C DNA content as Gi is an extremely quick event. To identify the 1C 
DNA content peak by flow cytometry the S. pombe temperature-sensitive mutant 
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Table 5.2: Average cell lengths of cdc37 temperature-sensitive mutant and cdc37' 
cells and the percentage of increase in cell length between 28 °C and after. 8 hours at 
36 °C. Strains were cultured in liquid YE at 28 and 36 °C and the lengths of 200 cells 
measured for each sample. 
Strain Average length (Elm) Length 
increase 0 hours 28 °C 8 hours 36 °C 
Wildtype 10.4 9.7 -7% 
Cdc37-184 9.1 15.6 71% 
Cdc37-681 8.1 17.4 115% 
Cdc37-13 10.0 21.7 117% 
Cdc374 12.3 1 	33.4 172% 
Figure 5.12: Mean cell length of cdc37 temperature-sensitive mutant and cdc37' cells 
(with standard deviation bars). Strains were cultured in liquid YE at 28 and 36 °C 
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Figure 5.13: Flow cytometry of cdc37 temperature-sensitive mutants, cdc37 ED 1022 
and cdcl0-129 was used to identify the DNA content of cells. Strains were cultured in 
YE at 28 and 36 °C over an 8 hour time course and samples of cells were taken every 
two hours. Cells were processed for flow cytometry, being stained with propidium 
iodide, and their DNA content was assayed in a FACScan (Becton Dickson). 
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cdclO-129 was employed, which is defective in DNA synthesis at 36 °C (Nurse et al., 
1976) and cells arrest unable to replicate their DNA producing a 1C DNA peak 
detectable by flow cytometry. The cdc37 temperature-sensitive mutants, cdclO-129 
and the cdc37 strain ED1022 were cultured as described in Section 2.7.4.3. Samples 
were taken from each cell culture incubated at 28 and 36 °C every 2 hours over an 8 
hour time course and were processed for flow cytometry (Section 2.8.7) by staining 
with propidium iodide. 
At 28 °C the cdc37 strain ED1022, cdclO-129, cdc37-681, cdc37-184, cdc374 and 
cdc37-13 cell populations predominantly contained a 2C DNA content (Figure 5.13). 
At 36 °C the cell population of cdclO-129 was split between a 1C and a 2C DNA 
content after 2 hours establishing the distribution for 1C and 2C DNA content peaks 
for other strains in this experiment. At 36 °C cdc37' and cdc37 temperature-sensitive 
mutant cells predominantly contained a 2C DNA content (Figure 5.13). These data 
indicate that the cdc37 temperature-sensitive mutants arrest with a replicated genome 
having passed through S phase. It is interesting to note that cdc37-184 produces a 
distinct peak of 1C DNA content after 2 hours at 36 °C, which completely disappears 
by the 4 hour time point (Figure 5.13). This could suggest that cells undergo a delay 
in Gi at J6 °C, producing a 1C DNA content peak. For all strains, the position of the 
peaks determined by flow cytometry shifted to the right along the graph x-axis at the 
later time points. This is thought to be a result of an increase in the mitochondrial 
DNA and RNA cellular content following elongation (Sazer and Sherwood, 1990). 
Flow cytometry data indicated that cdc37 temperature-sensitive mutants arrest at the 
restrictive temperature with a 2C DNA content, suggesting a G2 or M phase (mitosis) 
arrest. Nuclear morphology was examined with the aim of gaining a better 
understanding of the stage in which cdc37 temperature-sensitive mutant cells were 
arresting. The cdc37 temperature-sensitive mutant and cdc37 strains were cultured as 
described in Section 2.7.4.3 and samples of cells were taken every 2 hours. Cells were 
fixed and stained with DAPI that binds double stranded DNA and RNA and produces 
a blue fluorescence which can be visualised by microscopy. 
169 
Figure 5.14: Frequency of phenotypes observed with DAPI staining of cdc37 
temperature-sensitive mutant and cdc37 cells. Strains were cultured in YE at 28 and 
36 °C over an 8 hour time course and samples of cells were taken every two hours, 
fixed in formaldehyde and stained with DAM. Bar is 10.tm. 
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Three distinct nuclear morphologies were observed for all cdc37 temperature-
sensitive mutants and cdc37 cells at the permissive temperature of 28 °C (Figure 
5.14). Around 80% of the cell population were classified as phenotype 1, a single cell 
with one nucleus. Phenotype 2, consisting of a single cell with a divided nucleus, was 
observed for —5% of the cell population and phenotype 3, cells which had 2 nuclei 
separated by a septum, made up —15%. 
With increasing time at the restrictive temperature, cdc37 temperature-sensitive 
mutant cells were predominantly phenotype 1 with a small sub-population of 
phenotype 3 (-15%) (Figure 5.14). Phenotype 2 is absent from the cell population in 
all temperature-sensitive mutants after 2 hours at the restrictive temperature (Figure 
5.14). These data indicate that most cdc37 temperature-sensitive mutant cells arrest at 
the restrictive temperature with a single nucleus, most likely in G2 as chromatin was 
uncondensed and. no individual chromosomes were observed. It is interesting to note 
that over the 8 hour time course at the restrictive temperature all cdc3 7 temperature-
sensitive mutants showed a slight increase in the number of cells with aberrant 
morphologies, categorised as phenotype 4 with a single nucleus and a single septum, 
phenotype 5 with a single nucleus with a septum running through it, and phenotype 6 
containing multiple septa. However, these aberrant morphologies classified as 
phenotypes 4, 5 and 6 only represent a very small proportion of the total cell 
population. Interestingly, cdc374 differs in phenotype after 6 to 8 hours at the 
restrictive temperature compared to the other cdc37 temperature-sensitive mutants, as 
around half of the cells have leaked into mitosis, having divided their nuclei and 
formed septa. 
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Figure 5.15: Number of cells with and without septa. cdc37 temperature-sensitive 
mutant and cdc37 strains were cultured at 28 and 36 °C in YE over an 8 hour time 
course. Samples of cells were taken every two hours, fixed with formaldehyde and 
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5.3.8 	The aberrant cell morphology of cdc37-J 
When cells were stained with Calcofluor to measure the lengths of cdc37 temperature-
sensitive mutant cells, a large proportion of cdc374 cells were seen to be septated at 
the later time points at 36 °C. In wildtype cells, septa formed between two divided 
nuclei, in line with the actinomyosin contractile ring and are essential for cytokinesis, 
cleaving the mother cell to produce two daughter cells. To study further this 
observation, cdc37 temperature-sensitive and cdc37 strains were cultured in YE as 
described in Section 2.7.4.3, and samples of cells were taken every two hours, fixed 
and stained with Calcofluor for visualisation by microscopy. The proportion of cells 
with and without septa was determined for a minimum of 200 cells per sample. The 
proportion of cells containing septa did not dramatically change for the cdc37' strain 
ED 1022, cdc37-184, cdc37-681 and cdc37-13 at 28 and 36 °C (Figure 5.15). In 
contrast 67% of cdc374 cells were septated after 8 hours at the restrictive temperature 
(Figure 5.15). Septa in cdc374 cells were only observed at the later time points and 
may occur as a result of cells leaking through their G2 cell cycle arrest, entering 
mitosis and developing septa. 
The septal morphology of cdc37 temperature-sensitive mutant and cdc37 ED 1022 
cells was then studied to look for any defects in cytokinesis. Septated cells of cdc37 
temperature-sensitive mutants at the permissive temperature contained only 1 septum 
per cell. At the non-permissive temperature, cdc37-184, cdc37-681 and cdc37-13 all 
exhibited a very slight increase in the proportion of cells with 2 or more septa per cell 
after 6 hours at the restrictive temperature. In contrast, the number of septa observed 
in cdc374 cells increased dramatically over the 8 hour time course at 36 °C (Figure 
5.16). After 8 hours at 36 °C only 52% of the cell population contained 1 septum, 
38% contained 2 septa, 7.4% of cells contained 3 septa and 2.6% had multiple septa. 
These septa were often aberrant in morphology, curving and folding across the cell 
(Figure 5.16). cdc374 cells may be leaking through their G2 arrest after 8 hours at 36 
°C and arresting, unable to carry out cytokinesis and develop multiple, often aberrant 
septa in a large proportion of cells. 
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Figure 5.16: The number of septa per cell was quantitated for cdc37 temperature-
sensitive mutant strains cultured in YE at 28 and 36 °C. Samples of cells were taken 
every two hours, fixed and stained with Calcofluor to visualise septa by microscopy. 





112 [H 03 omultiple 2 , 
Oh, 	Oh, 	Ohl 	2hr 	4h 	6h, 	en, 






60 	 112 
40 	 03 
20 	
C multip le J 
Oh, 	2hr 	8 h 	21h 	4h, 	Ohl 	80, 





60 	 •2 
40 	 03 JJJjj 20 	 lo multiple 
Oh, 	2hr 	80r 	2 h 	4h 	6h 	80, 







40 	 03 
[0 multiple 20  
0 
Oh, 	2h, 	8h' 	2h 	40, 	60, 	8h 
28°C 	28°C 	28°C 	36°C 	36°C 	38°C 	36°C 
Condition 
174 
During normal cytokinesis the septum is positioned centrally along the length of the 
mother cell for division into two equally sized daughter cells. To better understand the 
aberrant septal morphologies observed in cdc374 cells and to determine whether 
these mutants are defective in septum positioning within the cell, the position of septa 
was determined for cdc37 temperature-sensitive and the cdc37' strains stained with 
Calcofluor. 200 cells from each sample were assayed, determining by eye whether 
septa were centrally positioned within the cell. Except for cdc37-J, cdc37 
temperature-sensitive mutant and cdc37 cells contained centrally positioned septa at 
36 °C over the 8 hour time course (data not shown). 93% of septa in cdc374 cells 
after 8 hours at the restrictive temperature were centrally positioned, indicating that 
cdc374 cells with aberrant septal morphologies are not defective in septa positioning. 
As nuclear division proceeds, an actinomyosin ring forms medially positioned within 
the cell, and the septum develops in alignment with this as the ring contracts during 
cytokinesis to produce two daughter cells (Krapp et al., 2004). To determine whether 
defects of the actinomyosin ring may contribute to aberrant septa morphology in 
cdc374 cells, cdc37 temperature-sensitive and cdc37' strains were cultured in YE as 
described in Section 2.7.4.3 and samples of cells were taken every two hours, fixed 
and stained with rhodamine-conjugated phalloidin (Chang et al., 1996) to visualise 
actin localisation by microscopy and DAPI to observe nuclear morphology. In 
-80.8% of cdc37' cells at 28 and 36 °C the actin was localised at the cell tips 
(phenotype 1(the classification of phenotypes is given in Figure 5.18)), which occurs 
to permit cell growth in the form of elongation (Figure 5.17A). On average 6% of the 
cell population contained two nuclei and .actin located at the cell tips (phenotype 2) 
and cells containing two nuclei separated by an actin contractile ring (phenotype 3) 
represented on average 13.1% of the cell population (Figure 5.17C). After 6 hours at 
36 °C cdc37 temperature-sensitive mutants showed a loss of actin localisation to cell 
tips and the actin contractile ring was absent (Figure 5.17). After 8 hours at 36 °C all 
cdc37 temperature-sensitive mutants were seen to contain mislocalised abnormal actin 
patches in cells containing a single nucleus (phenotype 11) or divided nuclei separated 
by a division septa (phenotype 12) (Figure 5. 17D). After 8 hours at the restrictive 
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Figure 5.17: The localisation of actin was examined in cdc37 temperature-sensitive 
mutant and cdc37 strains cultured at 28 and 36 °C over an 8 hour time course. 
Samples were taken every two hours and stained with rhodamine-conjugated 
phalloidin and DAPI. A Phentoypes observed by staining with rhodamine-conjugated 
phalloidin and DAPI B pictures of phenotypes 1, 3 and 12. 
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Figure 5.18: Classification of phenotype observed in cdc37 temperature-sensitive 
mutant and cdc37 strains cultured at 28 and 36 °C over an 8 hour time course and 
stained with rhodamine-conjugated phalloidin and DAPI to investigate actin 
localisation. 
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temperature 65.6%, 70%, 64.85% and 85.5% of cells from the strains cdc3 7-1 84, 
cdc37-681, cdc37-13 and cdc374 respectively displayed these abnormal actin patches 
(Phenotypes 11, 12 and 13) which were located at either end of the cell, but were 
separate from the cell tip wall as detailed schematically in Figure 5.17E. These 
aberrant actin patches may arise as a consequence of the cell cycle arrest in cdc37 
temperature-sensitive mutants or as an independent event due to loss of Cdc37 
function in these mutants. 
	
5.3.9 	Morphology of microtubules in cdc37 temperature-sensitive 
mutants 
To identify cellular defects that may explain the cell cycle arrest and observed 
cytological abnormalities in the cdc37 temperature-sensitive mutants at the restrictive 
temperature, immunofluorescence was carried out with the TAT1 antibody that allows 
microtubules to be visualised. The cdc37 strain ED1022 and cdc37 temperature-
sensitive mutants were cultured as described in Section 2.7.4.3 at 28 and 36 °C over 
an 8 hour time course. Samples were taken at 0, 4 and 8 hours and cells were fixed 
and treated for immunofluorescence with the TAT1 antibody and the anti-mouse IgG 
antibody Alexfluor488 for visualisation by microscopy (Section 2.8.4). In cdc37 and 
cdc37 temperature-sensitive mutant cells at both temperatures, microtubules appeared 
normal (Figure 5.19). The microtubules of cdc37 temperature-sensitive mutant cells 
cultured at the restrictive temperature were slightly more diffuse in appearance, but 
this may be a visual artefact as the cells are elongated. No mitotic spindles were 
observed in cdc37 temperature-sensitive mutant cells at the restrictive temperature, 
supporting the conclusion that cells arrest in G2. 
5.3.10 	Cdc37 localisation in cdc37 temperature-sensitive mutants 
The cellular distribution of the Cdc37 protein was analysed by immunofluorescence 
to determine its natural distribution pattern and whether its localisation changed in 
cdc37 temperature-sensitive mutants at 36 °C. The cdc37 temperature-sensitive 
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Figure 5.19: Microtubule morphology in cdc37 temperature-sensitive mutants and the 
cdc37 strain ED1022. Strains were cultured at 28 and 36 °C over an 8 hour time 
course. Samples of cells were taken every two hours and processed for 
immunofluorescence with the TAT1 antibody against tubulin (kind gift from Keith 
Gull). Bar is 10 lam. 
A 	cdc37 cells at 28°C 	Temperature sensitive mutant 




mutants and cdc37 strain ED 1022 were cultured at the 28 and 36 °C over an 8 hours 
time course as described in 2.7.4.3 and samples were taken every 2 hours and 
processed for immunofluorescence with the anti-S. pombe Cdc37 antibody (Section 
2.8.4) and anti—rabbit IgG antibody Alexfluor68° (Molecular Probes). In cdc37 
temperature-sensitive mutant and the cdc37' strains, Cdc37 localisation was diffuse 
throughout the cell at both 28 and 36 °C over the entire 8 hour time course (Figure 
5.20A). Cdc37 was seen to form punctate spots throughout the cells and does not 
display any specific localised pattern. 
A number of conditions were tested for immunofluorescence with the anti-S. pombe 
Cdc37 antibody to ensure specific staining and to optimise the technique. Cells from 
cdc37-184 and cdc37F  incubated at 28 and 36 °C for 8 hours were treated with 1:90, 
1:60 and 1:30 dilutions of the S. pombe Cdc37 antibody, secondary antibody only and 
a 1:30 dilution using anti-S. pombe Cdc37 serum that had been depleted of antibodies. 
Depletion of the anti-S. pombe Cdc37 serum was carried out by incubating a sample 
of the serum with GST-Cdc37 bound to glutathione beads (Section 2.9.9). The 
depleted antibody serum was used in western blots against GST-Cdc37 and total S. 
pombe protein extracts to show loss of anti-S. pombe Cdc37 antibodies from serum 
(Figure 5.20B). Fluorescence of Cdc37 was clearly observed with 1:30 and 1:60 
dilutions of the anti-S. pombe cdc37 antibody (Figure 5.20A). Staining cells with only 
secondary antibody or Cdc37 depleted serum did not produce any fluorescence 
(Figure 5.20A). 
5.4 	- 	Discussion 
In S. pombe four cdc37 temperature-sensitive mutants have been identified and their 
characterisation is described in this chapter. Three temperature-sensitive mutants of 
cdc37 were created in this work by random and directed mutagenesis. The 
temperature-sensitive mutant cdc37-184 was generated by introducing the equivalent 
mutation to the S. cerevisiae mutant cdc37-184 into the S. pombe cdc37 gene. The 
mutants cdc374 and cdc37-13 were isolated from a total of 11,750 G418 resistant 
Inc 
Figure 5.20: Immunofluorescence of cdc37 temperature-sensitive mutants and cdc37 
cells with the anti-S. pombe Cdc37 antibody. A cdc37' and cdc37-184 cells were 
stained with the anti-S. pombe Cdc37 antibody by immunofluorescence using a 
number of different conditions to verify specific staining. B Verification that the anti-
S. pombe serum had been depleted of Cdc37 antibodies by incubation with GST-
Cdc37 bound to glutathione beads. Bar is 10 urn. 
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colonies, generated by random mutagenic PCR with the inclusion of MnC12 into PCR 
reactions. The low yield of cdc37 temperature-sensitive mutants was not due to 
incorrect insertion of the PCR amplified fragments into the S. pombe genome, as 
random mutagenic PCR products were efficiently targeted to the cdc37 locus with 
92% efficiency. Therefore, mutagenic PCR conditions may have been the limiting 
factor in the generation of cdc37 temperature-sensitive mutants. Equally, the number 
of possible temperature-sensitive mutants that can be generated for S. pombe cdc37 
may be low due to conformational and/or functional constraints. It is interesting to 
note that all the mutations identified in these cdc37 temperature-sensitive mutants are 
located in very close proximity within the middle domain of the Cdc37 protein. 
Temperature-sensitive mutants of S. pombe cdc37 may only occur by mutations 
within this central region, around the postulated Hsp90-binding and homodimerisation 
domains in the 6-helix bundle (Roe et al., 2004). Mutations within this region may 
inhibit Cdc37 dimerisation, Hsp90 interactions and/or negatively affect protein 
conformation, inhibiting proper function in a temperature dependent manner. 
All four cdc37 temperature-sensitive mutants were able to form single colonies at 25, 
28 and 32 °C, but were unable to sustain colony formation at 36 °C. The ability to 
sustain growth was lost at 36 °C in cdc37-681, cdc37-184, cdc37-13 and cdc374 due 
to loss of Cdc37 function and not instability of the chaperone protein, as Cdc37 
protein levels remained constant at the restrictive temperature. In the S. cerevisiae 
temperature-sensitive mutants cdc37-34 (Fliss et al., 1997) and cdc37-1 (Gerber et al., 
1995) mutant Cdc37 protein levels were reduced at both the permissive and the 
restrictive temperature. Loss of Cdc37 function at the restrictive temperature in S. 
pombe cdc37 temperature-sensitive mutants did not affect Cdc37 cellular localisation. 
The Cdc37 protein remained diffuse in its localisation throughout the cell at 28 and 36 
°C over the 8 hour time course and no distinct alterations in the pattern of distribution 
were observed. When S. pombe Cdc37 was tagged with GFP, it was also found to 
localise throughout the cell, although distinct localisation was observed in the 
chromatin region of the nucleus (Tatebe and Shiozaki, 2003). This slight dissimilarity 
in localisation may reflect differences in experimental technique. 
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The loss of Cdc37 function in S. pombe cdc37 temperature-sensitive mutants was 
rapid as cells stopped dividing within 2 hours at the restrictive temperature. The cdc37 
temperature-sensitive mutants arrest at the non-permissive temperature with elongated 
cells, displaying a cdc phenotype. The cdc phenotype is characteristic of cells that 
have undergone a cell cycle arrest but can continue to grow at the tips producing 
elongated cells. Further analysis showed that all four S. pombe cdc37 temperature-
sensitive mutants arrest with a replicated DNA content, having passed through S 
phase. Cytological analysis revealed that the majority of cdc37 temperature-sensitive 
mutant cells at the restrictive temperature contained a single nucleus per cell with 
uncondensed chromatin, indicating a G2 arrest. In accordance with this, Drosophila 
cells treated with cdc37 RNAi arrested cell division with a 4N DNA content, having 
passed through S-phase (Lange et al., 2002). This is distinct from S. cerevisiae where 
the majority of CDC37 temperature-sensitive mutants arrest in Start (Reed, 1980; 
Reed, 1980; Valay et al., 1995). The exception is cdc37-34 which arrests at the 
restrictive temperature with a phenotypically mixed cell population that can be 
grouped into three categories; single uninucleated cells in GI arrest, budded 
uninucleated cells arrested in G2 and budded binucleate cells with a mitotic arrest 
(Dey et al., 1996). It is interesting to note that a proportion of S. pombe cdc37-184 
cells produced an unreplicated 1C DNA content peak after 2 hours at the restrictive 
temperature, and then all cells arrested in G2 after 4 hours. It is possible that at the 
restrictive temperature, cdc37-184 cells underwent a delay in GI prior to arresting in 
G2. 
cdc374 was the only temperature-sensitive mutant to leak beyond this G2 cell cycle 
arrest after 8 hours at the restrictive temperature. These cells had entered mitosis, 
dividing their nuclei and forming a division septum between them. These septa were 
often morphologically abnormal, occurring in multiple copies or being distorted in 
structure, which may contribute to the cells inability, to accomplish cytokinesis. 
Interestingly, these aberrant septa were always positioned correctly within the cell, 
indicating that positioning of septa was not defective. Actin was not found to form a 
contractile ring after 6 hour at 36 °C in these mutant cells, which may have been a 
contributing factor to the failure to carry out cytokinesis and the aberrant septal 
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morphologies observed. Interestingly, Drosophila cells harbouring cdc37 mutants 
have also been seen to be defective in cytokinesis (Lange et al., 2002). 
In all four cdc37 temperature-sensitive mutants the microtubules displayed no 
aberrant features at any time point at the restrictive temperature. However, after 6 
hours at 36 °C all cdc37 temperature-sensitive mutants contained mislocalised actin. 
The appearance of aberrant actin patches towards the cell tips has not been reported 
elsewhere in the literature. Actin mislocalising to produce numerous actin patches has 
previously been observed in the S. pombe itMyo1 mutant which has defects of the 
actin cytoskeleton, forming numerous delocalised actin patches (Lee et al., 2000). In 
S. pombe cdc37 temperature-sensitive mutants the mislocalisation of actin to form two 
distinct patches at, the restrictive temperature may be a secondary effect of cell cycle 
arrest in these mutants, or independent of the cell cycle arrest. 
The aim of generating temperature-sensitive mutants that show the effect of loss of 
Cdc37 function within a cell cycle at the restrictive temperature was achieved. All 
four S. pombe cdc37 temperature-sensitive mutants arrest within 2 hours at the non-
permissive temperature in 02 with a classic cdc phenotype. Interestingly, when Cdc2 
was inactivated in S. pombe, cells arrested at the G2/mitosis boundary but continued 
to elongate with an undivided nucleus (Snell and Nurse, 1994). Cdc2 could be a client 
of Cdc37 in S. pombe that relies on this chaperone for function. When Cdc37 function 
is lost in cdc37 temperature-sensitive mutants at the restrictive temperature, Cdc2 
function could be abolished inducing a cell cycle arrest at the G2/mitosis boundary. 
The Cdc2 homologue in S. cerevisiae, Cdc28, was found to physically interact with 
Cdc37 when truncated and expressed in the yeast two hybrid assay (Mort-Bontemps-
Soret et al., 2002). Investigations of Cdc2 as a postulated client of Cdc37 and the 
principal cause for the observed cell cycle arrest in Cdc37 temperature-sensitive 
mutants is described in Chapter 6. 
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6.0 	Cdc37 interactions with co-chaperones and clients 
in S. yombe 
6.1 	Introduction 
Cdc37 has been identified in a range of high molecular weight complexes (Boudeau et 
al., 2003; Mahony et al., 1998; Stepanova et al., 1996; Wang et al., 2002) indicating 
that this chaperone interacts with a wide variety of client proteins and co-chaperones. 
Cdc37 and the co-chaperone Hsp90 have been found by gel filtration in the same 450 
kDa high molecular weight complex, associated with the client protein kinase Cdk4 in 
NIH-3T3 cells (Stepanova et al., 1996). It is widely believed that the molecular 
chaperone Cdc37 binds client proteins and delivers them to the co-chaperone Hsp90, 
forming a tertiary complex (MacLean and Picard, 2003). Although, no tertiary 
complex between Cdc37, Hsp90 and a client protein has been isolated to date; most 
likely due to the transient nature of this complex which makes detection of these 
interactions problematic and these associations are believed to be more unstable in 
yeast systems than higher eukaryotes (Farrell and Morgan, 2000). 
A complex consisting of the interacting domains of yeast Hsp90 and human Cdc37 
has been crystallised and its structure determined (Roe et al., 2004). Amino acids 164-
170 and 204-208 of human Cdc37 were found to form a hydrophobic patch that 
interacts with the N-terminal region of yeast Hsp90 (Roe et al., 2004). Human Cdc37 
binds both the N-terminal domains and the adjacent linker regions of the Hsp90 dimer 
(Zhang et al., 2004). Cdc37 binds to Hsp90 as a dimer (Siligardi et al., 2002) at a 1:1 
molar ratio (Zhang et al., 2004), preferentially binding the non-ATP bound form of 
Hsp90 and suppressing ATP hydrolysis (Siligardi et al., 2002). It is widely believed 
that once Hsp90 has bound the client, Cdc37 is released from the tertiary complex. 
Hsp90 can then carry out ATP turnover which occurs as a two step process, 




The interaction between Cdc37 and Hsp90 in yeast has been less well studied as the 
tertiary complex is much less stable than in higher eukaryotes (Farrell and Morgan, 
2000). In S. cerevisiae recombinant GST-Cdc37 was found to interact with Hsp90 in 
pull-down experiments (Donze and Picard, 1999). An interaction between these two 
co-chaperones has also been detected in S. cerevisiae by yeast two-hybrid assay using 
an Hsp90 containing mutations that inhibit ATP hydrolysis (Millson et al., 2004). The 
work described in this chapter investigates the association between Hsp90 and Cdc37 
in the yeast S. pombe. 
Client proteins rely on molecular chaperones such as Cdc37 and Hsp90 for activation, 
folding and maintenance of cellular protein levels. Client proteins of Cdc37 bind the 
N-terminal domain of Cdc37 (Shao et al., 2003) and are predominantly protein 
kinases such as Raf-1 (Grammatikakis et al., 1999) and the cyclin dependent kinase 
(Cdk) Cdk4 (Dai et al., 1996; Lamphere et al., 1997; Stepanova et al., 1996). Cdk 
proteins are crucial for progression of the cell cycle; loss of Cdks from the cell results 
in a cell cycle arrest. In the previous chapter (Chapter 5) cdc37 temperature-sensitive 
mutants in S. pombe were found to arrest the cell cycle at the restrictive temperature 
in G2. In S. pombe, Cdc2 is the Cdk that is crucial for the transitions between 
U2/mitosis and Ui/S phase. Cdc2 protein levels remain constant throughout the cell 
cycle (Alfa et al., 1989). Regulation of cell cycle progression by Cdc2 is controlled by 
modulating its activity at different stages by associating with specific cyclin partners 
and both negative and positive phosphorylation. Prior to the G2/mitosis transition, 
Cdc2 is phosphorylated on threonine 167 (Gould et al., 1991) to promote cyclin 
association and on tyrosine 15 (Gould and Nurse, 1989) to keep the Cdk inactive 
during interphase. Phosphorylation on threonine 167 is carried out by the Cdk-
activating kinases (CAKs) (Lee et al., 1999) while tyrosine 15 is phosphorylated 
primarily by Wee! (Gould and Nurse, 1989). Phosphorylation on threonine 167 
allows Cdc2 to stably associate with a 482 amino acid B-type cyclin, Cdcl3 (Booher 
and Beach, 1988; Booher et al., 1989; Hagan et al., 1988). The Cdc!3 protein shows 
periodic changes in abundance (Alfa et al., 1989), accumulating through interphase 
and then being actively degraded at the metaphase-anaphase transition. To initiate 
mitosis, Cdc2 bound to Cdcl3 is activated by dephosphorylation on tyrosine 15 by the 
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phosphatase Cdc25 (Nurse, 1997). Active Cdc2 is then localised to the nucleus by 
cyclin Cdcl3 and the active complex promotes mitosis (Alfa et al., 1989). In light of 
the findings with S. pombe cdc37 temperature-sensitive mutants, interactions between 
Cdc2 and Cdc37 were investigated in S. pombe and are described in this chapter. 
Little is known about the interactions between Cdc37 and the co-chaperone Hsp90 
and client protein kinases in S. pombe. These interactions in yeast systems are though 
to be extremely unstable (Farrell and Morgan, 2000) making biochemical studies 
problematic. In addition, the non-specific binding affinity of both Cdc37 and Hsp90 
further complicates these investigations. Often mutational analysis or in vitro 
experiments have had to be employed to identify Cdc37 interactions, such as using 
truncation mutants of both cdc37 and cdc28 (the S. cerevisiae homologue of Cdc2) to 
detect an interaction by yeast two-hybrid assay (Mort-Bontemps-Soret et al., 2002). In 
S. pombe the only client protein identified to date is the kinase Spcl, which was found 
to co-inmiunoprecipitate with Cdc37 (Tatebe and Shiozaki, 2003). In this work the 
interactions between the co-chaperone Hsp90 and the putative client protein kinase 
Cdc2 with Cdc37 in S. pombe have been investigated using both genetic and 
biochemical techniques. 
6.2 	Hsp9O 
6.2.1 	Genetic interactions between Hsp90 and Cdc37 in S. pombe 
To investigate whether cdc37 and swol (the gene in S. pombe that codes for Hsp90) 
interact at the genetic level, cdc37 temperature-sensitive mutants cdc37-681, cdc37-
184, cdc37-13 and cdc374 were crossed with the Hsp90 temperature-sensitive mutant 
swol-26 (Aligue et al., 1994). (The cross between cdc37-681 and swol-26 was 
carried out by ma Martin). Resulting asci were dissected and the progeny were 
incubated at 28 °C and then replicated to 28 and 36 °C to determine the genotype of 
germinated spores. Table 6.1 shows the phenotypes of progeny from dissected asci for 
each cross. Progeny that contained both mutant alleles were identified by determining 
the phenotypes of each viable spore in each tetrad, assuming that segregation is 2:2. 
Spores containing both mutant alleles were found to be synthetically lethal at 
temperatures permissive for the individual mutations indicating that cdc37 and swol 
interact at the genetic level in S. pombe. 
To investigate further the genetic interaction between Hsp90 and Cdc37 in S. pombe, 
swol was expressed from pREP81 and pREP1 in all four cdc37 temperature-sensitive 
mutants to determine whether it could compensate for reduced Cdc37 function at the 
restrictive temperature. Strains were plated as serial dilutions and incubated at 28 and 
36 °C for 4 days. The increased expression of swol from high and low copy plasmids 
(pREP1 and pREP81 respectively) was able to partially rescue one of the four cdc37 
temperature-sensitive mutants at the restrictive temperature, cdc37-13 (Figure 6.1A). 
Increased expression of swol was able to support a low level of growth at the 
restrictive temperature in cdc37-13, although the cells displayed distinctly aberrant 
phenotypes, being either elongated or small and round (Figure 6.113). These data 
indicate that Hsp90 can partially compensate for reduced Cdc37 function, in certain 
circumstances. It should be noted that, cdc374 was able to support colony formation 
at the restrictive temperature with expression of all four plasmids, including pREP 
vector only. However, at 36 °C cells were elongated in appearance indicating that the 
phenotype of this mutant cannot be rescued by increased expression of swol. 
6.2.2 	Biochemical interactions between Cdc37 and Hsp90 in S. pombe 
6.2.2.1 	Yeast two-hybrid assay 
To study the interaction between the S. pombe co-chaperones Hsp90 and Cdc37 the 
yeast two-hybrid system was employed for detecting protein-protein interactions. A 
schematic diagram of the yeast two-hybrid system in Figure 2.6 shows how this 
system works. The DNA activating domain of Ga14 was fused to one candidate 
protein and the DNA binding element of Ga14 was fused to the other candidate 
protein. If the two candidate proteins physically interact then the DNA binding and 
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Table 6.1: Tetrad types and progeny phenotypes from crosses between cdc37 
temperature-sensitive mutants cdc37-681 (carried out by ma Martin), cdc37-184, 
cdc37-13 and cdc374 with the Hsp90 temperature-sensitive mutant swol-26 (Aligue 
et al., 1994). 
Tetrad types Genotypes of cdc37- cdc37- cdc37-13 cdc37-J 
progeny 681 184 





Tetrad type 1 wildtype, 1 2 6 4 2 





Non- 2 wildtype and 2 1 2 7 2 
parental dead spores 
ditype  
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Figure 6.1: Expression of swol from pREP81 and pREP1 in cdc37 temperature-
sensitive mutants, cdc37-681, cdc37-184, cdc37-13 and cdc37-J, at 28 and 36 °C. A 
Growth on plates of serial dilutions of S. pombe strains at 28 and 36 °C B cell 
morphology of cdc37-13 with overexpressed swol at 36 °C. 
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DNA activating domains of Ga14 come together and enable transcriptional activation 
of the reporter gene /3-galactosidase. The level of /3-galactosidase can be assayed by 
its enzymatic ability to hydrolyse the substrate X-gal to produce a blue color. 
The vectors pADC (DNA activating domain) and pBDC (DNA binding domain) 
(Milison et al., 2003) were used to enable N- and C- terminal tagging of Cdc37 and 
Hsp90. S. pombe swol was cloned into both vectors to allow C-terminal tagging as 
the N-terminal domain of this chaperone is known to bind Cdc37 (Roe et al., 2004). S. 
pombe cdc37 was cloned into both vectors for both N- and C- terminal tagging. 
Human cdc37 (p50) was also used, as an interaction with Hsp90 has been determined 
using various techniques, and was cloned into both vectors to enable N- and C-
terminal tagging. The swol, S. pombe and human cdc37 genes were PCR amplified 
with mutagenised oligonucleotides to introduce Smal sites at the 5' and 3' ends, and 
to remove stop codons where appropriate. Fragments were then cloned into the 
appropriate vectors. Plasmid constructs were transformed into S. cerevisiae strain 
AH109 using the lithium acetate method (Section 2.10.3.1) in combination (Table 
6.2) and individually, to ensure that they did not auto-activate. Positive and negative 
control plasmids pGADT7-T and pGBKT7-53 were also used to determine whether 
the system was working. The colony lift filter assay (Section 2.10.5.1) was carried 
out, identifying positive interactions by their ability to turn the yeast cells blue. The 
colonies tested did not turn blue except for the positive control, indicating that an 
interaction between Hsp90 and S. pombe or human Cdc37 was not detected by yeast 
two-hybrid (Figure 6.2). 
6.2.2.2 	GST-Cdc37 pull-down to detect an interaction between 
recombinant Cdc37 and Hsp90 
The GST pull-down technique was used with the aim of detecting an interaction 
between recombinant S. pombe or human Cdc37 and native S. pombe Hsp90. S. 
pombe and human cdc37 were cloned into the vector pGEX-1 (N-terminal GST tag) 
for high level expression in BL21 E. coli. (S. pombe cdc37 was cloned into the pGEX- 
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Table 6.2: Combination of plasmids transformed into AH109 S. cerevisiae strain for 
yeast two-hybrid analysis. 











Figure 6.2: Yeast two-hybrid colony lift filter assay using the Ga14 system to identify 
an interaction between S. pombe or human Cdc37 and Hsp90. Colonies were 
incubated with X-gal to observe their ability to turn blue to identify an interaction 
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I vector by ma Martin). GST and GST fusion proteins were purified from bacterial 
lysates by affinity chromatography using immobilised glutathione. GST, GST-S. 
pombe Cdc37 and GST-human Cdc37 were then bound to glutathione beads and 
incubated with whole cell protein extracts of the S. pombe strain ED 1537 in which the 
chromosomal swol gene is tagged with the HA epitope (Section 2.9.9). Samples were 
washed in appropriate buffer and treated with P reScissionTM Protease to cleave the 
GST-tag from fusion proteins, as GST-S. pombe Cdc37 has the same mobility by SDS 
PAGE as Hsp90-HA. The supernatant, containing the recombinant Cdc37 proteins, 
and the glutathione beads were separated by centrifugation and analysed by SDS 
PAGE and western blot. Probing western blots with the anti-HA antibody revealed 
that Hsp90-HA was present in both the beads matrix and supernatant fractions, 
presumably due to non-specific binding of GST, GST fusion proteins and glutathione 
bead matrix (Figure 6.3). To try to reduce the non-specific binding of Hsp90-HA a 
range of buffers was used with this technique: PBS, TEG, RIPA and R Buffer (See 
Materials and Methods). However, in all cases Hsp90-HA was found in both the bead 
matrix and supernatant fractions, presumably interacting non-specifically with GST, 
GST-fusion proteins and the bead matrix. 
An interaction between Hsp90 and Cdc37 could not be detected by GST pull-down 
experiments. The non-specific binding affinity of Hsp90-HA makes detection of an 
interaction between Cdc37 and Hsp90 problematic, especially if the association 
between these co-chaperones is weak and unstable in S. pombe. Furthermore, Cdc37 
is known to be phosphorylated in vivo in S. cerevisiae (Bandhakavi et al., 2003), rat 
(Miyata and Nishida, 2004) and human (Shao et al., 2003) cells and mutation of the 
phosphorylatable residues in S. cerevisiae Cdc37 greatly reduced its binding affinity 
towards the co-chaperone Hsp90 by yeast two-hybrid (Millson et al., 2004). 
Recombinant Cdc37 from E. co/i is not phosphorylated and may reduce the binding 
affinity of Cdc37 towards Hsp90 in this in vitro GST pull-down assay. However, 
mutations of human Cdc37 serine 13 to alanine or glutamic acid only reduced Cdc37 
binding affinity towards Hsp90 by 40 and 10% respectively (Shao et al., 2003), 
although the interaction between these two co-chaperones is thought to be tighter in 
mammalian systems than in yeast (Farrell and Morgan, 2000). 
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Figure 6.3: GST pull-down assay using recombinant S. pombe and human Cdc37 to 
detect an interaction with Hsp90-HA from native S. pombe protein extracts. These 
experiments were treated with P reSci ssionTM Protease as GST-S. pombe Cdc37 has 
the same mobility as Hsp90-HA by SDS PAGE. Hsp90-HA was identified by western 
blot analysis with anti-HA antibodies and all other proteins were identified by 
Coomassie staining of SDS polyacrylamide gels. 
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6.2.2.3 	Immunoprecipitation (IP) 
An alternative approach was taken to detect an interaction between Cdc37 and Hsp90 
using co-immunoprecipitation from whole cell protein extracts, so that 
phosphorylation or other modifications would not be a limiting factor. Whole cell 
protein extracts from the S. pombe strain ED 1537 containing a chromosomally tagged 
Hsp90-HA were made and co-immunoprecipitation (IP) experiments were carried out 
with both the anti-HA antibody and anti-S. pombe Cdc37 antibody, and no antibody 
or anti-rat IgG antibody in control IPs (Section 2.9.5). The immunoprecipitates were 
then analysed by western blot with anti-HA and anti-S. pombe Cdc37 antibodies. IPs 
with the anti-HA and anti-S. pombe Cdc37 antibodies precipitated Cdc37 and Hsp90-
HA respectively. However, control immunoprecipitates also precipitated Hsp90-HA 
and/or Cdc37 (Figure 6.4A), indicating that these chaperone proteins display non-
specific binding in these experiments. Therefore, numerous IP conditions were 
changed, as laid out in Table 6.3 in order to optimise the experimental technique. IP 
conditions were optimised so that non-specific binding by either co-chaperone did not 
occur (the technique is described in Section 2.9.5), but no interaction between Hsp90-
HA and Cdc37 was detected by IP (Figure 6.413). Detecting an interaction between 
Cdc37 and Hsp90-HA may be problematic as the association may be extremely 
unstable, although it is possible that these two proteins do not interact in S. pombe. 
6.2.2.4 	Size exclusion chromatography 
Previous experiments had been unable to identify an interaction between Hsp90 and 
Cdc37. A new approach was taken using size exclusion chromatography, to determine 
whether Cdc37 was present in a high molecular weight complex in S. pombe which 
might also include the co-chaperone Hsp90. Molybdate was included throughout 
these experiments as it is thought to stabilise Cdc37 interactions (Hartson et al., 2000; 
Hutchison et al., 1992). First, recombinant Cdc37 was studied using a Superose 6 
column to establish the elution pattern of the chaperone alone. The majority of 
recombinant Cdc37 was found to elute at around 200 kDa (Figure 6.5A), which was 
surprising given the predicted molecular weight of 64kDa. However, human Cdc37 is 
197 
Table 6.3: Conditions changed in co-immunoprecipitation experiments to optimise 
the technique. 
Condition Details of variables 
changed  
Buffer RIPA 150 mlvi NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50 
mM Tris [pH7.5], 10% glycerol & protease inhibitors 
Buffer 1 150 mM NaCl, 0.5% NP-40,50 mM Tris [pH7.5], 10% glycerol 
& protease inhibitors 
Buffer 2 50 mM NaCl, 1% NP-40,50 mM Tris [pH7.5], 10% glycerol & 
protease inhibitors 
Buffer 3 100 mM NaCl, 1% NP-40, 50 mM Tris [pH7.5], 10% glycerol 
& protease inhibitors 
Buffer A 10 mlvi NaCl, 0.01% Triton-X, 50 mM Tris [pH7.5], 10% 
glycerol & protease inhibitors 
Buffer B 50 mM NaCl, 0.1% Triton-X, 50 mlvi Tris [pH7.5], 10% 
glycerol & protease inhibitors 
Buffer C 10 mM NaCl, 0.35% Triton-X, 50 mM Tns [pH7.5], 10% 
glycerol & protease inhibitors 
Buffer TS As described in Tatebe & Shiozaki 2004 
Number of Washes IPs were washed 3, 4 and 5 times for comparison 
Amount of buffer 500 p.1 and 1 ml of buffer used to wash IPs 
used in washes 
Antibody Incubation of antibody with the Sepharose beads prior to the addition of S. 
pombe whole cell protein extracts. 
Incubation of antibody with whole cell protein extracts from S. pombe prior to 
addition of Sepharose beads. 
Amount of 2, 4 or 6 p.1 of antibody in IPs 
antibody in IFs 
Method of making Harvesting cells by centrifugation and making protein in a Ribolyser. 
Harvesting cells by centrifugation and making protein by vortexing tubes S. pombe whole 
cell protein containing 500 p.1 or 1 ml of acid washed glass beads. 
extracts Harvesting cells by filtration and making protein by vortexing tubes containing 
500 p.!_or_1_ml_of acid _washed _glass beads. 
Protein 125 p.g, 250 p.g, 500 p.g, & 1 mg of whole cell protein extracts 
concentration 
Amount of Cdc37 Protein was made from strains with endogenous Cdc37 
Increasing the level of Cdc37 by expressing cdc37 from high and low copy 
plasmids pREP1 or pREP81 
Amount of 5, 10, 20, 30 and 50 p.1 of beads in an equal volume of buffer 
Sepharose beads 
Type of Sepharose Protein A Sepharose beads 
Protein G Sepharose beads beads 
BSA Incubation of Sepharose beads with BSA prior to IPs to reduce non-specific 
binding 
Eppindorl Transfer to a new tube after washes 1 and 4 
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Figure 6.5: A Small scale size exclusion chromatography of recombinant Cdc37 and 
native S. pombe protein extracts using a Superose 6 column. Western blot analysis 
with anti-S. pombe Cdc37 antibody and anti-HA antibody to determine the elution 
pattern of Cdc37 and Hsp90-HA. B Large scale size exclusion chromatography using 
a Sephacryl S-300 HR 26/60 column and western blot with anti-S. pombe Cdc37 
antibody and anti-HA antibody to determine the elution pattern of Cdc37 and Hsp90. 
Immunoprecipitation experiments on fractions containing the Cdc37 high molecular 
weight complex were carried out to identify an interaction between Cdc37 and Hsp90 
and western blots were probed with anti-S. pombe Cdc37 antibody and anti-HA 
antibody. 
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a —50 kDa protein that exists as a dimer in its native state (Roe et al., 2004) and is 
structurally elongated which might affect its apparent size by size exclusion 
chromatography and explain the elution profile of S. pombe Cdc37. Size exclusion 
chromatography of S. pombe whole cell protein extracts showed the majority of 
Cdc37 also eluted at around 200 kDa (Figure 6.5B). Interestingly a small proportion 
of total Cdc37 protein eluted as a high molecular weight complex(es) at 
approximately 669 kDa, but no recombinant Cdc37 was found to elute at this position. 
These data suggest that in vivo, a small fraction of Cdc37 interacts stably with other 
proteins to form a high molecular weight complex. It is interesting to note that the 
elution pattern of the Cdc37 high molecular weight complex overlaps with the elution 
pattern of Hsp90-HA in these experiments. 
To analyse further the high molecular weight complex of Cdc37, a larger size 
exclusion chromatography experiment was carried out. The aim was to generate 
adequate material to carry out IN on fractions containing the Cdc37 high molecular 
weight complex to determine whether it also contains Hsp90-HA. Whole cell protein 
extracts from S. pombe ED1537 were made and treated by size exclusion 
chromatography using a Sephacryl S-300 HR 26/60 column. Fractions were run on 
SDS PAGE and western blot analysis was carried out using anti-S. pombe Cdc37 and 
anti-HA antibodies. As previously observed the majority of S. pombe Cdc37 eluted at 
around 200 kDa (Figure 6.5B). Only a small fraction of total Cdc37 protein eluted as 
a high molecular weight complex of approximately 669 kDa which overlapped with 
the elution pattern of Hsp90-HA (Figure 6.5A). Fractions containing Cdc37 in a high 
molecular weight complex were pooled and used as a source for IN (Section 2.9.5). 
IPs using the anti-S. pombe Cdc37 antibody co-precipitated Hsp90-HA, indicating 
that these two co-chaperones co-IP from the high molecular weight complex (Figure 
6.5B). However, the reverse IP using the HA antibody did not yield Cdc37. This may 
be due to a small relative amount of Hsp90 in the Cdc37 complex or an inability of 
the HA-antibody to access the epitope tag within the complex. 
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6.3 	Cdc2 
6.3.1 	Genetic interactions between Cdc37 and Cdc2 
To investigate the genetic interaction between Cdc2 and Cdc37, the temperature-
sensitive mutant cdc37-681 was crossed with cdc2-L7 and cdc2-33 and the progeny 
phenotypes studied. (These experiments were carried out by ma Martin). Tetrad 
dissection was carried out and spores were allowed to germinate at 28 °C. Progeny 
were then replicated to the permissive and restrictive temperature to determine their 
genotype. Double mutants of the cdc2 and cdc37 temperature-sensitive mutants were 
synthetically lethal at temperatures permissive for each individual mutant indicating 
that cdc2 and cdc37 interact genetically in S. pombe. 
To investigate further the genetic interaction between cdc37 and cdc2, the level of 
cdc2 expression was increased in all four cdc37 temperature-sensitive mutants to see 
whether the G2 cell cycle arrest could be overcome at the restrictive temperature. This 
was carried out by the introduction of a multicopy plasmid, pIRT2-cdc2 (a gift from 
Stuart MacNeill Lab), in cdc37 temperature-sensitive mutants that were plated as 
serial dilutions and incubated for 4 days at the 28 and 36 °C. At the restrictive 
temperature (36 °C) increased expression of Cdc2 fully rescued the temperature-
sensitive lethality of cdc374 and cdc37-13 (Figure 6.6A), producing cells that were 
phenotypically wildtype in appearance (Figure 6.6B). The increased expression of 
cdc2 in cdc37-184 and cdc37-681 was able to partially rescue these temperature 
sensitive mutants at the restrictive temperature. A low level of growth was observed at 
36 °C (Figure 6.6A) and cells were either wildtype or slightly elongated in appearance 
(Figure 6.6B). These data indicate that loss of fully active Cdc2 in cdc37 temperature-
sensitive mutants could be the cause of G2 cell cycle arrest, as increasing the cellular 
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Figure 6.6: Increased expression of Cdc2 in cdc37 temperature-sensitive mutant 
strain, plated as serial dilution and incubated at 28 and 36 °C. A Growth of strains at 
the different temperatures B cell morphology of strains expressing different constructs 
at the restrictive temperature of 36 °C. 
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6.3.2 	Studies of Cdc2 in cdc37 temperature-sensitive mutants 
To investigate the role of Cdc2 in the G2 cell cycle arrest in cdc37 temperature-
sensitive mutants, the kinase activity of Cdc2 in these mutants was assayed over a 
time course at the restrictive temperature. Cdc2 kinase activity was also investigated 
in the Hsp90 temperature-sensitive mutant swol-26, as these co-chaperones were 
previously found to co-IP from a high molecular weight complex in S. pombe (Section 
6.2.4). Cdc2 kinase activity can be assayed by its ability to phosphorylate histone Hi 
in vitro. Temperature-sensitive mutants and the cdc37' strain ED 1022 for comparison 
were cultured in liquid at 28 °C, then split and-incubated at 28 and shifted to 36 °C. 
Samples of cells were taken at 0 hours and then at hourly intervals over a 3 hour time 
course. Native protein extracts were made, Cdc2 was affinity-precipitated by 3SUC1 
beads and its activity assayed as described in Section 2.9.13. Cdc2 from wildtype cells 
showed a high level of histone Hi phosphorylation at all time points at both 
temperatures. In cdc37 and swol temperature-sensitive mutants the level of histone 
Hi phosphorylation was dramatically reduced when cells were shifted to the 
restrictive temperature (Figure 6.7) indicating that at 36 °C Cdc2 activity is rapidly 
reduced in these mutants. This data strongly points towards a role for Cdc2 in the cell 
cycle arrest after 2 hours at the restrictive temperature in cdc37 temperature-sensitive 
mutants, due to its reduced activity and therefore inability to promote mitosis. 
Cdc2 protein levels were also assayed to determine whether reduced Cdc2 activity 
was due to lower cellular Cdc2 protein in cdc37 and swol temperature-sensitive 
mutants, as Cdc28 protein levels in the S. cerevisiae temperature-sensitive mutant 
cdc37-1 were reduced (Gerber et al., 1995). swol and cdc37 temperature-sensitive 
mutants, and ED 1022 were cultured as previously described, and whole cell protein 
extracts were made for samples taken hourly at the permissive and restrictive 
temperature. Western blot analysis with anti-PSTAIR antibody that recognises S. 
pombe Cdc2 and TAT1 antibodies as a loading control, showed that Cdc2 protein 
levels did not decrease over time at 36 °C in the swol (Figure 6.7) or cdc37 (Figure 
6.8) temperature-sensitive mutants. These data indicate that Cdc2 protein levels are 
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Figure 6.7: Cdc2 kinase activity and protein levels were assayed in A swol and B 
cdc37 temperature-sensitive mutants at the permissive and restrictive temperatures. 
Temperature-sensitive mutants were cultured at 28 and 36 °C over a 3 hour time 
course. Samples of cells were taken hourly and native protein extracts were made. 
Cdc2 was affinity-precipitated on p13SUCI  beads and its activity determined by its 
ability to phosphorylate histone Hi. Cdc2 protein levels were determined by western 
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Figure 6.8: Cdc2 protein levels were assayed by western blot with anti-Cdc2 Y63.2 
antibody and TAT! antibodies as a loading control. Whole cell protein extracts were 
made from cdc37 temperature-sensitive mutants at the permissive and restrictive 
temperature at hourly time points over a 5 hour time course. 
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not the cause for reduced Cdc2 kinase activity in swol and cdc37 temperature-
sensitive mutants. 
Cdc2 activity might also be compromised by the aggregation of the Cdk into insoluble 
complexes in cdc37 temperature-sensitive mutants at 36 °C, as found in the S. 
cerevisiae mutant cdc37-1 (Farrell and Morgan, 2000). This would probably not 
affect overall cellular Cdc2 protein levels. To test this, whole cell protein extracts 
were made from cdc37 temperature-sensitive mutant and the cdc37' strains incubated 
at 28 and 36 °C over a three hour time course. The soluble and insoluble fractions of 
each protein preparation were separated by centrifugation at 11,000 xg for 5 minutes 
at 4 °C. The level of Cdc2 protein in soluble and insoluble fractions was analysed by 
SDS PAGE and western blot with anti-PSTAIR antibodies against Cdc2 (that also 
recognises the Cdk p31) and TAT1 antibodies as a'loading control. Cdc2 was found in 
both the soluble and insoluble fraction of all strains, the proportion of which did not 
change over the time course at 36 °C (Figure 6.9). Therefore, the kinase activity of 
Cdc2 is not reduced in• cdc37 temperature-sensitive mutants as a result of forming 
insoluble aggregates at the restrictive temperature. 
Cdc2 can also be inactivated, preventing entry into mitosis, by phosphorylation at 
tyrosine 15 by Wee!' (Lee et al., 1994), and this can be detected using the specific 
anti-phospho tyrosine 15 antibody. cdc37 temperature-sensitive mutants and ED1022 
were cultured as previously described at 28 and 36 °C. Whole cell protein extracts 
were made and run on SDS PAGE. Western blot analysis was carried out using TBS 
buffer, blocking with BSA, and the anti-phospho tyrosine 15 Cdc2 antibody with 
TAT1 antibody as a loading control. For all temperature-sensitive mutants and the 
strain ED 1022 the level of phosphorylation at tyrosine 15 was not seen to change over 
the time course at the restrictive temperature (Figure 6.10). These data show that 
inactivation of Cdc2 in temperature-sensitive mutants was not caused by increased 
phosphorylation at tyrosine 15 by Wee!. 
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Figure 6.9: The level Cdc2 protein in soluble and insoluble fractions in cdc37 
temperature-sensitive mutants was analysed at 28 and 36 °C. Strains were cultured in 
liquid at 28 °C, then split and incubated over a 3 hour time course at 28 and 36 °C. 
Whole cell protein extracts were made and the soluble and insoluble fractions 
separated by centrifugation at 11,000 xg for 5 minute at 4 °C. Samples were run on 
SDS PAGE and analysed by western blot with anti-PSTAIR antibody against Cdc2 
and TAT1 antibody as a loading control. * indicates p31 that is also recognised by the 
anti-PSTAIR antibody. 
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Figure 6.10: Level of phosphorylation on tyrosine 15 of Cdc2 in native S. pombe 
protein extracts from cdc37 temperature-sensitive mutants incubated at 28 and 36 °C 
over a 3 hour time course. Samples of cells were taken hourly, and native S. pombe 
protein extracts were made and western blot analysis was carried out with anti-
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To investigate further the reduction of Cdc2 activity in cdc37 temperature- sensitive 
mutants, the level of association between Cdc2 and its cyclin partner Cdcl3 was 
assayed. Cdc2 associates with Cdcl3 to promote the onset of mitosis. cdc37 
temperature-sensitive mutants and ED1022 were cultured as previously described 
over a 4 hour time course at 28 and 36 °C. Native protein extracts were made from 
samples taken hourly and IPs with the anti-Cdcl3 6F 10/11 antibody (kind gift from 
Paul Nurse Lab) were carried out to examine the level of Cdc2 association over the 
time course at the restrictive temperature. The level of Cdc2 that precipitated with 
Cdcl3 from the strain ED1022 did not change over the time course at the restrictive 
temperature. The level of Cdc2 associated with Cdcl3 in cdc37 temperature-sensitive 
mutants was seen to decrease over the time course at the restrictive temperature 
(Figure 6.11). Cdc2 activity may be compromised at 36 °C in cdc37 temperature-
sensitive mutants by the inability of Cdc2 and Cdcl3 to sustain a stable complex, 
resulting in a 02 cell cycle arrest. 
6.3.3 	Biochemical interaction between Cdc37 and Cdc2 
To investigate furthet the possibility that Cdc2 is a client of Cdc37, 
immunoprecipitation experiments were carried out to determine whether Cdc2 and 
Cdc37 interact biochemically in S. pombe. IPs with anti-S. pombe Cdc37 antibody 
were carried out on native protein extracts made from the strain ED 1022 and showed 
that Cdc37 precipitated Cdc2 (Figure 6.12A). Interestingly, the anti-PSTAIR antibody 
also recognises the Cdk p31 in S. pombe, which also precipitated with Cdc37 in these 
experiments (Figure 6.12A). The reverse IPs were also carried out using anti-HA 
antibodies with native protein extracts from the strain ED 1576 (gift from Paul Russell 
Lab), which contains a chromosomally tagged Cdc2-HA. IPs with the anti-HA 
antibody for Cdc2-HA were unable to precipitate Cdc37 (Figure 6.1213), this may be 
due to the inability of the HA-antibody to access the epitope tag within the complex. 
Figure 6.11: The interaction between Cdc2 and Cdcl3 in cdc37 temperature-sensitive 
mutants at was analysed. Strains were cultured at 28 °C then split and incubated at 28 
and 36 °C over a 4 hour time course. Whole cell protein extracts were made and 
immunoprecipitation (IP) experiments were carried out with the anti-Cdcl3 6F 10/11 
antibody (from Paul Nurse lab) to determine whether this cyclin was associated with 
Cdc2 with increasing time at the restrictive temperature. 
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Figure 6.12: Immunoprecipitation experiments to detect an interaction biochemically 
between Cdc2 and Cdc37 in native S. pombe protein extracts. A 
Immunoprecipitations with the anti-S. pombe Cdc37 antibody to determine whether 
Cdc2 precipitates with Cdc37 from native protein extracts from the S. pombe strain 
ED1022. B Immunoprecipitations with the anti-HA antibody to determine whether 
Cdc37 precipitates with Cdc2-HA from native protein extracts from the S. pombe 






























A small proportion of total cellular Cdc37 protein forms a high molecular weight 
complex, which was also found to contain the co-chaperone Hsp90. A biochemical 
interaction between the two co-chaperones, Hsp90 and Cdc37, was verified by 
immunoprecipitation from fractions containing the Cdc37 high molecular weight 
complex. The inclusion of molybdate in these experiments may have stabilised the 
interaction between Hsp90 and Cdc37, making it easier to detect, as molybdate 
inhibits the ATPase driven reaction cycle of Hsp90 thus freezing Cdc37 into 
association (Shao et al., 2003). These data indicate that Cdc37 and Hsp90 may 
associate in a high molecular weight complex. The high molecular weight complex is 
—669 kDa which is greater than the predicted size for the combined dimers of Cdc37 
and Hsp90, suggesting that other proteins, possibly co-chaperones or clients proteins 
are present. 
An interaction between Cdc37 and Hsp90 has also been detected genetically, similar 
to data from S. cerevisiae that also showed that CDC37 and HSP90 temperature-
sensitive mutants are synthetically lethal at temperatures permissive for each mutant 
(Kimura et al., 1997). Double mutants in S. pombe of swol and cdc37 temperature-
sensitive genes in S. pombe may be unable to sustain cellular viability at the 
permissive temperature because Cdc37 and Hsp90 carry out important functions 
together, such as forming a tertiary complex with protein kinase clients. Alternatively, 
Hsp90 and Cdc37 may carry out the same or similar essential roles, being able to 
compensate for one another in some instances, shown by the ability of Hsp90 to 
partially rescue the temperature-sensitive mutant cdc37-13. 
However, identification of an interaction between Hsp90 and Cdc37 in S. pombe has 
been problematic. Yeast two-hybrid assay, GST pull-down experiments with 
recombinant Cdc37 and immunoprecipitations from native S. pombe protein extracts 
all failed to detect any interaction between these two co-chaperones. Yeast two-hybrid 
experiments may have been unsuccessful in identifying an interaction between Hsp90 
and Cdc37 because the N- and C- terminal tags may have interfered with the function 
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of Cdc37 and/or Hsp90 preventing any form of interaction between the co-
chaperones. GST pull-down experiments were complicated by the non-specific 
binding affinity of Hsp90-HA. Furthermore, this technique used recombinant Cdc37 
which is in a non-phosphorylated form, and unphosphorylated S. cerevisiae Cdc37 
has be seen to have reduced binding affinity towards Hsp90 (Milison et al., 2004). 
Although phosphorylation mutants of rat and human Cdc37 were still able to interact 
with Hsp90 (Miyata and Nishida, 2004; Shao et al., 2003), possibly because this 
interaction is more stable in animal systems than yeast. Immunoprecipitation 
experiments using native protein were not limited by post-translational modifications 
required by Cdc37, but were problematic due to the non-specific binding of both 
Cdc37 and Hsp90-HA. An interaction between Hsp90 and Cdc37 could not be 
detected using total native protein extracts from S. pombe by IP. However, 
immunoprecipitation with the anti-S. pombe Cdc37 antibody from the Cdc37 high 
molecular weight complex precipitated Hsp90-HA and was the only technique that 
could repeatedly detect an interaction biochemically between Hsp90 and Cdc37. 
In the second part of this work, Cdc2 has been identified as a possible client of Cdc37 
in S. pombe as an interaction was biochemically identified between Cdc37 and Cdc2 
by immunoprecipitation. Further evidence comes from studies with S. pombe cdc37 
temperature-sensitive mutants. Consistent with findings in the S. cerevisiae 
temperature-sensitive mutant cdc37-1 (Gerber et al., 1995), phosphorylation of 
histone Hi by Cdc2 was dramatically reduced in S. pombe cdc37 temperature-
sensitive mutants at the restrictive temperature. These data indicate that the G2 cell 
cycle arrest observed in S. pombe cdc37 temperature-sensitive mutants may have 
resulted from reduced Cdc2 activity. 
Investigations were then carried out to determine the cause for reduced Cdc2 activity 
in S. pombe cdc37 temperature-sensitive mutants at 36 °C. In the S. cerevisiae 
temperature-sensitive mutant cdc37-1, Cdc28 protein levels were reduced and the 
protein was seen to aggregate (Farrell and Morgan, 2000; Gerber et al., 1995). In 
contrast in S. pombe, Cdc2 protein levels remained constant and aggregation of the 
Cdc2 protein did not increase in cdc37 temperature-sensitive mutants at 36 °C. 
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Furthermore, this work has established that Cdc2 was not inactivated at the restrictive 
temperature in S. pombe cdc37 temperature-sensitive mutants by increased 
phosphorylation at tyrosine 15 by Weel. The results presented here indicate that 
reduced Cdc2 activity in cdc37 temperature-sensitive mutants at 36 °C resulted from 
an inability of Cdc2 and Cdcl3 to maintain a stable complex and loss of this complex 
would promote a G2 cell cycle arrest. This has also been observed in the S. cerevisiae 
temperature-sensitive mutant cdc37-1, where mutant Cdc37 showed reduced binding 
of the GI cyclin C1n2 and the mitotic cyclin C1b2 at the restrictive temperature 
(Gerber et al., 1995). Further analysis of this' mutant revealed that Cdc28 was largely 
unphosphorylated at the restrictive temperature (Farrell and Morgan, 2000), 
specifically on threonine 169 (Gerber et al., 1995) which would inhibit cyclin 
association. 
Increased expression of Cdc2 rescued cdc37-13 and cdc374 and partially rescued 
cdc37-681 and cdc37-184 from lethality at the restrictive temperature. These data 
indicate that when Cdc37 is compromised in cdc37 temperature-sensitive mutants at 
36 °C, increasing the level of Cdc2 protein, raising its activity above a threshold level 
can overcome the G2 cell cycle arrest. Among S. cerevisiae temperature-sensitive 
mutants that arrest at Start, cdc37-184 was rescued by overexpression of CDC28 
(Mort-Bontemps-Soret et al., 2002), but cdc37-1 was not (Gerber et al., 1995). It is 
interesting to note that overexpression of Cdc37 did not rescue the S. cerevisiae 
temperature-sensitive mutants cdc28-1 and cdc28-4 temperature-sensitive mutants 
(Mort-Bontemps-Soret et al., 2002). 
In S. pombe cdc37 temperature-sensitive mutants, cells arrest at the non-permissive 
temperature in G2 which correlates with reduced Cdc2 activity. The decrease in Cdc2 
activity is most likely due to an inability to stably complex with the cyclin Cdcl3. 
Cdc37 may be important for promoting the interaction between Cdc2 and Cdcl3 as 
this has been observed with Cdk4 and cyclin D in mammalian systems, where Cdc37 
does not activate the complex but aids its assembly (Lamphere et al., 1997; Stepanova 
et al., 1996). Cdc2 activity was also rapidly reduced in the S. pombe swol 
temperature-sensitive mutant at the restrictive temperature. Previous data show that 
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Cdc37 and Hsp90 interact in a high molecular weight complex, indicating that Cdc37 
and Hsp90 may act on Cdc2 as molecular chaperones forming a tertiary complex. 
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Chapter 7: 
General discussion and conclusions 
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7.0 	General discussion and conclusions 
The aim of this work was to generate cdc37 mutants and to analyse them using 
various experimental techniques to gain a better understanding of the molecular 
chaperone Cdc37 in S. pombe. In order to generate a range of cdc37 mutants, several 
techniques were employed, including site directed mutagenesis, random mutagenic 
PCR and in vitro pentapeptide insertion mutagenesis. A variety of cdc37 mutants 
were created using these techniques: truncation mutants, in-frame insertions of five 
amino acids mutants, point mutations and temperature-sensitive mutants. By 
generating a range of cdc37 mutants, a variety of different investigations could be 
undertaken to study the cellular role of Cdc37, protein-protein interactions and to 
identify essential domains and residues of the Cdc37 protein. 
Truncation mutants were created by introducing stop codons throughout the cdc37 
gene by random and directed mutagenesis. These mutants were expressed from 
pREP81 in a cdc37A strain by plasmid shuffle assay with the aim of identifying the 
essential domains of Cdc37. The predicted domains for S. pombe Cdc37 were 
determined by alignment and mapping of the domains identified in the human Cdc37 
protein by limited proteolysis and peptide analysis (Shao et al., 2003) as shown in 
Chapter 3. Expression of the cdc37 truncation mutants from pREP8 1 revealed that the 
C-terminal domain is completely dispensable for function, consistent with findings for 
Cdc37 in S. cerevisiae (Lee et al., 2002). In S. cerevisiae, mutants lacking most of the 
middle and all of the C-terminal domain were only able to support growth in a 
temperature dependent manner when overexpressed in a cdc37E (Lee et al., 2002). 
The equivalent cdc37 truncation mutants in S. pombe were able to support a low level 
of growth at all temperatures with expression from pREP81, and successfully 
sustained growth and produced cells that were wildtype in appearance with 
overexpression from pREP 1. The protein levels of these truncation mutants expressed 
from pREP81 were reduced compared to endogenous Cdc37, but with overexpression 
from pREP1, protein levels were dramatically greater than endogenous Cdc37, as 
determined by western blot with the anti-S. pombe Cdc37 antibody. Therefore, 
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expression of the N-terminal domain of Cdc37 is sufficient to sustain cell viability 
providing the mutant protein levels are above a critical threshold level. 
It is interesting to note that the middle domain of Cdc37 is dispensable, as this region 
contains the predicted Hsp90-binding and homodimerisation domains as identified in 
human Cdc37 (Roe et al., 2004). These data suggest that Hsp90-binding and 
homodimerisation are not required for Cdc37 to carry out its essential functions in S. 
pombe. It is possible that dimerisation of Cdc37 is not crucial for interactions with 
client proteins, that bind the N-terminal domain of Cdc37 (Shao et al., 2003), and that 
a single monomer of the Cdc37 N-terminal domain is sufficient to bind the client 
protein and carry out the required chaperone activity. Therefore, one could speculate 
that Cdc37 does not play an active role in folding or activation of the client protein, 
but instead the N-terminal domain holds the client in an activation/folding' competent 
state for other ATPase chaperones to act on. Evidence for Cdc37 holding clients in an 
activation/folding competent state for other ATPase chaperones has been shown for 
Hdj 1 and Hsp70 (Kimura et al., 1997) and Cdc37 also holds and stabilises clients such 
as Cdk4 to promote binding of their cyclin partner (Lamphere et al., 1997; Stepanova 
et al., 1996). Non-ATPase chaperones holding and transferring client proteins to 
ATPase chaperones has been observed with other pairs of chaperones such the 
Hsp40s and the ATPase Hsp70 chaperones in S. cerevisiae (Lu and Cyr, 1998). 
Although the Hsp90-binding domain is not essential for Cdc37 to sustain cell 
viability, this work has shown that Cdc37 is present in a high molecular weight 
complex in S. pombe which also contains the chaperone Hsp90. Combined with the 
genetic evidence presented here, this strongly suggests that Cdc37 and Hsp90 interact 
directly or indirectly in S. pombe. Cdc37 is believed to deliver client proteins to the 
ATPase chaperone Hsp90 (MacLean and Picard, 2003), which then actively folds 
and/or activates the client. Although an interaction between Cdc37 and Hsp90 occurs 
in S. pombe, this association does not appear to be essential. Alternatively, when 
cdc37 C-terminally truncated constructs are overexpressed, their high abundance 
means that they may encounter chaperones such as Hsp90 by chance and do not 
require the binding domain for the interaction. However, Cdc37 interactions are 
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thought to be unstable, especially in. yeast systems (Farrell and Morgan, 2000) and 
interactions between Cdc37 and Hsp90 where Cdc37 lacks the Hsp90-binding domain 
may be extremely unstable and inefficient at transfer of the client protein. 
Alternatively, the essential function of the N-terminal domain of Cdc37 may involve 
interactions with chaperones other than Hsp90. Cdc37 also interacts with other 
chaperones such as Hop/Stil (Abbas-Terki et al., 2002), Hsp70 and Hdj 1 (Kimura et 
al., 1997), and associations with these chaperones may be able to compensate for the 
inability of Cdc37 truncation mutants lacking the Hsp90-binding domain to interact 
with Hsp90. The binding domains of Cdc37 co-chaperones such as Stil/Hop and 
Hsp70 have not been determined and it is possible that their binding regions are 
located within the N-terminal domain of Cdc37. The relationship between Cdc37 and 
chaperones other than Hsp90 is an interesting area for future investigations. 
The essential N-terminal domain of Cdc37 in S. pombe is the region that interacts 
with client proteins (Shao et al., 2003), and these associations with rat Cdc37 are 
dependent on phosphorylation on serine 13 by casein kinase II (CKII) (Miyata and 
Nishida, 2004). Serine 14 and 17 in S. cerevisiae (Bandhakavi et al., 2003), and serine 
13 in rat (Miyata and Nishida, 2004) and human (Shao et al., 2003), which are 
equivalent to S. cerevisiae serine 14, are phosphorylated by CKJI. Mutational analysis 
of serine 14 in S. pombe Cdc37, equivalent to serine 13 in rat and human and serine 
14 in S. cerevisiae, identified this amino acid as important for Cdc37 function. 
Mutation of S. pombe Cdc37 serine 14 to glutamic acid (cdc37414E) to mimic a 
phosphoserine was able to support growth in the plasmid shuffle assay when 
expressed from pREP81, whereas cdc37414A and cdc37414L were not. Although 
glutamic acid was not a complete substitute for a phosphoserine, as cells expressing 
this mutant allele were morphologically aberrant, even when overexpressed from 
pREP 1. 
Interestingly, overexpression of cdc37-S14L produced a temperature-sensitive 
phenotype and overexpression of cdc37414A supported growth at all temperatures 
and cells were wildtype in appearance. Therefore, mutations of serine 14 to alanine 
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and leucine do not completely abolish Cdc37 function, but appear to reduce it below a 
critical threshold as protein levels were not affected. Increasing the level of mutant 
Cdc37 protein by expression from pREP1 increases the overall level of Cdc37 activity 
in the cell above a critical threshold that can sustain cell viability. These mutations 
may negatively affect Cdc37 function by altering the conformation and proper folding 
of the molecular chaperone as the substituted amino acids are of a different size and 
structure to the serine residue. Alternatively, it is possible that phosphorylation does 
occur at serine 14 but that it is not essential, though important, for Cdc37 activation in 
S. pombe. Unfortunately development of a system by which to determine the 
phosphorylation status of Cdc37 was not successful and other avenues of 
investigation should be considered for the future. For example the phosphorylation 
status of Cdc37 could be assayed using mass spectrometry or 2-D gels. Furthermore, 
it would be interesting to investigate further the role of phosphorylation at serine 14 in 
S. pombe for interactions with client proteins and co-chaperones. 
In order to analyse the cellular role of Cdc37 in S. pombe, cdc37 temperature-
sensitive mutants were generated by both random and directed mutagenesis. Three 
cdc37 temperature-sensitive mutants were generated in this work and a fourth cdc37-
681 (Tatebe and Shiozaki, 2003) was analysed in parallel. It is interesting to note that 
all the mutations identified in these temperature-sensitive mutants were located in 
close proximity. By alignment with the human Cdc37 protein these mutations are 
found around the Hsp90-binding and homodimerisation domain in the middle domain, 
in the large 6-helix bundle (Roe et al., 1999). It is possible that temperature-sensitive 
mutants of cdc37 in S. pombe may only be generated by mutations in this region. 
These mutations may produce temperature-sensitive mutants by negatively affecting 
proper folding and conformation of the 6-helix bundle of Cdc37 which dramatically 
reduces the essential activity of this molecular chaperone in a temperature dependent 
manner. 
At the restrictive temperature the majority of cells for all four cdc37 temperature- 
sensitive mutants displayed an elongated phenotype, characteristic of the cdc 
phenotype. All four cdc37 temperature-sensitive mutants were found to arrest the cell 
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cycle in G2 with a single nucleus. Interestingly, a proportion of cdc37-184 cells were 
seen to contain an unreplicated DNA content after 2 hours at the restrictive 
temperature, but all arrested with a replicated DNA content after 4 hours. These cells 
may undergo a delay in GI due to defects caused by loss of Cdc37 function, and then 
finally arrest the cell cycle in G2, consistent with the other three cdc37 temperature-
sensitive mutants. 
All four cdc37 temperature-sensitive mutants arrest with a phenotype that has also 
been observed with loss of Cdc2 activity which resulted in elongated S. pombe cells 
that arrest at the G2IM boundary with an undivided nucleus (Snell and Nurse, 1994). 
Cdc2 is the cyclin-dependent kinase (Cdk) in S. pombe that regulates the cell cycle 
transitions between GuS phase and G2/mitosis (Nurse, 1997). For cells to enter 
mitosis, Cdc2 must be associated with the cyclin Cdcl3 (Booher et al., 1989) and 
phosphorylated on threonine 167 (Gould et al., 1991) by Cdk-activating kinases 
(CAKs) (Lee et al., 1999). Cdc2 is then activated by dephosphorylation on tyrosine 15 
by Cdc25 (Nurse, 1997). In this work, Cdc2 activity was dramatically reduced at the 
restrictive temperature in cdc37 temperature-sensitive mutants. Increased expression 
of Cdc2 in these temperature-sensitive mutants fully rescued cdc37-13 and cdc37-J, 
and partially rescued cdc37-184 and cdc37-681. These data indicate that that loss of 
Cdc2 activity may be the principal cause for the cell cycle arrest and suggest that 
Cdc2 could be a client of Cdc37 in S. pombe. One explanation is that Cdc37 function 
may be reduced in cdc37 temperature-sensitive mutants below a critical threshold 
level, but not abolished, so that elevating the cellular level of Cdc2 increases the 
chances of Cdc37 carrying out its required chaperone activity on Cdc2. Differences in 
the ability of Cdc2 to rescue the cdc37 temperature-sensitive mutants may arise from 
the different types of mutations that affect Cdc37 at varying levels of severity. 
Investigations into the cause of reduced Cdc2 activity in cdc37 temperature-sensitive 
mutants determined that interactions between Cdc2 and Cdc 13 were dramatically 
reduced at the restrictive temperature. This may be an indirect consequence of loss of 
Cdc37 function in these temperature-sensitive mutants or Cdc2 may be a client of 
Cdc37 that relies on this molecular chaperone to promote its activation by aiding in 
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the complex assembly with the Cdcl3 cyclin. Cdc37 has been seen to promote the 
assembly of Cdk-cyclin complexes in other systems, such as Cdk4 and its cyclin 
partners (Lamphere et al., 1997; Stepanova et al., 1996). Similar observations have 
been observed in the S. cerevisiae temperature-sensitive mutant cdc37-1, where 
Cdc28, the S. cerevisiae homologue of Cdc2, failed to bind the cyclin partner at the 
restrictive temperature and was found to be largely unphosphorylated on Threonine 
169 (Farrell and Morgan, 2000; Gerber et al., 1995). However, in contrast to the 
findings in S. pombe, the Cdc28 protein in S. cerevisiae cdc37-1 was present at 
reduced levels and was found to aggregate into insoluble complexes (Farrell and 
Morgan, 2000; Gerber et al., 1995). Further investigations should be carried out to 
gain a better understanding of the inability of Cdcl3 and Cdc2 to interact in these 
mutants and to examine phosphorylation on threonine 167 ; equivalent to S. cerevisiae 
threonine 169, which can be analysed by 2D gel (Gould et al., 1991). In the S. 
cerevisiae temperature-sensitive mutant cdc37-1 at the restrictive temperature, the 
CAK Caki that phosphorylates threonine 169 was present at reduced protein levels 
and displayed decreased activity (Farrell and Morgan, 2000). This may be a direct or 
indirect consequence of reduced Cdc37 function in S. cerevisiae temperature-sensitive 
mutants, but may be an interesting avenue for investigation in the S. pombe cdc37 
mutants generated in this work. 
Evidence supporting the idea of Cdc2 as a client of Cdc37 comes from the 
identification of both biochemical and genetical interactions between them. Cdc2 co-
immunoprecipitates with Cdc37 and mutants containing temperature-sensitive mutant 
alleles for both Cdc2 and Cdc37 are synthetically lethal. Cdc2 may rely on Cdc37 for 
folding, activating or promoting its association with Cdcl3, independently of Cdc2 
interactions with Hsp90, or Cdc37 may deliver the Cdk to a co-chaperone such as 
Hsp90 for these activities to be carried out. Interactions between Hsp90 and Cdc2 
have also been identified both biochemically by co-immunoprecipitation (A. Santino, 
personal communication) and genetically in S. pombe (Munoz and Jimenez, 1999). 
Furthermore, this work has shown that Cdc2 activity is dramatically reduced in the S. 
pombe Hsp90 temperature-sensitive mutant swol-26 at the restrictive temperature, 
indicating that Hsp90 may play a role in maintaining the activity of Cdc2. However, 
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Cdc2 activity was not affected in the S. pombe mutant cdc2-33 in combination with 
swo1 or the mutant swol-wi, but samples were only examined at the permissive 
temperature (Munoz and Jimenez, 1999). A future direction for further experiments 
would be to investigate further the relationships between Hsp90, Cdc37 and Cdc2. 
In conclusion the N-terminal domain of Cdc37 in S. pombe is essential for Cdc37 
function to sustain cell viability. These mutants lack the postulated Hsp90-binding 
and homodimerisation domains indicating that these interactions are not essential for 
Cdc37 function. However, a small proportion of Cdc37 in S. pombe is present in high 
molecular weight complexes that were also found to contain Hsp90, indicating that 
these two co-chaperones do interact, though possibly in a non-essential manner. This 
work proposes that Cdc37 holds client proteins in an activation/folding competent 
state for other ATPase co-chaperones to act on or to enable clients to interact with 
partner proteins. A likely client of Cdc37 in S. pombe that has been identified in this 
work is Cdc2, which is an exciting finding as the only other client identified in S. 
pombe to date is the kinase Spcl (Tatebe and Shiozaki, 2003). In cdc37 temperature-
sensitive mutants at the restrictive temperature, Cdc2 activity was dramatically 
reduced possibly because the complex between Cdc13 and Cdc2 breaks down. The 
reduction of this Cdk-cyclin complex from cdc37 temperature-sensitive mutants at the 
restrictive is a possible cause for the G2 cell cycle arrest observed in all four mutants. 
These data indicate that Cdc37 or its association with a co-chaperone such as Hsp90 






Abbas-Terki, T., Briand, P. A., Donze, 0., and Picard, D. (2002). The Hsp90 Co. 
chaperones Cdc37 and Stil interact physically and genetically. Biol Chem 383, 1335- 
1342. 
Abbas-Terki, T., Donze, 0., and Picard, D. (2000). The molecular chaperone Cdc37 is 
required for Stel 1 function and pheromone-induced cell cycle arrest. FEBS Lett 467, 
111-116. 
Alberti, S., Bohse, K., Arndt, V., Schmitz, A., and Hohfeld, J. (2004). The 
cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation 
of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 15, 4003- 
4010. 
Alberts, B., Johnson, A., Lewis, J. R., M, Roberts, K., and Walter, P. (2002). Molecular 
Biology of the Cell. 4th Edition. 
Alfa, C. E., Booher, R., Beach, D., and Hyams, J. S. (1989). Fission yeast cyclin: 
subcellular localisation and cell cycle regulation. J Cell Sci Suppl 12, 9-19. 
Alfa, C. E., Gallagher, I. M.,and Hyams, J. S. (1993). Antigen localization in fission 
yeast. Methods Cell Biol 37, 201-222. 
Aligue, R., Akhavan-Niak, H., and Russell, P. (1994). A role for Hsp90 in cell cycle 
control: Weel tyrosine kinase activity requires interaction with Hsp90. Embo J 13, 
6099-6106. 
Bahler, J., Wu, J. Q., Longtine, M. S., Shah, N. G., McKenzie, A., 3rd, Steever, A. B., 
Wach, A., Philippsen, P., and Pringle, J. R. (1998). Heterologous modules for 
efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. 
Yeast 14,943-95 1. 
Bandhakavi, S., McCann, R. 0., Hanna, D. E., and Glover, C. V. (2003). Genetic 
interactions among ZDS1,2, CDC37, and protein kinase CK2 in Saccharomyces 
cerevisiae. FEBS Lett 554, 295-300. 
Bandhakavi, S., McCann, R. 0., Hanna, D. E., and Glover, C. V. (2003). A positive 
feedback loop between protein kinase CKII and Cdc37 promotes the activity of 
multiple protein kinases. J Biol Chem 278, 2829-2836. 
Barral, J. M., Broadley, S. A., Schaffar, G., and Hard, F. U. (2004). Roles of 
molecular chaperones in protein misfolding diseases. Semin Cell Dev Biol 15, 17-29. 
Basi, G., Schmid, E., and Maundrell, K. (1993). TATA box mutations in the 
Schizosaccharomyces pombe nmtl promoter affect transcription efficiency but not the 
transcription start point or thiamine repressibility. Gene 123, 131-136. 
Bonatti, S., Simili, M., and Abbondandolo, A. (1972). Isolation of temperature- 
sensitive mutants of Schizosaccharomyces pombe. J Bacteriol 109, 484-491. 
Booher, R., and Beach, D. (1988). Involvement of cdcl3+ in mitotic control in 
Schizosaccharomyces pombe: possible interaction of the gene product with 
microtubules. Embo J 7, 2321-2327. 
Booher, R. N., Alfa, C. E., Hyams, J. S., and Beach, D. H. (1989). The fission yeast 
cdc2/cdcl3/suc 1 protein kinase: regulation of catalytic activity and nuclear 
localization. Cell 58, 485-497. 
226 
Borkovich, K. A., Farrelly, F. W., Finkelstein, D. B., Taulien, J., and Lindquist, S. 
(1989). hsp82 is an essential protein that is required in higher concentrations for 
growth of cells at higher temperatures. Mo! Cell Bio! 9, 3919-3930. 
Boudeau, J., Deak, M., Lawlor, M. A., Morrice, N. A., and Alessi, D. R. (2003). Heat-
shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem J 
370, 849-857. 
Cadwell, R. C., and Joyce, G. F. (1992). Randomization of genes by PCR 
mutagenesis. PCR Methods App! 2, 28-33. 
Carrello, A., Allan, R. K., Morgan, S. L., Owen, B. A., Mok, D., Ward, B. K., 
Minchin, R. F., Toft, D. 0., and Ratajczak, T. (2004). Interaction of the Hsp90 
cochaperone cyclophilin 40 with Hsc70. Cell Stress Chaperones 9, 167-181. 
Casas, S., 011ila, J., Aventin, A., Vihinen, M., Sierra, J., and Knuutila, S. (2003). 
Changes in apoptosis-related pathways in acute myelocytic leukemia. Cancer Genet 
Cytogenet 146, 89-101. 
Chang, F., Woo!!ard, A., and Nurse, P. (1996). Isolation and characterization of 
fission yeast mutants defective in the assembly and placement of the contractile actin 
ring. J Cell Sci 109 (Pt 1), 131-142. 
Chen, G., Cao, P., and Goeddel, D. V. (2002). TNF-induced recruitment and 
activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9, 401-4 10. 
Chen, S., Prapapanich, V., Rimerman, R. A., Honore, B., and Smith, D. F. (1996). 
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock 
proteins hsp90 and hsp70. Mo! Endocrinol 10, 682-693. 
Chemoff, Y. 0., Lindquist, S. L., Ono, B., Inge-Vechtomov, S. G., and Liebman, S. 
W. (1995). Role of the chaperone protein Hsp 104 in propagation of the yeast prion-
like factor [psi+]. Science 268, 880-884. 
Cooper, G. M. (2000). The Cell - A Molecular Approach. 2nd Edition. 
Cyr, D. M. (1995). Cooperation of the molecular chaperone Ydji with specific Hsp70 
homologs to suppress protein aggregation. FEBS Lett 359, 129-132. 
Dai, K., Kobayashi, R., and Beach, D. (1996). Physical interaction of mammalian 
CDC37 with CDK4. J Biol Chem 271, 22030-22034. 
Demand, J., Albrti, S., Patterson, C., and Hohfeld, J. (2001). Cooperation of a 
ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome 
coupling. Curr Biol 11, 1569-1577. 
Dey, B., Lightbody, J. J., and Boschel!i, F. (1996). CDC37 is required for p60v-src 
activity in yeast. Mol Biol Cell 7, 1405-1417. 
Dobson, C. M. (2004). Principles of protein folding, misfolding and aggregation. 
Semin Cell Dev Biol 15, 3-16. 
Donze, 0., and Picard, D. (1999). Hsp90 binds and regulates Gcn2, the ligand-
inducible kinase of the alpha subunit of eukaryotic translation initiation factor 2 
[corrected]. Mo! Cell Biol 19, 8422-8432. 
Fan, C. Y., Lee, S., Ren, H. Y., and Cyr, D. M. (2004). Exchangeable chaperone 
modules contribute to specification of type I and type II Hsp40 cellular function. Mo! 
Biol Cell 15, 761-773. 
Farrell, A., and Morgan, D. 0. (2000). Cdc37 promotes the stability of protein kinases 
Cdc28 and Caki. Mo! Cell Biol 20, 749-754. 
Finkelstein, D. B., and Strausberg, S. (1983). Identification and expression of a cloned 
yeast heat shock gene. J Biol Chem 258, 1908-1913. 
227 
Finkelstein, D. B., Strausberg, S., and McAlister, L. (1982). Alterations of 
transcription during heat shock of Saccharomyces cerevisiae. J Biol Chem 257, 8405- 
8411. 
Hiss, A. E., Fang, Y., Boschelli, F., and Caplan, A. J. (1997). Differential in vivo 
regulation of steroid hormone receptor activation by Cdc37p. Mol Biol Cell 8, 2501- 
2509. 
Forsburg, S. L. (1994). Codon usage table for Schizosaccharomyces pombe. Yeast 10, 
1045-1047. 
Fromant, M., Blanquet, S., and Plateau, P. (1995). Direct random mutagenesis of 
genesized DNA fragments using polymerase chain reaction. Anal Biochem 224, 347- 
353. 
Gao, Y., Thomas, J. 0., Chow, R. L., Lee, G. H., and Cowan, N. J. (1992). A 
cytoplasmic chaperonin that catalyzes beta-actin folding. Cell 69, 1043-1050. 
Gerber, M. R., Farrell, A., Deshaies,R. J., Herskowitz, I., and Morgan, D. 0. (1995). 
Cdc37 is required for association of the protein kinase Cdc28 with Gi and mitotic 
cyclins. Proc Nati Acad Sci U S A 92, 4651-4655. 
Gietz, D., St Jean, A., Woods, R. A., and Schiestl, R. H. (1992). Improved method for 
high efficiency transformation of intact yeast cells. Nucleic Acids Res 20, 1425. 
Gould, K. L., Moreno, S., Owen, D. J., Sazer, S., and Nurse, P. (1991). 
Phosphorylation at Thr 167 is required for Schizosaccharomyces pombe p34cdc2 
function. Embo J 10, 3297-3309. 
Gould, K. L., and Nurse, P. (1989). Tyrosine phosphorylation of the fission yeast 
cdc2+ protein kinase regulates entry into mitosis. Nature 342, 39-45. 
Grammatikakis, N., Grammatikakis, A., Yoneda, M., Yu, Q., Banerjee, S. D., and 
Toole, B. P. (1995). A novel glycosaminoglycan-binding protein is the vertebrate 
homologue of the cell cycle control protein, Cdc37. J Biol Chem 270, 16198-16205. 
Grammatikakis, N., Lin, J. H., Grammatikakis, A., Tsichlis, P. N., and Cochran, B. H. 
(1999). p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mo! 
Cell Biol 19, 1661-1672. 
Grimm, C., Kohli, J., Murray, J., and Maundrell, K. (1988). Genetic engineering of 
Schizosaccharomyces pombe: a system for gene disruption and replacement using the 
ura4 gene as a selectable marker. Mol Gen Genet 215, 81-86. 
Hagan, I., Hayles, J., and Nurse, P. (1988). Cloning and sequencing of the cyclin-
related cdc13+ gene and a cytological study of its role in fission yeast mitosis. J Cell 
Sci 91 (Pt 4), 587-595. 
Hartson, S. D., Irwin, A. D., Shao, J., Scroggins, B. T., Volk, L., Huang, W., and 
Matts, R. L. (2000). p50(cdc37) is a nonexclusive Hsp90 cohort which participates 
intimately in Hsp90-mediated folding of immature kinase molecules. Biochemistry 
39, 7631-7644. 
Hartwell, L. H. (1974). Saccharomyces cerevisiae cell cycle. Bacteriol Rev 38, 164- 
198. 
Heikkila, J. J. (2004). Regulation and function of small heat shock protein genes 
during amphibian development. J Cell Biochem 93, 672-680. 
Hesterkamp, T., Hauser, S., Lutcke, H., and Bukau, B. (1996). Escherichia coli trigger 
factor is a prolyl isomerase that associates with nascent polypeptide chains. Proc Nat! 
Acad Sci U S A 93, 4437-4441. 
228 
Horowitz, N. H., and Leupold, U. (1951). Some recent studies bearing on the one 
geneone enzyme hypothesis. Cold Spring Harb Symp Quant Biol 16, 65-74. 
Huang, L., Grammatikakis, N., and Toole, B. P. (1998). Organization of the chick 
CDC37 gene. J Biol Chem 273, 3598-3603. 
Hunter, T., and Sefton, B. M. (1980). Transforming gene product of Rous sarcoma 
virus phosphorylates tyrosine. Proc Nat! Acad Sci U S A 77, 1311-1315. 
Hutchison, K. A., Brott, B. K., De Leon, J. H., Perdew, G. H., Jove, R., and Pratt, W. 
B. (1992). Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a 
cell-free system. J Biol Chem 267, 2902-2908. 
Hutchison, K. A., Stancato, L. F., Jove, R., and Pratt, W. B. (1992). The protein-
protein complex between pp60v-src and hsp90 is stabilized by molybdate, vanadate, 
tungstate, and an endogenous cytosolic metal. J Biol Chem 267, 13952-13957. 
Inoue, H., Nojima, H., and Okayama, H. (1990). High efficiency transformation of 
Escherichia coli with plasmids. Gene 96, 23-28. 
Ish-Horowicz, D., Pinchin, S. M., Gausz, J., Gyurkovics, H., Bencze, G., 
Goldschmidt-Clermont, M., and Holden, J. J. (1979). Deletion mapping of two D. 
melanogaster loci that code for the 70,000 dalton heat-induced protein. Cell 17, 565- 
571. 
Jakob, U., Lilie, H., Meyer, I., and Buchner, J. (1995). Transient interaction of Hsp90 
with early unfolding intermediates of citrate synthase. Implications for heat shock in 
vivo. J Biol Chem 270, 7288-7294. 
Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K., and 
Nukina, N. (2005). Co-chaperone CHIP associates with expanded polyglutamine 
protein and promotes their degradation by proteasomes. J Biol Chem. 
Javerzat, J. P., Cranston, G., and Allshire, R. C. (1996). Fission yeast genes which 
disrupt mitotic chromosome segregation when overexpressed. Nucleic Acids Res 24, 
4676-4683. 
Kimura, Y., Matsumoto, S., and Yahara, I. (1994). Temperature-sensitive mutants of 
hsp82 of the budding yeast Saccharomyces cerevisiae. Mo! Gen Genet 242, 517-527. 
Kimura, Y., Rutherford, S. L., Miyata, Y., Yahara, I., Freeman, B. C., Yue, L., 
Morimoto, R. I., and Lindquist, S. (1997). Cdc37 is a molecular chaperone with 
specific functions in signal transduction. Genes Dev 11, 1775-1785. 
Kleizen, B., and Braakman, I. (2004). Protein folding and quality control in the 
endoplasmic reticulum. Curr Opin Cell Biol 16, 343-349. 
Krapp, A., Gulli, M. P., and Simanis, V. (2004). SIN and the art of splitting the fission 
yeast cell. Cuff Biol 14, R722-730. 
Kuenzel, E. A., Mulligan, J. A., Sommercorn, J., and Krebs, E. G. (1987). Substrate 
specificity determinants for casein kinase II as deduced from studies with synthetic 
peptides. J Biol Chem 262, 9136-9140. 
Kumar, R., Grammatikakis, N., and Chinkers, M. (2001). Regulation of the atrial 
natriuretic peptide receptor by heat shock protein 90 complexes. J Biol Chem 276, 
11371-11375. 
Lamphere, L., Fiore, F., Xu, X., Brizuela, L., Keezer, S., Sardet, C., Draetta, G. F., 
and Gyuris, J. (1997). Interaction between Cdc37 and Cdk4 in human cells. Oncogene 
14, 1999-2004. 
229 
Lange, B. M., Rebollo, E., Herold, A., and Gonzalez, C. (2002). Cdc37 is essential for 
chromosome segregation and cytokinesis in higher eukaryotes. Embo J 21, 5364-
5374. 
Langer, T., Lu, C., Echols, H., Flanagan, J., Hayer, M. K., and Hart!, F. U. (1992). 
Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-
mediated protein folding. Nature 356, 683-689. 
Lecker, S., Lill, R., Ziegelhoffer, T., Georgopoulos, C., Bassford, P. J., Jr., 
Kumamoto, C. A., and Wickner, W. (1989). Three pure chaperone proteins of 
Escherichia coli--SecB, trigger factor and GroEL--form soluble complexes with 
precursor proteins in vitro. Embo J 8, 2703-2709. 
Lecker, S. H., Driessen, A. J., and Wickner, W. (1990). ProOmpA contains secondary 
and tertiary structure prior to translocation and is shielded from aggregation by 
association with SecB protein. Embo J 9, 2309-2314. 
Lee, K. M., Saiz, J. E., Barton, W. A., and Fisher, R. P. (1999). Cdc2 activation in 
fission yeast depends on Mcs6 and Cskl, two partially redundant Cdk-activating 
kinases (CAKs). Curr Biol 9,441-444. 
Lee, M. G., and Nurse, P. (1987). Complementation used to clone a human 
homologue of the fission yeast cell cycle control gene cdc2. Nature 327, 3 1-35. 
Lee, M. S., Enoch, T., and Piwnica-Worms, H. (1994). mikl+ encodes a tyrosine 
kinase that phosphorylates p34cdc2 on tyrosine 15. J Biol Chem 269, 30530-30537. 
Lee, P., Rao, J., Fuss, A., Yang, E., Garrett, S., and Caplan, A. J. (2002). The Cdc37 
protein kinase-binding domain is sufficient for protein kinase activity and cell 
viability. J Cell Biol 159, 1051-1059. 
Lee, P., Shabbir, A., Cardozo, C., and Caplan, A. J. (2004). Stil and Cdc37 can 
stabilize Hsp90 in chaperone complexes with a protein kinase. Mol Biol Cell 15, 
1785-1792. 
Lee, W. L., Bezanilla, M., and Pollard, T. D. (2000). Fission yeast myosin-I, Myolp, 
stimulates actin assembly by Arp2/3 complex and shares functions with WASp. J Cell' 
Biol 151, 789-800. 
Lin-Goerke, J. L., Robbins, D. J., and Burczak, J. D. (1997). PCR-based random 
mutagenesis using manganese and reduced dNTP concentration. Biotechniques 23, 
409-412. 
Litchfield, D. W., Luscher, B., Lozeman, F. J., Eisenman, R. N., and Krebs, E. G. 
(1992). Phosphoryiation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol 
Chem 267, 13943-1395 1. 
Lopez, N., Aron, R., and Craig, E. A. (2003). Specificity of class II Hsp40 Sisi in 
maintenance of yeast prion [RNQ+]. Moi Biol Cell 14, 1172-1181. 
Lu, Z., and Cyr, D. M. (1998). Protein folding activity of Hsp70 is modified 
differentially by the hsp40 co-chaperones Sisi and Ydji. J Biol Chem 273, 27824-
27830. 
MacLean, M., and Picard, D. (2003). Cdc37 goes beyond Hsp90 and kinases. Cell 
Stress Chaperones 8, 114-119. 
MacNeil!, S. A., and Fantes, P. A. (1993). Controlling entry into Mitosis in Fission 
yeast. Frontiers in Molecular Biology: The Cell Cycle IRL Press. 
Mahony, D., Parry, D. A., and Lees, E. (1998). Active cdk6 complexes are 
predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 
16, 603-611. 
230 
Maier, R., Scholz, C., and Schmid, F. X. (2001). Dynamic association of trigger factor 
with protein substrates. J Mo! Biol 314, 1181-1190. 
Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A. L., and Hart!, F. U. 
(1991). Chaperonin-mediated protein folding at the surface of groEL through a 
'molten globule'-like intermediate. Nature 352, 36-42. 
Martin, J., Mayhew, M., Langer, T., and Hard, F. U. (1993). The reaction cycle of 
GroEL and GroES in chaperonin-assisted protein folding. Nature 366, 228-233. 
Matsuda, S., Suzuki-Fujimoto, T., Minowa, A., Ueno, H., Katamura, K., and Koyasu, 
S. (1999). Temperature-sensitive ZAP70 mutants degrading through a proteasome-
independent pathway. Restoration of a kinase domain mutant by Cdc37. 3 Biol Chem 
274, 34515-34518. 
Maundrell, K. (1990). nmtl of fission yeast. A highly transcribed gene completely 
repressed by thiamine. J Biol Chem 265, 10857-10864. 
Maundrell, K. (1993). Thiamine-repressible expression vectors pREP and pRIP for 
fission yeast. Gene 123, 127-130. 
McLaughlin, S. H., Ventouras, L. A., Lobbezoo, B., and Jackson, S. E. (2004). 
Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform. 
J Mo! Biol 344, 813-826. 
Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., and Cyr, D. M. (2001). 
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. 
Nat Cell Biol 3, 100-105. 
Mendenhall, M. D., and Hodge, A. E. (1998). Regulation of Cdc28 cyclin-dependent 
protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae. 
Microbiol Mol Biol Rev 62, 1191-1243. 
Millson, S. H., Truman, A. W., and Piper, P. W. (2003). Vectors for N- or C-terminal 
positioning of the yeast Gal4p DNA binding or activator domains. Biotechniques 35, 
60-64. 
Millson, S. H., Truman, A. W., Wolfram, F., King, V., Panaretou, B., Prodromou, C., 
Pearl, L. H., and Piper, P. W. (2004). Investigating the protein-protein interactions of 
the yeast Hsp90 chaperone system by two-hybrid analysis: potential uses and 
limitations of this approach. Cell Stress Chaperones 9, 359-368. 
Mitchison, J. M. (1957). The growth of single cells. I. Schizosaccharomyces pombe. 
Exp Cell Res 13, 244-262. 
Mitchison, J. M. (1990). The fission yeast, Schizosaccharomyces pombe. Bioessays 
12, 189-191. 
Miyata, Y., and Nishida, E. (2004). CK2 controls multiple protein kinases by 
phosphorylating a kinase-targeting molecular chaperone, Cdc37. Mol Cell Biol 24, 
4065-4074. 
Mort-Bontemps-Soret, M., Facca, C., and Faye, G. (2002). Physical interaction of 
Cdc28 with Cdc37 in Saccharomyces cerevisiae. Mo! Genet Genomics 267, 447-458. 
Moser, B. A., and Russell, P. (2000). Cell cycle regulation in Schizosaccharomyces 
pombe. Curr Opin Microbiol 3, 631-636. 
Munoz, M. J., and Jimenez, J. (1999). Genetic interactions between Hsp90 and the 
Cdc2 mitotic machinery in the fission yeast Schizosaccharomyces pombe. Mol Gen 
Genet 261, 242-250. 
231 
Nguyen, T. H., Law, D. T., and Williams, D. B. (1991). Binding protein BiP is 
required for translocation of secretory proteins into the endoplasmic reticulum in 
Saccharomyces cerevisiae. Proc Nat! Acad Sci U S A 88, 1565-1569. 
Ni, J., Gao, Y., Liu, H., and Chen, J. (2004). Candida albicans Cdc37 interacts with 
the Crkl kinase and is required for Crkl production. FEBS Lett 561, 223-230. 
Nurse, P. (1997). Regulation of the eukaryotic cell cycle. Eur J Cancer 33, 1002-1004. 
Nurse, P., Thuriaux, P., and Nasmyth, K. (1976). Genetic control of the cell division 
cycle in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet 146, 167-178. 
O'Keeffe, B., Fong, Y., Chen, D., Zhou, S., and Zhou, Q. (2000). Requirement for a 
kinase-specific chaperone pathway in the production of a Cdk9/cyclin Ti heterodimer 
responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 
275, 279-287. 
Obermann, W. M., Sondermann, H., Russo, A. A., Pavietich, N. P., and Hard, F. U. 
(1998). In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. 
J Cell Biol 143, 901-910. 
Pain, R. (2000). Mechanisms of Protein Folding. Oxford University Press. 
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., 
and Pearl, L. H. (1998). ATP binding and hydrolysis are essential to the function of 
the Hsp90 molecular chaperone in vivo. Embo J 17, 4829-4836. 
Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J. K., Singh, S., 
Millson, S. H., Clarke, P. A., Naaby-Hansen, S., Stein, R., et al. (2002). Activation of 
the ATPase activity of hsp90 by the stress-regulated cochaperone ahal. Mol Cell 10, 
1307-1318. 
Pardee, A. B. (1974). A restriction point for control of normal animal cell 
proliferation. Proc Nat! Acad Sci U S A 71, 1286-1290. 
Parsell, D. A., Kowal, A. S., Singer, M. A., and Lindquist, S. (1994). Protein 
disaggregation mediated by heat-shock protein Hsp104. Nature 372, 475-478. 
Peng, H. M., Morishima, Y., Jenkins, G. J., Dunbar, A. Y., Lau, M., Patterson, C., 
Pratt, W. B., and Osawa, Y. (2004). Ubiquitylation of neuronal nitric-oxide synthase 
by CHIP, a chaperone-dependent E3 ligase. J Biol Chem 279, 52970-52977. 
Perdew, G. H., Wiegand, H., Vanden Heuvel, J. P., Mitchell, C., and Singh, S. S. 
(1997). A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is 
a mammalian homolog of the cell cycle control protein cdc37. Biochemistry 36, 3600- 
3607. 
Picard, D. (2002). Heat-shock protein 90, a chaperone for folding and regulation. Cell 
Mol Life Sci 59, 1640-1648. 
Pollard, T., and Earnshaw, W. (2002). Cell Biology. Saunders Publishing, Elsevier 
Science. 
Prince, T., and Matts, R. L. (2004). Definition of protein kinase sequence motifs that 
trigger high affinity binding of Hsp90 and Cdc37. J Biol Chem 279, 39975-3998 1. 
Rao, J., Lee, P., Benzeno, S., Cardozo, C., Albertus, J., Robins, D. M., and Caplan, A. 
J. (2001). Functional interaction of human Cdc37 with the androgen receptor but not 
with the glucocorticoid receptor. J Biol Chem 276, 58 14-5 820.  
Reed, S. I. (1980). The selection of amber mutations in genes required for completion 
of start, the controlling event of the cell division cycle of S. cerevisiae. Genetics 95, 
579-588. 
232 
Reed, S. I. (1980). The selection of S. cerevisiae mutants defective in the start event 
of cell division. Genetics 95, 561-577. 
Roe, S. M., Au, M. M., Meyer, P., Vaughan, C. K., Panaretou, B., Piper, P. W., 
Prodromou, C., and Pearl, L. H. (2004). The Mechanism of Hsp90 regulation by the 
protein kinase-specific cochaperone p50(cdc37). Cell 116, 87-98. 
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. 
(1999). Structural basis for inhibition of the Hsp90 molecular chaperone by the 
antitumor antibiotics radicicol and geldanamycin. J Med Chem 42, 260-266. 
Rustici, G., Mata, J., Kivinen, K., Lio, P., Penkett, C. J., Burns, G., Hayles, J., 
Brazma, A., Nurse, P., and Bahler, J. (2004). Periodic gene expression program of the 
fission yeast cell cycle. Nat Genet 36, 809-817. 
Samejima, I., Mackie, S., and Fantes, P. A. (1997). Multiple modes of activation of 
the stress-responsive MAP kinase pathway in fission yeast. Embo J 16, 6162-6170. 
Sazer, S., and Sherwood, S. W. (1990). Mitochondrial growth and DNA synthesis 
occur in the absence of nuclear DNA replication in fission yeast. J Cell Sci 97 (Pt 3), 
509-5 16. 
Scheibel, T., Bloom, J., and Lindquist, S. L. (2004). The elongation of yeast prion 
fibers involves separable steps of association and conversion. Proc Natl Acad Sci U S 
A 101, 2287-2292. 
Scholz, G., Hartson, S. D., Cartledge, K., Hall, N., Shao, J., Dunn, A. R., and Matts, 
R. L. (2000). p50(Cdc37) can buffer the temperature-sensitive properties of a mutant 
of Hck. Mol Cell Biol 20, 6984-6995. 
Scholz, G. M., Cartledge, K., and Hall, N. E. (2001). Identification and 
characterization of Harc, a novel Hsp90-associating relative of Cdc37. J Biol Chem 
276, 30971-30979. 
Schutz, A. R., Giddings, T. H., Jr., Steiner, E., and Winey, M. (1997). The yeast 
CDC37 gene interacts with MPS 1 and is required for proper execution of spindle pole 
body duplication. J Cell Biol 136, 969-982. 
Schwarze, S. R., Fu, V. X., and Jarrard, D. F. (2003). Cdc37 enhances proliferation 
and is necessary for normal human prostate epithelial cell survival. Cancer Res 63, 
4614-4619. 
Scroggins, B. T., Prince, T., Shao, J., Uma, S., Huang, W., Guo, Y., Yuri, B. G., 
Hedman, K., Matts, R. L., and Hartson, S. D. (2003). High affinity binding of Hsp90 
is triggered by multiple discrete segments of its kinase clients. Biochemistry 42, 
12550-12561. 
Shao, J., Grammatikakis, N., Scroggins, B. T., Uma, S., Huang, W., Chen, J. J., 
Hartson, S. D., and Matts, R. L. (2001). Hsp90 regulates p50(cdc37) function during 
the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase. J 
Biol Chem 276, 206-214. 
Shao, J., Irwin, A., Hartson, S. D., and Matts, R. L. (2003). Functional dissection of 
cdc37: characterization of domain structure and amino acid residues critical for 
protein kinase binding. Biochemistry 42, 12577-12588. 
Shao, J., Prince, T., Hartson, S. D., and Matts, R. L. (2003). Phosphorylation of serine 
13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. J Biol Chem 
278, 38117-38120. 
233 
Siligardi, G., Panaretou, B., Meyer, P., Singh, S., Woolfson, D. N., Piper, P. W., 
Pearl, L. H., and Prodromou, C. (2002). Regulation of Hsp90 ATPase activity by the 
co-chaperone Cdc37p/p5Ocdc37. J Biol Chem 277, 20151-20159. 
Silverstein, A. M., Grammatikakis, N., Cochran, B. H., Chinkers, M., and Pratt, W. B. 
(1998). p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on 
hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol 
Chem 273, 20090-20095. 
Snell, V., and Nurse, P. (1994). Genetic analysis of cell morphogenesis in fission 
yeast--a role for casein kinase II in the establishment of polarized growth. Embo J 13, 
2066-2074. 
Songyang, Z., Lu, K. P., Kwon, Y. T., Tsai, L. H., Filhol, 0., Cochet, C., Brickey, D. 
A., Soderling, T. R., Bartleson, C., Graves, D. J., et al. (1996). A structural basis for 
substrate specificities of protein Ser/Thr kinases: primary sequence preference of 
casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, 
CDK5, and Erki. Mol Cell Biol 16, 6486-6493. 
Sorger, P. K., and Pelham, H. R. (1987). The glucose-regulated protein grp94 is 
related to heat shock protein hsp90. J Mol Biol 194, 341-344. 
Stepanova, L., Finegold, M., DeMayo, F., Schmidt, E. V., and Harper, J. W. (2000). 
The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and 
collaborates with both c-myc and cyclin Dl in transformation of multiple tissues. Mol 
Cell Biol 20, 4462-4473. 
Stepanova, L., Leng, X., Parker, S. B., and Harper, J. W. (1996). Mammalian 
p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes 
Cdk4. Genes Dev 10, 1491-1502. 
Stepanova, L., Yang, G., DeMayo, F., Wheeler, T. M., Finegold, M., Thompson, T. 
C., and Harper, J. W. (2000). Induction of human Cdc37 in prostate cancer correlates 
with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. 
Oncogene 19, 2186-2193. 
Streiblova, E., Hasek, J., and Jelke, E. (1984). Septum pattern in ts mutants of 
Schizosaccharomyces pombe defective in genes cdc3, cdc4, cdc8 and cdc12. J Cell 
Sci 69, 47-65. 
Tatebe, H., and Shiozaki, K. (2003). Identification of Cdc37 as a novel regulator of 
the stress-responsive mitogen-activated protein kinase. Mol Cell Biol 23, 5132-5142. 
Tateishi, Y., Kawabe, Y., Chiba, T., Murata, S., Ichikawa, K., Murayama, A., Tanaka, 
K., Baba, T., Kato, S., and Yanagisawa, J. (2004). Ligand-dependent switching of 
ubiquitin-proteasome pathways for estrogen receptor. Embo J 23, 4813-4823. 
Valay, J. G., Simon, M., Dubois, M. F., Bensaude, 0., Facca, C., and Faye, G. (1995). 
The K1EN28 gene is required both for RNA polymerase II mediated transcription and 
phosphorylation of the Rpblp CTD. J Mol Biol 249, 535-544. 
Vogel, J. P., Misra, L. M., and Rose, M. D. (1990). Loss of BiP/0RP78 function 
blocks translocation of secretory proteins in yeast. J Cell Biol 110, 1885-1895. 
Wang, H., Goode, T., lakova, P., Albrecht, J. H., and Timchenko, N. A. (2002). 
CfEBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest. 
Embo J 21, 930-941. 
Wang, X., Grammatikakis, N., and Hu, J. (2002). Role of p50/CDC37 in 
hepadnavirus assembly and replication. J Biol Chem 277, 24361-24367. 
234 
Wartmann, M., and Davis, R. J. (1994). The native structure of the activated Raf 
protein kinase is a membrane-bound multi-subunit complex. •J Biol Chem 269, 6695-
6701. 
Watson, H. A., Cope, M. J., Groen, A. C., Drubin, D. G., and Wendland, B. (2001). In 
vivo role for actin-regulating kinases in endocytosis and yeast epsin phosphorylation. 
Mol Biol Cell 12, 3668-3679. 
Wawrzynow, A., and Zylicz, M. (1995). Divergent effects of ATP on the binding of 
the DnaK and DnaJ chaperones to each other, or to their various native and denatured 
protein substrates. J Biol Chem 270, 19300-19306. 
Wegele, H., Muller, L., and Buchner, J. (2004). Hsp70 and Hsp90--a relay team for 
protein folding. Rev Physiol Biochem Pharmacol 151, 1-44. 
Westwood, P. K., Martin, I. V., and Fantes, P. A. (2004). Fission yeast Cdc37 is 
required for multiple cell cycle functions. Mol Genet Genomics 271, 82-90. 
Xu, Y., Singer, M. A., and Lindquist, S. (1999). Maturation of the tyrosine kinase c-
src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc 
Nati Acad Sci U S A 96,109-114. 
Young, J. C., Agashe, V. R., Siegers, K., and Hart!, F. U. (2004). Pathways of 
chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5, 781-791. 
Zhang, W., Hirshberg, M., McLaughlin, S. H., Lazar, G. A., Grossmann, J. G., 
Nielsen, P. R., Sobott, F., Robinson, C. V., Jackson, S. E., and Laue, E. D. (2004). 
Biochemical and structural studies of the interaction of Cdc37 with Hsp90. J Mol Biol 
340, 891-907. 
Zhao, Q., Boschelli, F., Caplan, A. J., and Arndt, K. T. (2004). Identification of a 
conserved sequence motif that promotes Cdc37 and cyclin Dl binding to Cdk4. J Biol 
Chem 279, 12560-12564. 
Ziemienowicz, A., Skowyra, D., Zeilstra-Ryalls, J., Fayet, 0., Georgopoulos, C., and 
Zylicz, M. (1993). Both the Escherichia coli chaperone systems, GroEL/GroES and 
DnaK/DnaJ/GrpE, can reactivate heat-treated RNA polymerase. Different 
mechanisms for the same activity. J Biol Chem 268, 25425-2543 1. 
235 
